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Abstract
Dystrophia Myotonica Protein Kinase (DMPK) is the defining member of a family of
complex, multidomain kinases of major biomedical relevance. These kinases are
characterized by a highly conserved catalytic domain and a coiled-coil motif (CC)
involved in the regulation of their activity. DMPK has been related to a progressive
neuromuscular disorder known as Myotonic Dystrophy (DM), the most prevalent
muscular dystrophy in adults. DM is a multisystemic disease characterized by
myotonia and progressive skeletal muscle weakness. Affected patients suffer from
DMPK insufficiency due to retention of mRNA transcripts in the nucleus. However, it
is not currently understood how low levels of this kinase affect cellular function and
its involvement in disease remains elusive. The sequestration of the CUG-binding
protein (CUGBP), a putative DMPK substrate by a trinucleotide repeat extension in
the 3’ non-coding region of the DMPK gene has been suggested to play a role in the
disease. DMPK is speculated to be involved in the modulation of the plasma
membrane depolarization and reorganization of the actin cytoskeleton during tissue
development, possibly, acting as a downstream effector of the actin cytoskeleton-
linked GTPase Rac1. In order to gain a better understanding of the complex
mechanism of regulation of this kinase, its oligomeric state and intrasteric regulation
were investigated. Self-assembly is crucial for the regulation of DMPK and related
kinases. Their CC domains are thought to form dimeric arrangements and, thus, to
mediate dimerization in this family of kinases. In addition, a role as intrasteric
regulators has been attributed to these moieties. In the current work, the role of the
CC domain of DMPK in kinase assembly and possible Rac1 docking has been
analyzed using structural, biophysical and biochemical approaches. Contrary to
expectations, the self-assembly of DMPK is not dictated by the association properties
of its CC domain, instead, it appears driven by sequence segments flanking both N-
and C-termini of the catalytic kinase fraction, leading to the formation of head-to-
head dimers. Our findings support a shared pattern of assembly across DMPK,
ROCKs and MRCK members of this family.
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Chapter 1. Introduction
3
1.1 Myotonic Dystrophy
1.1.1 Introduction
Myotonic Dystrophy (DM), also known as dystrophia myotonica or Steinert’s disease,
was first described one century ago (Batten 1909; Steinert 1909). It is the most
common form of muscular dystrophy in adults, with an incidence of 1:8000 (Harper
1989). This is an autosomal dominant neuromuscular disorder characterized by an
extremely variable clinical phenotype. Onset is usually in early adulthood and the life
span of affected individuals is typically six decades. The causative genetic agent for
DM was identified in 1992 as a CTG repeat expansion in chromosome 19q13.3 within
the 3’ untranslated region (UTR) of a gene coding for a Ser/Thr kinase, Dystrophia
Myotonica Protein Kinase (DMPK) (Figure 1.1) (Brook et al. 1992; Fu et al. 1992;
Mahadevan et al. 1992).
Figure 1.1: Schematic representation of the DM locus. The DM locus is strongly conserved between
mouse and man and contains three genes, DMWD, DMPK and SIX5, located closely together in a
gene-dense region. DMWD gene is split over five exons and encodes a WD-repeat protein, DMPK
gene is split over 15 exons and encodes a Ser/Thr protein kinase, and SIX5 gene is split over three
exons and encodes a homeodomain transcription factor. The unstable (CTG)n repeat is located in the 3’
proximal exon (exon 15) of the human DMPK gene.Transcription initiation sites are indicated with
arrows and alternative splice events with curved lines. DMWD and SIX5 are coloured in red, DMPK in
blue and alternative exons are in green (Groenen and Wieringa 1998).
WD-repeat protein Homeo-domainprotein
Ser/Thr kinase coiled-coil
  DMWD                     DMPK                         SIX5
Homeodomain 
transcription factor
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1.1.2 Clinical Features
DM symptoms are characterized by involuntary persistence of muscle contraction
(myotonia) and progressive weakness and wasting of muscle (dystrophy). However,
this is a multisystemic disorder with a consistent constelation of associated
disturbances including cardiac conduction defects1, smooth muscle2 involvement,
mental changes, hypersomnia, ocular cataract3, digestive problems and diabetes
mellitus type 24. Also common are testicular atrophy and premature frontal balding in
men. In several patients, tumors have been also found but a direct link to DM is yet to
be proven (Harper 1989; Brewster 1998).
A congenital form of DM exhibits the most severe phenotype and faces a neonatal
mortality rate of 25 %. Features include severe mental retardation, hypotonia, as well
as facial diplegia5 and compromised respiratory function (Harper 1989).
1.1.3 Myotonic Dystrophy Type 2
In 1995, several reports described families with dominantly inherited multisystemic
disorders that were genetically distinct from the classical DM (DM1) (Ricker et al.
1994). This new form of DM was designated Myotonic Dystrophy Type 2 (DM2) or
Proximal Myotonic Myopathy (PROMM). The manifestations of DM1 and DM2 are
similar. The muscle histopathology in DM2 resembles that seen in DM1. The non-
muscle manifestations of DM1 are also observed in DM2, including cardiac
arrhythmias, frontal balding, insulin resistance, fatigue and cataracts.
1 A cardiac conduction disorder is a dysfunction in the heart's electrical conduction system, which can make the
heart beat too fast, too slow, or at an uneven rate.
2  Smooth muscle is a type of non-striated muscle, found within the "walls" of hollow organs such as blood vessels,
the bladder, the uterus, and the gastrointestinal tract.
3  Cataract is any opacity of the lens or capsule of the eye, causing impairment of vision or blindness.
4  Diabetes mellitus type 2 (formerly called non-insulin-dependent diabetes) is a long-term metabolic disorder that
is primarily characterized by insulin resistance, relative insulin deficiency, and hyperglycemia.
5  Facial diplegia is a paralysis of both sides of the face. DM patients present a characteristic facial diplegia with an
inverted “V” shaped upper lip.
Chapter 1. Introduction
5
Although clinically similar to DM1, DM2 patients tend to experience less severe
symptoms of cognitive impairment, ptosis6, muscle wasting, dysphagia7, and
gastrointestinal or respiratory insufficiency. DM2 symptoms are commonly attributed
to arthritis, fibromyalgia8 and overuse of muscles. Some of the brain manifestations of
DM1, such as hypersomnolence or mental retardation, have not been observed in
DM2 patients. The mutation in patients with DM2, was recently characterized as and
expanded CCTG repeat (Liquori et al. 2001) located in a non-coding region of the
ZNF9 (zinc finger protein 9) gene on chromosome 3q21.3.
1.1.4 Triplet-repeat Disorders
Exactly how the expansions in the DMPK gene result in DM is still uncertain. So far,
there are 14 diseases known to be caused by triplet repeats (Sobczak et al. 2003).
Triplet-repeat disorders are generally classified into two groups, according to the
location of the expansion. In the first group the expanded repeats are exonic, whereas
in the second group the repeats are localized in non-coding sequences. The non-
coding triplet-repeat disorders typically have large and variable repeat expansions that
result in multiple tissue dysfunction or degeneration, and exhibit anticipation
(genetic instability leading to longer tract lengths with each generation, which is
generally accompanied by increasing severity). They include Fragile X syndrome
(FRAXA), Fragile XE syndrome (FRAXE), Friedreich ataxia, spinocerebellar ataxia
SCA8, SCA12 and DM1. Tetranucleotide (CCUG)n repeats involved DM2 occur in
an intron.
6   Ptosis is the paralysis of the muscles of the eyelid. It is commonly called droopy eyelids.
7   Dysphagia is the difficulty in swallowing.
8   Fibromyalgia is a common form of generalized muscular pain and fatigue.
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1.2 Proposed Mechanisms of DM pathogenesis
The mechanism by which CTG expansion leads to disease in DM is not currently
understood. Several pathological models, non-mutually excluding, have been
proposed at the DNA, RNA and protein levels.
1.2.1 Haploinsufficiency of DMPK
Initially, the location of the mutation at the 3’ end of a kinase gene suggested that
alterations in DMPK expression might be the obvious cause of the disease. Most of
the early expression studies were consistent with this hypothesis, indicating that
DMPK mRNA and protein levels were reduced in patient muscle and cell culture (Fu
et al. 1992; Hofmann-Radvanyi et al. 1993; Novelli et al. 1993). However, DMPK
knockout mice generated to test this hypothesis did not have the typical multisystemic
features of the disease. Initial reports showed that, surprisingly, the heterozygote
animals presented none of the symptoms characteristic of the DM phenotype,
whereas, homozygous mice, did eventually showed a very mild, late-onset myopathy
(Reddy et al. 1996). Thus, the characteristic plethora of symptoms associated with the
DM phenotype did not develop despite complete loss-of-function of DMPK. More
recently, the same question was approached (Jansen et al. 1996)  using an elaborate
experimental design: in addition to knocking out the endogenous mouse DM gene, the
normal human DM gene was simultaneously overexpressed. These knock-
out/overexpressor mice with multiple copies of the human DM gene also did not
develop the characteristic human DM phenotype. Nevertheless, mice with >20 copies
of the human DM gene showed signs of cardiac conduction abnormalities. When
considered together, these results suggested that DMPK may contribute to the cardiac
features of DM1, but haploinsufficiency of DMPK does not cause the multisystemic
clinical features of DM1 (Jansen et al. 1996).
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1.2.2 CTG-Expansion Effects on Chromosome Structure
A second proposed mechanism is that the expanded repeat affects the expression of
multiple genes in the region. Support for this hypothesis comes from the observation
that the CTG expansion is a strong nucleosome-binding site that could potentially
alter chromatin structure and have regional effects on the expression of DMPK and its
neighboring genes (Wang et al. 1994; Otten and Tapscott 1995). This mapped six
further genes: DMWD and SIX5 near the vicinity of DMPK, and SYMPLEKIN, 20-D7,
human gastric inhibitory polypeptide receptor gene (GIPR) and Radial spokehead-like
gene RSHL1 to within 200 kb of DMPK and its associated repeat. All six additional
genes could play a contributory role in the DM1 phenotype. The expansion overlaps
not only the 3’ end of DMPK, but also the 5’ promoter region of the neighboring gene
SIX5. SIX5 has a strong resemblance to the fruit fly gene sine oculis (needed for eye
development) and to a family of mouse genes that regulate distal limb muscle
development. Because cataracts and distal muscle wasting are common in DM1,
haploinsufficiency of SIX5 was suggested as a possible contributor to DM1
pathogenesis (Shaw et al. 1993; Boucher et al. 1995; Jansen et al. 1995). The most
compelling support for the involvement of neighboring genes in DM pathogenesis
came from the fact that Six5 knockout mice developed cataracts (Klesert et al. 1997).
DMWD  gene, immediately upstream of DMPK,  is expressed in the testis and
therefore is proposed to play a role in male infertility (Junghans et al. 2001).
SYMPLEKIN, has been suggested to function in the assembly of the polyadenylation
machinery (Takagaki and Manley 2000). Obvious implications therefore arise with
respect to this gene and the multisystemic nature of DM1. The other three transcripts
in this region may be involved in DM-associated testis problems and diabetes.
RSHL1, which lies immediately upstream of DMWD, and 20-D7, located downstream
of SIX5 have been detected in adult testis (Eriksson et al. 2001), thus, altered
expression of these genes may result in testicular atrophy in males. Finally GIPR is
involved in insulin secretion and so could be responsible for the increased incidence
of diabetes observed in DM1 patients (Alwazzan et al. 1998).
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1.2.3 The RNA gain-of-function hypothesis
Several independent lines of evidence indicate that the predominant mechanism for
DM pathogenesis is a gain-of-function of RNA transcribed from the expanded alleles.
First, no point mutations or deletions within the DM1 or DM2 protein products cause
DM, indicating that the repeats are determinative for these diseases rather than a loss
of function associated with the DM1 or DM2 loci. Second, the fact that two different
loci containing similar expanded repeats cause strikingly similar diseases strongly
suggests that DM1 and DM2 share a common pathogenic mechanism that is
independent of a loss of function for the affected locus. Third, RNAs containing long
tracks of CUG or CCUG repeats are transcribed from the expanded DMPK and ZNF9
alleles, and both repeat-containing RNAs accumulate in discrete nuclear foci (Taneja
et al. 1995; Davis et al. 1997; Liquori et al. 2001) (see Figure 1.2).
Figure 1.2: Mutant DMPK mRNA forms foci in the nucleus of DM1
myoblasts. Fluorescence in situ hybridization performed on DM1 myoblasts
with 3000 CTG repeats using a Cy3-labeled (CAG)5 PNA
9 probe and DAPI10
staining (Langlois et al, unpublished data). Reproduced from
www.theses.ulaval.ca/2003/21404/21404.pdf.
9   Peptide nucleic acid (PNA) oligomers are DNA/RNA analogs in which the natural sugar–phosphate backbone is
replaced by a synthetic peptide backbone. PNA were labeled with the fluorescence dye Cyanine 3 (Cy3).
10 DAPI (41,6-Diamidino-2-Phenylindole Dihydrochloride) is a highly fluorescent cationic dye, which specifically
binds to A-T-rich DNA. This fluorescent character permits the use of DAPI for fluorescent microscopy and
analytical biochemistry.
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Fourth, transgenic mice expressing 250 CUG repeats in the 3’-UTR of the human
skeletal α-actin gene reproduced myotonia and the histopathological features
observed in DM1 muscle (Mankodi et al. 2000), demonstrating that expression of
CUG repeats independent of the DM1 locus is sufficient to induce major features of
the disease.
According to the RNA gain-of-function hypothesis, DMPK expanded-repeats exert a
toxic gain of function through their inappropriate association with CUG-binding
proteins, which are required for the maduration, stability and translation of specific
mRNAs  (Timchenko et al. 1996). The first RNA-binding protein found to be
sequestered by the expansion repeats was CUG-binding protein (CUG-BP), a
conserved heterogeneous ribonucleoprotein, which associates with pre-mRNAs
during transcription and is believed to play a role in their processing (Timchenko et
al. 1996). CUG-BP was first identified in band shift assays using a (CUG)8 repeat
probe (Timchenko et al. 1996). However, recent data questions the role of this protein
in the pathology of DM1. As shown above (Figure 1.2), DMPK transcripts
accumulate as nuclear foci in DM1 cell lines, whereas the localization pattern of
CUG-BP in the same lines was unaltered. Furthermore, this protein has been shown to
localize at the base of the RNA hairpin structure and not along the CUG repeat
(Michalowski et al. 1999). On the other hand, muscleblind-like protein (MBNL), a
second class of CUG binding protein, has a strong affinity for double-stranded CUG-
repeat RNA in vitro and colocalizes with the nuclear foci containing CUG and CCUG
repeat RNA in DM cells (Begemann et al. 1997; Michalowski et al. 1999; Miller et al.
2000; Fardaei et al. 2001). This protein is a homolog of a protein required for
development of muscle and photoreceptor cells in Drosophila (Begemann et al. 1997)
and contain two Cys3His-type zinc finger motifs.
Although the physical evidence links MBNL and not CUG-BP with the nuclear foci
of CUG-repeat RNA, functional analyses indicate that increased activity of CUG-BP
is responsible for the aberrant regulation of cardiac troponin T (cTNT), insulin
receptor (IR), and muscle-specific chloride channel (Clc-1) alternative splicing
observed in DM1, contributing to cardiac conduction problems, insulin resistance and
myotonia in DM (Philips et al. 1998; Savkur et al. 2001; Charlet et al. 2002). Further
details on CUG-BP and its role in DM are given in section 1.7.
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Interestingly, spinocerebellar ataxia SCA8 is caused by a CTG expansion in the
3’ UTR of chromosome 13q21, a genetic flaw of the same nature than that found in
DM1. The striking similarities between the SCA8, DM1 and DM2 mutations suggest
that a toxic RNA mechanism at the cellular level may cause SCA8. Supporting this
hypothesis, progressive retinal degeneration is seen in Drosophila melanogaster on
expression of both expanded and normal human SCA8 RNA (Mutsuddi et al. 2004).
SCA8 transcripts are almost exclusively expressed in the brain, which is consistent
with the central nervous system involvement of that disease (Janzen 1999).
1.2.4 Additive Model of DM1 Pathogenesis
Subsequently, an additive model was proposed in which each of the above
mechanisms contributes to DM1 pathogenesis, with some aspects of the disease
caused by haploinsufficiency of DMPK, SIX5, and other neighboring genes and other
clinical features resulting from effects of the CUG expansion in RNA (see Figure
1.3).
Figure 1.3: Model of pathogenesis in DM1. CUG expanded repeats affect the expression of multiple
genes in the region by altering chromatin structure. Additionally, triplet repeats form imperfect hairpins
that are bound by the double-stranded RNA-binding protein MBNL (red). Nuclear accumulation of the
repeat-containing RNA elevates expression of CUG-BP (green) by an unknown mechanism. The
consecuences of MBNL sequestration remain to be determined. Increased CUG-BP activity alters
regulated splicing of three CUG-BP targets, ultimately resulting in the characteristic symptoms of DM.
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1.3 Therapeutic strategies for DM
Currently, there is no cure for DM and treatment is aimed at controlling symptoms to
maximize the quality of life of affected patients. In general, patients are given
supportive care, such as occupational and physical therapy to maximize their ability to
function in daily life. Stretching limbs to avoid tightened tendons and muscles is
particularly important (when tightness of tendons develops surgery can be
performed). It is very important to monitor the function of the respiratory muscles on
regular basis, as some patients may require assistance with their breathing. Similarly,
the heart may need to be checked by a cardiologist on a regular basis to detect early
signs of cardiac dysfunction. Patients with cardiac and respiratory problems can be
treated using a pacemaker and ventilator, respectively. Cataract surgery in the form of
lens replacement may be done to improve the vision of affected patients.
More severe cases might demand treatment with corticosteroids to slow muscle
degeneration and anticonvulsants such as quinine, phenytoin and others to control
seizures and some muscle activity. Medication can also be prescribed for some
muscular dystrophy (MD)-related heart problems.
In addition, people with MD are given age-appropriate dietary therapy to help them
follow a healthy meal plan while avoiding obesity. Obesity is especially harmful to
patients with muscular dystrophy because it places additional strain on their already
weak muscles.
Two experimental procedures may hold some promise for treating MD. One of these
is called myoblast transfer. In this procedure, millions of immature muscle cells are
injected into a patient's damaged muscle. The goal is to provide the person's body
with normal, healthy cells that may be able to function in the place of damaged ones.
Thus far, there seems to be no evidence that this procedure is successful, although
research of this topic continues. The second procedure is gene therapy. In this case, a
person with MD is injected with artificially produced genes that are correct copies of
the faulty genes in their body. The expectation is that the correct genes will restore the
function of genes responsible for the disorder. However, gene therapy is a difficult
task complicated with many side effects. Nevertheless, it may become the most likely
way of curing DM.
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1.4 Dystrophia Myotonica Protein Kinase (DMPK)
1.4.1 Characteristics of DMPK
DMPK was first identified and cloned as a protein kinase in the quest to establish the
molecular basis of disease in DM, now more than a decade ago (Brook et al. 1992; Fu
et al. 1992; Mahadevan et al. 1992). The DMPK gene is composed of 15 exons, which
via three different alternative splicing events lead to six major DMPK isoforms A to F
(Groenen et al. 2000), conserved between human and mice, and one less abundant
isoform designated G, only present in humans (Tiscornia and Mahadevan 2000).
All isoforms share an N-terminal leucine-rich (LR) region, a Ser/Thr protein kinase
domain (K), and a coiled-coil region (CC) (Leung et al. 1998; Madaule et al. 1998;
Tan et al. 2001), but vary in the presence or absence of a five-amino acid VSGGG
motif and in the nature of a C-terminal variable region (VR) (Groenen et al. 2000),
see Figure 1.4.
The LR region was initially suggested to act as a signal peptide (Groenen et al. 2000).
However, recent availability of the crystal structure from ROCKI (Jacobs et al. 2006),
as well as our own results on DMPK, show that this region participates in protein
dimerization. Likewise, the CC domain is also thought to mediate oligomerization
(Cohen and Parry 1990). Recently, the VSGGG motif was suggested to modulate
DMPK autophosphorylation activity and probably folding configuration based on
indirect evidence inferred from the characteristic protein gel migration behaviour and
in vitro kinase assays (Wansink et al. 2003). Four different types of C-terminal VR
exist on DMPK isoforms: two long hydrophobic (tail 1) and relatively hydrophilic
(tail 2) C-termini, a two-residue C-terminus (tail 3) and a fourth type of tail, of which
the N-terminal half is identical to tail 1 (tail 4) (Tiscornia and Mahadevan 2000;
Wansink et al. 2003). DMPK isoforms with long tails are predominant in the heart,
skeletal muscle and brain, and DMPKs wih a 2-amino-acid tail in smooth muscle
(Jansen et al. 1992; Groenen et al. 2000). Besides this, different alternative tails have
been reported to anchor DMPK isoforms in distinct intracellular localization; long
isoforms containing either tail 1 (DMPK A and B) or tail 2 (DMPK C and D) are
membrane associated and anchor to the endoplasmatic reticulum and to the
mitochondrial outer membrane, respectively, whereas, isoforms containing either
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short tail 3 (DMPK E and F) or tail 4 (DMPK G) adopt a cytosolic localization
(Wansink et al. 2003; van Herpen et al. 2005).
Figure 1.4: Domain organization of DMPK isoforms. Major DMPK isoforms A to F have an N-
terminal leucine-rich (LR) region, a Ser/Thr kinase domain (K), and a coiled-coil region (CC).
Differences between isoforms originate from alternative splicing, conserved between human and mice:
(i) a VSGGG-sequence can be present (isoforms A, C and E) or absent (isoforms B, D and F) and (ii)
three different C-terminal variable regions (VR) occur. Less abundant spliceoform DMPK G, only
present in humans, carries a fourth type of VR, similar to tail 1. The figure was adapted from Wansink
et al. 2003.
1.4.2 DMPK localization
DMPK protein is expressed in high levels in skeletal and cardiac muscle, but it is also
present in brain cortex, cerebellum, eye lens, liver, testis, ovaries and intestine (Jansen
et al. 1996; Balasubramanyam et al. 1998). DMPK was localized at neuromuscular
junctions (van der Ven et al. 1993), myotendinous junctions (Whiting et al. 1995), and
terminal cisternae of the sarcoplasmic reticulum in the skeletal muscle (Dunne et al.
1996; Salvatori et al. 1997; Shimokawa et al. 1997) and intercalated discs in the
cardiac muscle (Ueda et al. 1998).
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1.4.3 DMPK-related family of kinases (DMRFK)
DMPK was described as a member of the large AGC group of Ser/Thr kinases (Hanks
and Hunter 1995), but it has been recently revealed as the canonical member of the
“DMPK-related family of kinases” (DMRFK) (Zhao et al. 1997), a family of
multidomain kinases which is expected to regulate novel signalling pathways in the
tissues involved. Members of this family include kinases such as Rho-associated
kinases I and II (ROCKI/II, also known as β and α, respectively) (Leung et al. 1995;
Ishizaki et al. 1996), Caenorhabditis elegans LET-502 (a C. elegans homolog of
ROCK) (Wissmann et al. 1997), Neurospora Cot1 (Yarden et al. 1992), Drosophila
Warts (Justice 1995), Drosophila Genghis Khan (GEK) (a Drosophila homologue of
MRCK) (Luo et al. 1997), murine Citron Rho-interacting kinase (Di Cunto et al.
1998) and Cdc42-binding kinases (MRCKs) (Leung et al. 1998; Ng et al. 2004) (see
Figure 1.5). Members of this family show strong conservation in their kinase domain
and a CC domain, expected to regulate activity by oligomerization.
Figure 1.5: Domain organization in DMPK-related family of kinases. Domain composition of
DMPK, ROCKs, LET-502, MRCKα, MRCKβ, MRCKγ, GEK and Citron kinase. LR: leucine-rich
region; K: kinase; CC: coiled-coil; VR: variable region; RBD: Rho-binding domain; KIM: kinase
inhibitory motif; PH: pleckstrin homology domain; CR: cysteine-rich domain, CH: citron homology
domain; CRIB: Cdc42/Rac interactive binding site; PRD: proline-rich domain; PDZ: post-synaptic
density-95/discs large/zonula occludens-1 domain.
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1.4.4 Function of DMPK and related kinases
Although the cellular function of DMPK has not been established so far, recent
findings indicate that it might participate in a variety of cellular processes including i)
regulation of the electrical excitability of the plasma membrane, ii) myoblast
differentiation, iii) cytoskeletal movement or intracellular transport dynamics and iv)
tumors formation.
DMPK has been suggested to be involved in the regulation of the electrical
excitability of the plasma membrane. Evidence reveals that lack of DMPK protein
may be associated with typical DM1 symptoms like myopathy and heart conduction
defects, perhaps via effects on sodium and calcium ion homeostasis (Jansen et al.
1996; Reddy et al. 1996; Benders et al. 1997; Mounsey et al. 2000b).
In addition to this, a role of DMPK in myoblast differentiation has also been
suggested. Over-expression studies of DMPK demostrate that the kinase is expressed
in various myoblast cell lines and slightly up-regulated during skeletal myogenesis in
vitro. Importantly, a 4-10-fold DMPK over-expression markedly inhibits myogenesis,
which seems to correlate with the marked delay in muscle terminal differentiation
observed in severe cases of DM (Sabourin et al. 1997).
Besides that, DMPK has also been suggested to participate in cytoskeletal movement
or intracellular transport dynamics (Jin et al. 2000; Schulz et al. 2003). Given the
sequence homology between DMPK and other members of the DMFPK family, it is
expected that certain functionality is shared. Most of these kinases function as
effectors of small Rho GTPases (Rho, Rac and Cdc42 subclasses), which are known
to regulate cytoskeletal dynamics. Accordingly, several members of the family are
functionally related to cytoskeletal reorganization events, as illustrated by the
involvement of Gek in actin polymerization (Luo et al. 1997) and the role of Citron
kinase, LET-502 and ROCKII in regulating cleavage furrow contraction during
cytokinesis (Madaule et al. 1998; Kosako et al. 2000; Piekny and Mains 2002).
An effect of DMPK in synaptic plasticity through an effect on actin cytoskeleton
could be relevant to the cognitive dysfunction associated with DM (Schulz et al.
2003).
In addition, a Ser/Thr kinase from fission yeast orb6 related to DMPK (Verde et al.
1998) has been proven to maintain cell polarity during interphase and to induce actin
reorganization during morphological transitions, thus, coordinating cell
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morphogenesis with cell cycle. Orb6 shares functional similarities with Drosophila
warts. Mutations in the latter gene cause an overgrowth phenotype and loss of warts
results in cell-autonomous formation of epithelial tumors. This suggests that this is a
tumor repressor gene and, therefore, is essential for the control of cellular
morphogenesis as well as proliferation. This observation could be highly relevant to
DM, considering that sometimes this disorder presents associated calcifying
epitheliomas, neurofibromas and parathyroid adenomas.
1.4.5 Substrates of DMPK
Various potential substrates have been proposed for DMPK by in vitro studies
including the β-subunit of the dihydropyridine receptor (DHPR) calcium channel
(Timchenko et al. 1995), phospholemman (Mounsey et al. 2000a), phospholamban
(Kaliman et al. 2005), the myosin phosphatase targeting subunit 1 (MYPT1) (Muranyi
et al. 2001) and CUG-BP (Timchenko et al. 1996).
DHPR is a voltage-dependent calcium channel, which functions in skeletal muscle
essentially as a voltage sensor, triggering intracellular calcium release for excitation-
contraction coupling (Rios and Brum 1987). Phospholamban is a regulator of the
calcium pump in cardiac muscle cells. Phospholemman is a membrane-bound
protein involved in ion transport. Modification of muscle calcium and sodium ion
channels homeostasis could lead to an alteration of muscle excitability, as seen in DM
(Benders et al. 1997; Mounsey et al. 2000b). Nevertheless, an in vivo demostration of
the phosphorylation of these substrates by DMPK remains to be established, and a
link with clinical manifestations of DM is unclear.
MYPT1 has also been identified as a substate for DMPK. DMPK controls the status
of myosin regulatory light chain posphorylation, either directly or indirectly via
regulation of myosin phosphatase activity, thereby affecting stress fiber formation,
smooth muscle contraction or cytokinesis. However, the effects of DMPK-mediated
phosphorylation on actomyosin dynamics have not yet been studied in detail
(Muranyi et al. 2001).
C U G - B P  has also been suggested as a DMPK substrate. It exists in a
hyperphosphorylated cytoplasmic (CUG-BP1) and hypophosphorylated nuclear
(CUG-BP2) forms and concentration of the latter isoform is increased in nuclei in DM
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disease. Data from two biological systems with reduced levels of DMPK,
homocygous DM patients and DMPK knockout mice, show that DMPK regulates
both phosphorylation and intracellular localization of CUG-BP (Timchenko et al.
1996; Roberts et al. 1997). Besides this, DMPK mRNAs are accumulating in nuclei of
DM patients (Taneja et al. 1995). Because CUG-BP was suggested to interact with
DMPK mRNA (Timchenko et al. 1996) and hypophosphorylated form is
accumulating in nuclei, it is speculated that nuclear retention of DMPK transcripts is,
at least in part, mediated by CUG-BP protein. Therefore, a feedback mechanism has
been proposed, whereby DMPK phosphorylates CUGBP, which, in turn, facilitates
the transport or processing of the mRNA for DMPK and other CUG-BP dependent
mRNAs. According to this autoregulatory loop, it is likely that the expansion of the
triplet repeats in DM cells impairs the ability of DMPK to phosphorylate CUG-BP.
Decreased phosphorylation of CUG-BP results in decrease of DMPK mRNA
expression and possibly other mRNAs resulting in the multiple organ involvement
that is observed in DM. (Timchenko et al. 1996; Roberts et al. 1997).
1.4.6  Regulation of DMPK activity
Self-assembly is a main feature of the DMPK-related family of kinases. Given that
CCs are established oligomerization motifs, these were initially thought to be
essential for molecular assembly in these kinases. CC domains from DMPK-related
kinases were thought to form dimeric assemblies and, thereby, to mediate
dimerization. To date, only two closely related CC motifs from this family have been
characterized. These correspond to the C-terminal Rho-binding domains (RBDs) of
ROCKII-CC and ROCKI-CC that share 52% sequence identity. For these, crystal
structures have been reported in free form (Shimizu et al. 2003) and complexed to
RhoA (Dvorsky et al. 2004), respectively, confirming that both coils form parallel
dimers (Figure 1.6).
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Figure 1.6: Structures of the RBD from ROCKII in free form and ROCKI complexed with
RhoA. (A) Structure of ROCKII-RBD. A ribbon representation of the parallel CC structure is shown
with the two helices in green. The dashed-lined box points at the Rho binding motif (Shimizu et al.
2003). (B) Top view of the complex between two RhoA molecules (gold and beige) and the Rho-
interacting motif of the RBD molecules (blue and cyan) shown in ribbon representation. The bound
GTPγS11 molecule (black) is shown as a ball-and-stick model. Switch regions12 I and II of both RhoA
molecules are highlighted in red and orange, respectively (Dvorsky et al. 2004).
However, recent studies on ROCKs have shown that CC moieties are not required for
their oligomerization and other domains are responsible for self-association in these
kinases, namely the N-terminal LR region and a tail C-terminal to the kinase domain.
(Doran et al. 2004; Jacobs et al. 2006). The structure from the dimeric N-terminal
fraction (i.e., lacking CC segments) from ROCKI bound to the ATP-inhibitor Y-
2763213 (reported after the present work) shows how head-to-head dimers interact via
two dimerization domains: a small, N-terminal domain comprising the α-helical LR
region as well as a region, C-terminal to the kinase domain, which wraps around the
catalytic core to reach the subunit interface (Jacobs et al. 2006), see Figure 1.7. The
latter agrees with a biochemical study on MRCK, which also reported self-association
in the absence of CC fractions (Tan et al. 2001).
11 GTPγS (guanosine-5'-0-3-thiotriphosphate) is a non-hydrolyzable GTP analogue.
12 Switch I and switch II regions, often referred to as the effector region, are involved in effector interactions.
13 Y-27632 is a highly potent, cell permeable, selective ATP competitive inhibitor of ROCK1 and ROCK2.
A
B
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Figure 1.7: Crystal structure of the ROCK/Y-27632 complex. (A) The ROCK protein dimer is
drawn with β-sheets as arrows and α-helices as cylinders. One monomer is drawn in gray, and the
others are colored by protein region. The N-terminal dimerization domain is shown in red. The N-
terminal kinase domain (dark blue) is shown with the glycine-rich loop drawn in green. The hinge
connecting the two domains is colored orange. The C-terminal kinase domain is shown in light blue
with the activation loop in purple and the kinase tail in yellow. Y-27632 is shown in the active site near
the glycine-rich loop and the hinge. (B) Surface representation of the dimer, where both monomers are
colored by region. Y-27632 is shown in the active site as spheres. The figure was reproduced from
Jacobs et al. 2006.
Often, self-association is aimed to ensure efficient autophosphorylation in trans by
increasing the local concentration of the catalytic domains. This phenomenon is now
generally known to be an activation mechanism common to many protein kinases
including nonreceptor and receptor tyrosine kinases as well as Ser/Thr kinases.
Phosphorylation of key residues at two sites within the kinase domain: a conserved
threonine residue in the activation loop and a Ser/Thr residue in a hydrophobic
phosphorylation motif (consensus sequence FXX(F/Y)(S/T)(F/Y)), (Wansink et al.
2003)  near the C-terminus, provide the means of activation of many protein kinases
(Palaty et al. 1997; Chan et al. 1999; Millward et al. 1999).
Studies on MRCK and ROCK found that residues S204, T240 and T403 of MRCK
(Tan et al. 2001) within the activation loop and the hydrophobic motif, respectively,
as well as T398 within the hydrophobic motif of ROCK (Tan et al. 2001; Zhao and
Manser 2005), are involved in modulation of the kinase activity. Although no
consensus phosphorylation site has been proposed for DMPK, and
autophosphorylation is considered to be mainly conformationally driven (Wansink et
BA
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al. 2003), however, it might be that DMPK undergoes a similar regulatory
phosphorylation scenario. Nevertheless, the VSGGG motif present at the C-terminus
of the kinase domain of DMPK, unique among DMPK-related kinases, has been
suggested to modulate both autophosphorylation activity and probably folding in this
kinase (Wansink et al. 2003).
In addition to its multimerization property, CC motifs of DMPK-related kinases have
also been found to act as intrasteric regulators. In ROCKs and MRCKs, the CC
regions interact with their respective kinase domains, functioning as intrasteric
inhibitors of kinase activity (Amano et al. 1999; Tan et al. 2001). In ROCKs, the
putative negative regulatory region involves both RBD at the C-terminal portion of its
large CC motif and the pleckstrin homology (PH) domain. Constructs lacking the C-
terminal portion of ROCK kinase appeared to be constitutively active, whilst those
without the kinase region or various C-terminal fractions of Rho-kinase act as
dominant negative forms. So far, the only model for regulation of the catalytic activity
in ROCK that has been proposed, suggests that the RBD and the PH domain interact
with the catalytic domain to keep the enzyme in the resting state, inactive (Amano et
al. 1999). Accordingly, binding of the Rho GTPase to the RBD disrupts the inhibition
by the RBD and the PH domain in response to extracellular signals and results in an
open conformation that facilitates N-terminus mediated oligomerization, auto-
phosphorylation and subsequent activation of the kinase. Furthermore, It has been
reported that also some lipids, such as arachidonic acid, can activate ROCK in vitro
(Feng et al. 1999), by binding to the negative autoregulatory region, most likely to the
PH domain, and subsequent release from the catalytic site.
In contrast to ROCK, the regulation of MRCK does not appear to involve the PH
domain, but a small region within the extensive MRCK CC region, termed the kinase
inhibitory motif (KIM) and located at the end of the distal CC2/CC3 domains, which
acts as a negative autoregulatory domain by interacting to and inhibiting the catalytic
domain (Tan et al. 2001; Ng et al. 2004). Co-expression of MRCKγ KIM domain is
sufficient to inhibit the activity of either MRCKα  or β. A proposed model of
activation suggests that upon phorbol 12-myristate 13-acetate (PMA) binding to the
CR domain, the kinase inhibition by KIM would be disrupted, thus facilitating N-
terminus mediated dimerization, auto-transphosphorylation and following activation.
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Opposite to ROCK and MRCK, DMPK-CC has been proposed to act as an enhancer
of its kinase activity (Zhang and Epstein 2003). In addition, the presence of an
autoinhibitory domain at the extreme C-terminus of the full-length kinase (residues
617-629) has been suggested (Bush et al. 2000). Studies with synthetic peptide
substrates and inhibitors suggested this region as a pseudosubstrate autoinhibitory
domain (Bush et al. 2000). For an illustration of the models of activation proposed for
the DMPK-related kinases ROCK and MRCK, see Figure 1.8.
Figure 1.8: Models for the regulation of DMPK-related kinases ROCK and MRCK.
(A) Model for the regulation of ROCK. In ROCK, It is likely that the RB and PH domains interact
with the catalytic domain to inactivate the enzyme in the resting state, and the active form of Rho
interacts with the RB domain, alters the conformation of Rho-kinase and thereby cancels the inhibition
by the RB and PH domains in response to extracellular signals. It has been reported that arachidonic
acid cancels the inhibitory effect of RB/PH region, and activates Rho-kinase in vitro. (C) Model for
regulation of the catalytic activity of MRCK. The intramolecular interaction between the kinase
inhibitory motif (KIM) located at the end of the distal CC2/CC3 and the kinase domain keeps the
kinase in a closed, inactive, dimeric structure. Disruption of this interaction (e.g., PMA14 binding to the
cysteine rich domain CRD or co-expression with a mutant kinase domain) resulted in an open structure
that facilitates N terminus-mediated dimerization, autophosphorylation, and subsequent kinase
activation. These figures were reproduced from Amano et al. 1999 and Tan et al. 2001.
14 PMA: phorbol 12-myristate 13-acetate is the most commonly used phorbol ester.
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In this family of kinases, a complex, multistep regulation process is expected,
comprising both, phosphorylation by up-stream kinases and interactions with
regulatory molecules. For DMPK, it has been reported that DMPK-binding protein
(MKBP) enhances its catalytic activity (Suzuki et al. 1998). MKBP is a novel member
of the small heat shock protein family that specifically associates with DMPK. It
activates DMPK kinase activity in vitro and protects it from heat-induced
inactivation. The expression of MKBP in skeletal muscles from DM1 patients is
selectively upregulated, suggesting that a protein interaction between DMPK and
MKBP might be involved in the pathogenesis of DM1 (Suzuki et al. 1998).
In addition, several DMPK-related kinases have been shown to interact with members
of the Rho family of small GTPases, which includes Rho, Rac1 and Cdc42. To date,
no endogenous activators of DMPK are known. However, a recent study based on
pull-down assays using bacterially expressed Rho GTPases and DMPK (Shimizu et
al. 2000) suggests that the actin cytoskeleton-linked GTPase Rac1 binds to DMPK,
and co-expression of Rac1 and DMPK activates its transphosphorylation activity in a
GTP-sensitive manner. DMPK seems to also bind Raf-1 kinase, the Ras-activated
molecule of the MAP kinase pathway, which phosphorylates and activates DMPK
(Shimizu et al. 2000).
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1.5 Coiled-coils (CCs)
 α-Helical CCs, first proposed by Crick in 1953, represent what is probably the most
widespread assembly motif found in proteins. CCs are comprised of α-helices that
wind around each other, usually forming a left-handed superhelix (Crick 1953;
Chothia et al. 1981; Burkhard et al. 2001). The sequences of left-handed CCs are
characterized by heptad repeats, (a b c d e f g)n , where positions a and d are
characteristically occupied by hydrophobic residues like Leu, Ile, or Val, and
constitute the structural core of the motif. (Hodges 1992; Adamson et al. 1993;
Hodges 1996). Whereas positions e and g are often charged and form networks of
intra- and inter- helical salt bridges crucial to fold stability and interchain recognition
(O'Shea et al. 1991; Ellenberger et al. 1992; Glover and Harrison 1995)  (Figure 1.9).
Figure 1.9: Helical wheel diagram of a parallel dimeric CC. The residues are labeled a–g in one
helix and a’–g’ in the other. The hydrophilic interactions (g–e`/g`–e) and the hydrophobic core (a/a’
and d/d’) are shown.
The CC geometry can be readily parameterized (Crick 1953). Any helical structure is
mathematically defined by three parameters, radius, pitch, and multiplicity. The CC
radius refers to the radius of the superhelix, the CC pitch is the distance along the axis
of the superhelix that corresponds to an exact 360° turn, and the multiplicity of a
superhelix is defined by the number of α-helices forming it (Strelkov and Burkhard
2002).
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Typically, CCs are very specific oligomers with high thermodynamic stability, which
enables them to function as oligomerization domains in many proteins (Burkhard et
al. 2001). However, CCs can also be implicated in refolding processes and molecular
recognition events (Lupas and Gruber 2005).
CCs can form dimers, trimers, tetramers and pentamers depending on their amino acid
sequence and the enviroment. Furthermore, CCs can display 11-residues and 15-
residues repeats, alternative to the common 7-residues pattern, and may present
discontinuities along the α-helices (Figure 1.10).
Although the majority of two-stranded CCs have parallel strands, a number of CCs
with antiparallel strands have been observed. Such CCs may be intrachain, where the
CC is formed by two helices joined by a turn, or they can be interchain interactions
between separate polypeptide chains.
Few factors have been found, so far, to be crucial for determining the number of
strands in a CC.  For example, changing a two-stranded helix to a three- or four-
stranded one, by changing the sets of buried hydrophobic residues at the core a and d
positions (Harbury et al. 1993), this indicates that the shape of the hydrophobic side
chain is an important determinant. Moreover, residues at positions e and g have also
been found to play an important role in the stoichiometry of a CC. A study by Zeng
and colleagues changed the oligomerization state of GCN4 by alteration of the g/e
pairings (Zeng et al. 1997). Particularly, by varying specific g/e residues, they were
able to increase the oligomerization state, presumably by widening the hydrophobic
interface available.
To date, numerous structures are available for proteins containing the heptad repeat
characteristic of trimeric CCs, including α-fibrous proteins (Conway and Parry 1991;
Woolfson and Alber 1995) and other proteins like, for example, a soluble trimeric
fragment of influenza hemagglutinin (Bullough et al. 1994) and a trimeric fragment of
C-type mannose-binding proteins (Weis and Drickamer 1994). However, there is a
relative lack of reports on the stability and folding of four-chain and five-chain CCs
compared to the number of reports on dimeric CCs. Nevertheless, some tetrameric
(DeGrado et al. 1989; Peters et al. 1995) and pentameric (Kammerer 1997) CCs have
been characterized.
In addition, the heptad repeat can have discontinuities, known as stutter, stammer and
shift, which correspond to a four- three- and one-residue insert, respectively, into a
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sequence with an otherwise continuos heptad repeat (Brown et al. 1996).
In addition to the most common CCs with heptad repeats, structures with longer
repeats are possible. In 1951, Pauling and co-workers mentioned the possibility of
other periodicities, including 11-residue repeats (three α-helical turns, 11/3) and 15-
residue repeats (15/4) (Pauling et al. 1951). Accordingly, 11-residue repeats and 15-
residue repeats were found recently in the tetrabrachion protein from Staphylothermus
marinus (Peters et al. 1996) and the tetramerization domain (TD) from human
vasodilator-stimulated phosphoprotein (VASP) (Kuhnel et al. 2004), respectively,
which revealed a right-handed supercoiling.
Figure 1.10: Periodicities of CC proteins. Gallery of parallel and antiparallel CC structures with
heptad and non-heptad repeats. From the left to the right: General control protein GCN4 shows a
regular dimeric CC, influenza hemagglutinin reveals a trimeric CC plus a stutter, tetrabrachion shows a
parallel right-handed tetrameric with the periodically occuring water molecules (spheres) in the cavities
of the hydrophobic core, and colicin E3 shows an antiparallel CC (adapted from Gruber and Lupas
2003).
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1.6 Rac1
1.6.1 Introduction
The actin cytoskeleton mediates a variety of essential biological functions in all
eukaryotic cells. In addition to providing a structural framework around which cell
shape and polarity are defined, its dynamic properties provide the driving force for
cells to move and to divide. Understanding the biochemical mechanisms that control
the organization of actin is thus a major goal of contemporary cell biology, with
implications for health and disease. Members of the Rho family of small GTPases
have emerged as key regulators of the actin cytoskeleton. A recent study suggests that
the small Rho GTPase Rac1 interacts with DMPK and co-expression of Rac and
DMPK triggers its activity in a GTP-sensitive manner (Shimizu et al. 2000). Protein
binding assays were performed by Shimizu and co-workers to study a possible
interaction between DMPK and the three small Rho GTPases RhoA, Rac1 and Cdc42
using pull-downs and bacterially expressed GTPases and DMPK samples. DMPK was
shown to bind exclusively to Rac1, but not to RhoA or Cdc42. These results indicated
that Rac1 can physically interact with DMPK. Furthermore, co-transfection of DMPK
with GTP-bound Rac1 activated DMPK phosphorylation of histone H1 by almost 3-
fold, consistent with a potential regulatory interaction. This interaction of DMPK with
the actin cytoskeleton-linked Rho GTPase Rac1 may play a critical role in the diverse
pleiotropy of DM.
Rac GTPase has three mammalian isoforms, Rac1, Rac2 and Rac3. Rac1 is expressed
in most cell tissues (Moll et al. 1991), Rac2 is specifically expressed in hematopietic
cells (Gu et al. 2002) whereas Rac3 is localized mostly to the adult brain and
expression in the developing nervous system (Haataja et al. 1997; Albertinazzi et al.
1998).
Rac1 tertiary structure consists of one central β-sheet made up of six strands, five
parallel and one anti-parallel, six α-helices and two short 310 helices (Figure 1.11).
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Figure 1.11: Structure of the GTP-coordinated human Rac1 molecule. Ribbon diagram of the
GTP-Rac1 molecule. Secondary elements are labeled (reproduced from Muller et al. 1999).
1.6.2 Rho GTPases
1.6.2.1    Characteristics of the Rho GTPases
The Rho GTPase cycle
Rho GTPases are proteins with a typical molecular mass (MM) of 20-25 kDa that act
as molecular switches utilizing a simple biochemical strategy to regulate complex
cellular processes. They cycle between two conformational states: one bound to GTP
(active state) and the other bound to GDP (inactive state), hydrolyzing GTP to GDP.
In the “on” (GTP) state, GTPases recognize target proteins and generate a response
until GTP hydrolysis returns the switch to the “off" state (Takai et al. 2001). For a
graphic illustration of the GTPase cycle see Figure 1.12.
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Figure 1.12: The GDP/GTP cycle of Rho GTPases. Small GTPases are in an active conformation
when they have GTP bound, and are inactivated when the GTP is hydrolyzed to GDP. When the
GTPase is in the active conformation it is able to interact with effector proteins, which transmit the
signal downstream of the GTPase. The rate of the intrinsic hydrolysis can be enhanced by the
interaction with GTPase activating proteins (GAPs), which promote the inactivation of the GTPase.
Guanine nucleotide exchange factors (GEFs) accelerate the exchange of GDP for GTP, thereby
activating the GTPase Rho guanine nucleotide dissociation inhibitors (Rho GDIs), which keeps the
Rho GTPase in the GDP-bound, inactive state (Etienne-Manneville and Hall 2002).
Key functional domains of Rho GTPases
Rho GTPases typically consists of the GTPase-domain and additional short
sequences in the C-terminus and N-terminus (Takai et al. 2001; Wennerberg and Der
2004). The Rho insert motif is an insertion of about 13 amino acid residues in the
GTPase-domain of Rho GTPases, not present in GTPase-domains of other small
GTPases (Vetter and Wittinghofer 2001) The differences in the conformation of
GDP- and GTP-bound small GTPases are basically manifested in two regions within
the GTPase-domain, the so-called Switch I and Switch II regions, often referred to as
the effector region. In the GTP-bound Rho GTPase, the conformation of the switches
are stabilized. When GTP is hydrolyzed to GDP, the conformation relaxes (Vetter and
Wittinghofer 2001; Hakoshima et al. 2003), see Figure 1.13. Amino acid residues in
the switch regions mediate the interaction between the GTPase and its effector
proteins, which bind only to the GTP-bound conformation (Vetter and Wittinghofer
2001). The presence of Mg2+ ions in the catalytic cleft of the GTPase-domain is
crucial for both guanine nucleotide binding and catalytic function (Vetter and
Wittinghofer 2001; Hakoshima et al. 2003).
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Most of the small GTPases require lipid modifications to be fully active, and this
occurs at the conserved CAAX-motif in the C-terminus of the protein. The most
common lipid modification of Rho GTPases is isoprenylation of the cysteine residue
by addition of farnesyl or geranylgeranyl isoprenoid, but palmitoylation also occur on
some Rho GTPases. The lipid modifications promote the localization of Rho GTPases
to membranes, which is crucial for their function (Wennerberg and Der 2004; Winter-
Vann and Casey 2005).
Figure 1.13:  Superposition of selected Ras-related proteins in the GDP and the GTP bound
form. Whereas in the GTP bound form, all switches are stabilized in a similar conformation, they are
much more flexible in the GDP bound form and show divergent conformations. Extra elements in the
structures of Ras-related proteins are highlighted (reproduced from Vetter and Wittinghofer, 2001).
Rho GTPase mutants as research tools
Over-expression of mutant Rho GTPases has been an extensively used tool to
investigate their role in signaling pathways and regulation of cellular processes. These
mutations were first identified and evaluated in Ras, and then, based on sequence
homology the corresponding mutants of Rho GTPases were produced, see Figure 1.14
(Feig 1999).
A
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Figure 1.14: Schematic diagram of the structure of a typical Rho GTPase. The key funcional
domains of a typical Rho GTPase; the insert region, the switch I and II regions and the CAAX-motif,
as well as mutations used in studies, are depicted in the figure.
1.6.2.2    Rho GTPase Subfamilies
The Rho GTPase family is defined by the presence of the Rho-like GTPase domain,
and 22 human genes have been found to encode Rho GTPases. A phylogenetic tree
where the Rho GTPases are organized according to sequence homology in their
GTPase domain is shown in Figure 1.15.
Figure 1.15: Phylogenetic tree representation of Rho GTPases. The mammalian Rho GTPases can
be subdivided, according to sequence homology in their GTPase domain, into eight different classes
consisting of the following members: Rho (RhoA, RhoB, RhoC), Rac (Rac1, Rac2, Rac3, RhoG),
Cdc42  (Cdc42, TC10, TCL, Wrch-1, Chp), RhoBTB  (RhoBTB1, RhoBTB2), RhoH, Rnd
(RhoE/Rnd3, Rnd1, Rnd2), RhoD (RhoD, Rif) and Miro (Miro-1, Miro-2). These classes can be
classified into 2 further groups: “typical” or “atypical” categories. The typical Rho GTPases include
most of the members, except Chp, Wrch-1, RhoBTB1-2 and Miro-1 and 2 small GTPases, which
constitute the atypical category of small Rho GTPases (Aspenstrom et al. 2004).
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The amino acid sequences of Rho GTPases show approximately 30% similarity to
Ras and within the Rho GTPase family the homology is 40-95 % (Takai et al. 2001;
Furstoss et al. 2002; Burridge and Wennerberg 2004; Wennerberg and Der 2004).
RhoA, Rac1 and Cdc42 are the best studied Rho GTPases.
1.6.2.3 Functional features of Rho GTPases
Rho GTPases are key regulators of actin cytoskeleton reorganization. Most of the
functional information on Rho-family proteins has come from studies of RhoA, Rac1
and Cdc42. Rho promotes stress fibres formation and focal adhesion assembly; Rac1
promotes actin-rich surface protrusions (lamellipodia) formation and membrane
ruffling; and Cdc42 was revealed to induce the formation of actin microspikes and
actin-rich finger-like membrane extensions (filopodia). Consequently, Rho GTPases
have been implicated in the regulation of cell polarity, cell movement, cell shape, and
cell-cell and cell-matrix interactions, as well as in regulation of endocytosis and
exocytosis (Ridley 2001). Beside this, interest in Rho GTPases has increased since
they have also been found to participate in the regulation of many other signal
transduction pathways, in addition to those linked to the cytoskeleton. They are
involved in the regulation of gene transcription, cell cycle progression, microtubule
dynamics, vesicular transport pathways and a variety of enzymatic activities ranging
from a NADPH oxidase in phagocytes to a glucan synthase in yeast (Etienne-
Manneville and Hall 2002).
The multiple effectors identified for RhoA, Rac1, Cdc42 and other family members
reflect the complex and diverse functional properties of these proteins.
1.6.2.4 Rho GTPases effector proteins
Given the involvement of Rho GTPase in such wide variety of important cellular
processes, a great deal of effort has been put into identifying their cellular targets o
effector proteins. To date about 30 potential effectors for Rho, Rac and Cdc42 have
been identified, primarily using affinity chromatography pull-down assays and the
yeast two-hybrid system.
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GTPase binding motifs
Sequence elements involved in the interaction between Rho family GTPases and their
effectors are of considerable interest since their definition should permit the
identification of further potential effector proteins. The first such motif to be
identified was the CRIB (Cdc42/Rac interactive binding) motif, which specifies
interaction with Rac1 and Cdc42, but not Rho (Burbelo et al. 1995).  A second motif,
REM (Rho effector motif), is found in the N-terminal Rho-binding domains of the
Rho effectors (Watanabe et al. 1996) (Figure 1.16).
CRIB motif
The CRIB motif is necessary for the binding to Cdc42 and Rac GTPases, however, it
is not sufficient to give high-affinity binding (Rudolph et al. 1998; Thompson et al.
1998). A less conserved inhibitory switch (IS) domain responsible for maintaining the
proteins in a basal (autoinhibited) state is located C-terminally of the CRIB-motif
(Hoffman and Cerione 2000; Kim et al. 2000; Lei et al. 2000). CRIB domains can
adopt related but distinct folds depending on context. Although CRIB domains are
largely unstructured in the free state, the IS domain forms an N-terminal β-hairpin
that immediately follows the conserved CRIB motif and a central bundle of three α-
helices in the autoinhibited state.  The interaction between CRIB domains and their
respective GTPase proteins leads to the formation of a high-affinity complex in which
unstructured regions of both the effector and the GTPase become rigid. Recently
reported NMR structures of Cdc42 bound to activated Cdc42-associated tyrosine
kinase (ACK) (Mott et al. 1999) and Wiskott-Aldrich Syndrome Proteins (WASP)
(Rudolph et al. 1998) show that the CRIB motifs have no discernable structure in
solution, but when bound to Cdc42 they form tight intermolecular β-sheet across the
GTPase switch regions. Binding of Cdc42 or Rac to the CRIB domain causes a
dramatic conformational change, refolding part of the IS domain and unfolding the
rest (Rudolph et al. 1998; Mott et al. 1999; Hoffman and Cerione 2000; Kim et al.
2000; Lei et al. 2000; Morreale et al. 2000).
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REM motif
The REM repeat, which is also called Rho effector or HR1 domain, was first
described as a three times repeated homology region of the N-terminal non-catalytic
part of protein kinase PRK1 (PKN) (Palmer et al. 1995). The first two of these repeats
were later shown to bind the small G protein Rho (Shibata et al. 1996; Flynn et al.
1998) known to activate PKN in its GTP-bound form. Similar Rho-binding domains
also occur in a number of other protein kinases and in the Rho-binding proteins
rhophilin and rhotekin. Recently, the structure of the N-terminal REM repeat of PKN
complexed with RhoA has been determined by X-ray crystallography (Maesaki et al.
1999). It forms an antiparallel CC fold termed an ACC finger. No sequence motifs
common to other RhoA effectors have been identified, although the defined Rho-
binding regions of Citron, Kinectin, and the ROCKs are all found in regions of
extended α-helical CC structure (Alberts et al. 1998).
Figure 1.16: Crystal structures of CRIB and REM motifs. (A) Crystal structure of the complex
between activated Cdc42 and an extended N-terminal GTPase-binding domain (GBD) peptide that
includes the CRIB motif from WASP. Ribbon diagram with Cdc42 colored blue and WASP yellow.
The Switch I and II regions of Cdc42 are colored in red and the CRIB motif of WASP is colored in
black (Abdul-Manan et al. 1999). (B) Crystal structure of the complex between RhoA and the effector
domain of PKN. Interaction RhoA-PKN occurs via the second REM motif from the PKN effector
domain. Ribbon representation of the PKN effector domain (blue) bound to RhoA (brown). The bound
GTPγS molecule (black) and the magnesium ion (yellow) are shown in ball-and-stick models (Maesaki
et al. 1999).
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1.6.3  Activation of effectors by Rho GTPases
When considering how a GTPase might regulate the activity of a target protein, and
how these proteins subsequently transduce signals to the cell, the whole effector
protein must be considered. The most common mechanism of effector activation by
Rho GTPases appears to be the disruption of intramolecular autoinhibitory
interactions, to expose functional domains within the effector protein (see Figure
1.17).
According to this model, inhibitory domains have been described for several Rho
GTPase effector proteins. Among Rac/Cdc42 targets, PAK1-3 (Rac effectors)
(Bagrodia and Cerione 1999; Tu and Wigler 1999) and the DMPK-related MRCK
kinase (Cdc42 effector) (Tan et al. 2001; Ng et al. 2004) contain an intramolecular
regulatory domain that inhibits kinase activity (see section 1.4.6).
Figure 1.17:  General model of activation of Rho GTPase effectors. (1) Binding of Rho GTPase to
effector relieves an autoinhibitory intramolecular interaction (this is clearly the case for the kinase
PAK, WASP, and maybe also for other effectors that contain autoinhibitory domains; see the text). (2)
The effector remains active until GTP hydrolysis takes place. (3) Alternatively, a modification of the
effector (Y, orange ellipses) (e.g. autophosphorylation, phosphorylation by a separate kinase or binding
to a different activating protein) may maintain activity even after dissociation of the GTPase. (4)
Inactivation of the effector occurs through removal of modification Y (e.g. dephosphorylation or
removal of a bound activating protein), allowing the effector to re-enter its inactive conformation
(Bishop and Hall 2000).
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WASP, N-WASP and protein IQGAP14, three related Cdc42 targets, also appear to be
regulated by an intramolecular interaction (Kim et al. 2000).  Rho effectors include
ROCK and PKN kinases. In ROCKα, a region of the autoinhibitory domain (amino
acids 941-1388), located at the C-terminal part of the CC domain, comprises the
GTPase-binding and PH domains, and when mutated so as to disrupt binding to Rho,
will inhibit endogenous ROCK (Amano et al. 1999) (see section 1.4.6).
Activation of DMPK-related kinases via small Rho GTPases involves different
binding sequences. In ROCK and Citron kinases a RBD overlaps the extensive CC
region. The recent crystal structure of a region of ROCKI (residues 947-1015)
indicates the homodimer binds GTP-RhoA as a CC, but employs only 10-13 residues
present at the extreme C-terminal end of the extended parallel CC region to bind a
predominantly hydrophobic patch assembled by the switch regions of RhoA (Dvorsky
et al. 2004). The specificity of ROCK interaction with RhoA (versus Rac1 and
Cdc42) appears to involve residues F39, Y66, and L69 of RhoA.
On the other hand, MRCK possess a CRIB motif. Uniquely among CRIB containing
effectors MRCKα  can exist as a product with two PDBs, while the other two
isoforms, MRCKβ and MRCKγ, are restricted to a single such CRIB motif (Tan et al.
2003). Interstingly CRIB1 binds preferentially to GTP-Cdc42, but addition of CRIB2
increases MRCK interaction with GTP-Rac.
14 IQGAPs are scaffolding proteins that have been shown to be components of the actin cytoskeleton.
1.7 CUG-BP protein
1.7.1 Introduction
CUG-BP is a human RNA-binding protein that was first characterized as a novel
human heterogeneous nuclear ribonucleoprotein (hnRNP). HnRNPs bind to nascent
RNA polymerase II transcripts, and have been suggested to play important roles in
nuclear pre-mRNA splicing and polyadenylation as well as the nucleocytoplasmic
export and cytoplasmic stability of mRNAs. CUG-BP was purified based on its
sequence-specific binding to RNA containing CUG repeats (Timchenko et al. 1996)
and has been proposed to play a role in the pathogenesis of the trinucleotide
expansion disease DM1, in which nuclear accumulation of DMPK transcripts
containing expanded triplet repeats may sequester CUG-BP, thus creating an RNA
gain-of-function mutation (see section 1.2.3).
CUG-BP is the defining member of the CELF (CUG-BP and ETR-3-like factor)
family of RNA-binding proteins, which also includes an embryonically lethal
abnormal vision (ELAV)-type RNA binding protein 3 (ETR-3), CELF3, CELF4,
CELF5 and CELF6 proteins (Lu et al. 1999; Ladd et al. 2001; Ladd et al. 2004).
CELF proteins have a similar domains arrangement and act as regulators of pre-
mRNA alternative splicing.
1.7.2 Domain structure
All six proteins have the same domain structure including two adjacent RNA
recognition motifs (RRM1 and RRM2) near the N-terminus and one RRM (RRM3)
near the C-terminus, which are separated by a 160-230 residue “divergent domain” of
unknown function (see Figure 1.18A). The CELF RRMs show a high degree of
sequence identity among family members, however, there is little sequence identity in
the divergent domain. The six CELF proteins can be divided into two groups based on
sequence identity (see Figure 1.18B). One group contains CUG-BP and ETR-3, which
are 78% identical. The second group contains CELF3, CELF4, CELF5 and CELF6,
which exhibit at most 44% identity to CUG-BP and 62-66% identity to each other
(Ladd et al. 2001).
Figure 1.18: CELF family members are closely related. (A) All of the CELF proteins possess the
same domain structure: three RRMs and a divergent domain of unknown function between RRM2 and
RRM3. (B) Evolutionary relationship of human CELF proteins. Nomenclature is designed to consider
CUG-BP and ETR-3 as CELF1 and CELF2, respectively. Figure adapted from Ladd et al. 2001.
The RNA recognition motif, RRM, also known as ribonucleoprotein domain (RNP) is
one of the most abundant and best-characterized protein domains in eukaryotes and
the most common nucleic acid binding protein motif (Birney et al. 1993; Burd and
Dreyfuss 1994). The structure of RRM mainly has two identical binding domains,
RNP1 and RNP2 that bind on opposite sides of a RNA loop. Each RRM has a α/β-
fold, which consists of a compact globule made of a four-stranded antiparallel β-sheet
that forms the RNA-binding surface backed by two α -helices. Thus, specific
interactions are found in the space between the two RRM domains that serve as a
region of recognition. Though many of the protein–RNA interactions are through
amino acids located on the β-sheet of the RRM core structure, the specificity for the
RNA ligands usually requires residues outside the conserved structural elements. For
example, loops connecting the β-strands or regions outside the conserved RRM
domain can play prominent roles in RNA recognition (Scherly et al. 1990; Ding et al.
1999). In addition, many RNA-binding proteins have multiple RRMs. To date, six
structures of proteins with two tandem RRMs have been determined (Scherly et al.
1990; Shamoo et al. 1997; Xu et al. 1997; Crowder et al. 1999; Deo et al. 1999; Allain
et al. 2000; Conte et al. 2000; Wang and Tanaka Hall 2001). For a graphic illustration
of an RRM motif, see the crystal structure of the complex between the two RRMs of
RRM1 RRM2 RRM3Divergent Domain
CELF4
CELF5
CELF3
CELF6
CUG-BP
ETR-3
A
B
the Sex-lethal (Sxl) protein and a 12-nucleotide single-stranded RNA derived from
the tra polypyrimidine tract (Handa et al. 1999) (Figure 1.19).
Figure 1.19: Crystal structure of the complex between the two RRMs of the Sex-lethal (Sxl)
protein and the tra mRNA precursor. Overall view of the complex between Drosophila Sxl protein,
a developmental regulator of alternative splicing, bound to a 12-nucleotide single-stranded RNA
derived from the tra polypyrimidine tract (Perez-Canadillas and Varani 2001).
1.7.3 Function
CELF proteins are well-characterized alternative splicing regulators of a subset of
pre-mRNAs, including human and chicken cardiac troponin T (cTNT), human insulin
receptor (IR) and human muscle-specific chloride channel (Clc-1) (Cooper 1998;
Savkur et al. 2001; Charlet et al. 2002).
Apart from the difference in their sequences, the two CELF protein groups also differ
in their ability for RNA-binding and splicing function (Ladd et al. 2004). To define
regions required for RNA-binding and splicing regulation, a functional analysis was
performed on two CELF protein family members, CELF4 and ETR-3, which
represent the two different CELF family subgroups.
For CELF4, it had been demonstrated that either RRM1 or RRM2 are necessary and
sufficient for RNA binding and RRM2 plus 66 amino acids within the divergent
domain were sufficient to function as a splicing activator for cTNT exon 5 (Singh et
al. 2004).
Whereas deletion analysis within ETR-3 suggest that the residues required for
activation by ETR-3 involve non-overlapping N- and C-terminal regions containing
either RRM1 and RRM2 or RRM3 plus segments of the adjacent divergent domain
(Han and Cooper 2005).
1.7.4 Involvement of CUG-BP protein in DM1
Five pre-mRNAs have been identified to be aberrantly spliced in DM1 tissues and
mouse models: tau (Sergeant et al. 2001), myotubularin-related protein 1 (MTMR1)
(Buj-Bello et al. 2002), IR (Savkur et al. 2001), cTNT (Philips et al. 1998) and Clc-1
(Charlet et al. 2002; Mankodi et al. 2002). While the role of MTMR1 is still elusive in
DM1, disruption of appropriate splicing of cTNT, IR and CLc-1 mRNAs can be
associated with symptoms of the disease. It has not yet been demonstrated that the
splicing defect of tau is associated with particular symptoms of DM1. However, tau is
a microtubule-associated protein implicated in axon and neurite development in the
brain (Shahani and Brandt 2002). Alterations in the balance of tau isoforms may well
be responsible for the abnormal personality traits of myotonic dystrophy patients and
could explain the severe involvement of the CNS in congenital cases.
Human cTNT exists as two splicing isoforms with either inclusion or exclusion of
exon 5. The isoform that includes exon 5 is normally only expressed during
embryonic development in the heart and skeletal muscle, while in adults exon 5 is
excluded (Cooper and Ordahl 1984). Homozygous and heterozygous DM1 patients
show alternate splicing patterns with a significant increase in cTNT mRNAs with
exon 5 inclusion (Philips et al. 1998).
The insulin receptor is composed of two extracellular α and two intracellular β
subunits. Alternative splicing of exon 11 generates two isoforms of the α subunit:
isoform A (IRA) lacking exon 11 and isoform B (IRB) that includes exon 11 (Figure
1.20A) (Seino and Bell 1989). Expression of the two isoforms is tissue specific
depending on glucose requirement of each particular tissue since both isoforms do not
have the same signalling capabilities (Moller et al. 1989; Kellerer et al. 1992). The B
isoform, that is expressed dominantly in skeletal muscle, adipose tissue and the liver,
has been reported to signal more efficiently in response to insulin binding despite
having a 2-fold lower affinity for insulin (Moller et al. 1989; McClain 1991; Mosthaf
et al. 1991; Yamaguchi et al. 1993). In myotonic dystrophy, the IR is aberrantly
spliced thus promoting the IRA isoform in skeletal muscle (Savkur et al. 2001).
Myotonia is one of the major cardinal features of DM. The inability to relax muscles
after contractions is due to hyperpolarization of the muscle fibers after ion entry
(Lehmann-Horn and Jurkat-Rott 1999). Several channelopathies such as mutations in
the muscle-specific sodium (SCN4A) and chloride (CLCN1) channel genes are
known to cause myotonia in humans and animals (Lehmann-Horn and Jurkat-Rott,
1999). The Clc-1 channel is the product of the CLCN1 gene and is the major skeletal
muscle chloride channel in humans (Lehmann-Horn and Jurkat-Rott 1999).
Since defects in both sodium and chloride conductance have been documented in
DM1, Charlet and co-workers investigated whether SCN4A and CLCN1 gene
products are misregulated in the disease (Franke et al. 1990; Koty et al. 1996; Charlet
et al. 2002). Their study showed, that similar to cTNT and the IR, the Clc-1 mRNA
was aberrantly spliced resulting in 3 defective isoforms containing a premature
termination codon (Fig. 1.20B) (Charlet et al. 2002; Mankodi et al. 2002). Using a
DM mouse model it was determined that loss of Clc-1 function was sufficient to
induce myotonia (Mankodi et al. 2002).
A shared mechanism links the processing of IR, cTNT and Clc-1: they are all natural
targets for the alternative splicing-regulator CUG-BP (Ladd et al. 2001). CUG-BP has
been shown to bind U/G-rich motifs in introns adjacent to splice sites in all three of
these pre-mRNAs (Charlet et al. 2002; Philips et al. 1998; Savkur et al. 2001).
Furthermore, over-expression of CUG-BP in normal cells induces the same defective
alternative splicing as that seen in DM1 patients (Faustino and Cooper 2003). The
exact mechanism by which CUG-BP accumulates in the nucleus of DM1 cells is
unknown.
Figure 1.20: Diagram of the alternative splicing of IR and Clc-1. (A) Insulin receptor (IR) a-subunit
alternative splicing. IR-A is produced with inclusion of exon 11, while the IR-B isoform is produced by
exclusion of exon 11. IR-A is the high-signalling isoform normally found in insulin-responsive tissue
like skeletal muscle and the liver. (B) Alternative splicing of the chloride channel-1 (Clc-1) mRNA.
Aberrant splicing generates 3 isoforms coding for inactive proteins with premature stop codons.
Illustration reproduced from: (A) (Savkur et al. 2001) (B) (Charlet et al. 2002).
The current explanation suggests that double strand RNA binding proteins (dsRNA-
BP) attach themselves to the CUG expansion hairpin loop thereby forming the
characteristic foci and consequently inducing an elevation in CUG-BP steady-state
levels in DM1 cells (Charlet et al. 2002; Faustino and Cooper 2003; Miller et al.
2000; (Timchenko et al. 2001). In addition, CUG-BP has also been proposed as a
substrate of DMPK. The haploinsufficiency or complete lack of DMPK might favours
the hypophosphorylated form of CUG-BP that is shown to accumulate in the nucleus
(Philips et al. 1998; Roberts et al. 1997).
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The coiled-coil domain of dystrophia myotonica protein kinase
(DMPK) has been cloned, overexpressed, puri®ed and crystallized.
Two crystal forms have been obtained that belong to space groups P3
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1. Introduction
Regulation by oligomerization is a key feature
of the dystrophia myotonica protein kinase
(DMPK) related family of Ser/Thr kinases.
This group of complex multi-domain kinases
includes important members such as human
p160ROCK (ROCKI), Rho-kinase (ROCKII),
citron Rho-interacting kinase and Cdc42-
binding kinase (MRCK) among others (Riento
& Ridley, 2003). They are functionally related
to reorganization events in the cytoskeleton
during cellular processes such as cytokinesis,
neurite outgrowth and smooth-muscle
contraction. These kinases are characterized
by the high conservation of their catalytic
domains and by the unusual presence of one or
more coiled-coil domains (CC) that are central
to regulation of their activity. Based on
sequence data, the CC domains from members
of this family are predicted to form dimeric
arrangements. However, it is remarkable that
little or no overall sequence homology can be
detected across these domains and that
different biochemical roles have been attrib-
uted to them. At their C-termini, the CC
moieties of ROCKI, ROCKII and citron
kinase (Di Cunto et al., 1998; Riento & Ridley,
2003) house binding motifs for small Rho
GTPases that are known to regulate cyto-
skeletal dynamics. The CC domains of MRCK
and DMPK are not known to mediate protein
interactions, but have instead been proposed to
act as an inhibitor and an enhancer of kinase
activity, respectively (Tan et al., 2001; Zhang &
Epstein, 2003). Furthermore, it is generally
accepted that these CC sections mediate
dimerization in these kinases (Zhang &
Epstein, 2003). However, it has been shown
that other domains within these complex
systems can also lead to oligomerization (Chen
et al., 2002; Tan et al., 2001). In summary, the
functionality of CC domains from this kinase
family remains unclear in the absence of
structural data.
To date, the structures of only two closely
related CC fragments from this kinase family
have been reported. These correspond to the
C-termini of ROCKII-CC and ROCKI-CC,
both of which are dimeric and span the Rho-
binding motif. Their structures have been
elucidated in the free form (PDB code 1uix;
Shimizu et al., 2003) and in complex with
RhoA (PDB code 1s1c; Dvorsky et al., 2004),
respectively. In order to gain further under-
standing of the contribution of CC moieties to
kinase regulation in this family, we have
undertaken the study of the CC domain from
DMPK (DMPK-CC). DMPK is speculated to
be related to a progressive neuromuscular
disorder known as myotonic dystrophy (DM),
which is the most common form of muscular
dystrophy in adults (Larkin & Fardaei, 2001).
Its involvement in disease, however, remains
polemic. Understanding the activation
mechanism of DMPK will contribute to further
clarifying its functionality.
2. Construction of the plasmid
Based on structure-prediction results from
MULTI-COIL (Wolf et al., 1997), DMPK-CC
was identi®ed to span residues 461±537. An
expression construct comprising these residues
was derived from human DMPK cDNA
(GenBank L08835) using primers 50-CA-
TGCCATGGCAGAGGCTGAGGCCGAG-30
and 50-GGGGTACCTTACCCCGTGACAGC
TGTGG-30 carrying NcoI and KpnI restriction
sites (in bold). The PCR product was puri®ed
(Wizard, Promega) and cloned into the simi-
larly digested expression vector pET-M11
(EMBL). This modi®ed version of pET-24d
(Novagen) includes a His6 tag plus a TEV
(tobacco etch virus) protease-cleavage site
electronic reprint
crystallization papers
N-terminal to the expression construct. The
plasmid was constructed in Escherichia coli
strain DH5.
3. Protein overexpression and
purification
DMPK-CC was expressed in E. coli
BL21(DE3) grown in LB medium supple-
mented with 25 mg mlÿ1 kanamycin and
34 mg mlÿ1 chloramphenicol at 310 K.
Induction took place at an OD600 nm of 0.6 by
the addition of 1 mM isopropyl--d-thio-
galactopyranoside (IPTG) and expression
took place overnight at 298 K. Cells were
harvested by centrifugation at 5000g for
30 min at 277 K. The bacterial pellet was
resuspended in lysis buffer (50 mM Tris pH
7.5, 50 mM NaCl) and sonicated in the
presence of 1 mg mlÿ1 lysozyme. The
homogenate was clari®ed by centrifugation
at 20 000g for 1 h and 277 K. For af®nity
puri®cation, the supernatant was applied
onto a HiTrap Ni2+-Chelating HP column
(Amersham Biosciences) equilibrated in
lysis buffer containing 40 mM imidazole.
Protein was eluted at 200 mM imidazole. Tag
removal took place by incubation with TEV
protease (0.4 mg mlÿ1) for 2 h at room
temperature during dialysis against 50 mM
Tris±HCl pH 7.5, 200 mM NaCl. Subtractive
puri®cation of protease (His6-tagged at the
C-terminus) and non-digested protein was
carried out on a subsequent chelating step.
The cleaved protein was then concentrated
to 5±10 mg mlÿ1 according to a Bradford
assay (Bradford, 1976) and used in crystal-
lization trials. Higher purity DMPK-CC
could be obtained by further size-exclusion
chromatography using a Hi-Load 16/60
Superdex 75 prep-grade column (Amersham
Biosciences) equilibrated in 50 mM Tris pH
7.5 and 200 mM NaCl. However, this addi-
tional procedure did not result in detectable
variation of crystallization results and was
discontinued.
4. Crystallization
Crystallization was carried out by the
hanging-drop vapour-diffusion method at
291 K. Each drop consisted of equal
volumes (1.5 ml) of protein solution and
reservoir solution. The components of the
protein solution are described above and the
protein concentration was 10 mg mlÿ1.
Initial screening used a wide range of
commercially available crystallization kits.
Crystals were obtained from Structure
Screen 1 (Molecular Dimensions) under two
sets of conditions: (i) 2.0 M ammonium
sulfate, 100 mM Tris±HCl pH 8.5 and (ii)
100 mM sodium acetate pH 4.6, 8% PEG
4000. Crystals obtained under condition (i)
grew as stacks of multiple plates. Single
crystals grew from optimized media
containing 2.5 M ammonium sulfate,
100 mM Tris±HCl pH 7.5 and either 3%
2-propanol or 5% dioxane (Figs. 1a and 1b).
Despite the good visual appearance of these
crystals, their poor diffraction quality made
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Figure 1
Crystal habits. (a) Crystals grown under condition (i) supplemented with 3% 2-propanol. (b) Crystals grown
under condition (i) supplemented with 5% dioxane. (c) Thin crystal plates grown from heavy precipitate under
condition (ii). (d) Best diffracting crystals obtained from condition (iii).
Table 1
X-ray data and phasing statistics.
Data processing and reduction used the MOSFLM/SCALA software (Kabsch, 1988; Leslie, 1992). Phase calculation and
re®nement was performed in SHARP (de La Fortelle and Bricogne, 1997) using data to 3.0 AÊ resolution. Phasing
statistics are given for acentric re¯ections.
P3 P212121
Native Native SeMet peak SeMet remote SeMet edge
Unit-cell parameters (AÊ ) a = b = 38.05,
c = 114.37
a = 39.09, b = 46.17, c = 143.48
No. chains in AU 3 3
VM (AÊ
3 Daÿ1) 1.3 2.4
Solvent content (%) 32 48
Wavelength (AÊ ) 0.886 0.98 0.9793 0.9392 0.9795
Resolution (AÊ ) 20±2.4 (2.53±2.40) 20±1.6 (1.69±1.6) 20±2.3 (2.42±2.3) 20±2.5 (2.64±2.5) 20±2.9 (3.06±2.9)
Unique re¯ections 5395 (728) 33876 (3951) 11724 (1440) 9565 (1379) 6105 (873)
Completeness (%) 74.1 (68.2) 96.3 (79.2) 97.2 (83.9) 99.5 (99.5) 99.2 (100.0)
Rsym(I) 0.123 (0.228) 0.059 (0.330) 0.079 (0.204) 0.091 (0.316) 0.104 (0.304)
Redundancy 2.0 (1.3) 4.4 (2.3) 12.7 (8.7) 6.8 (7.0) 6.7 (7.0)
hI/(I)i 6.5 (1.4) 15.0 (2.5) 25.6 (8.2) 17.8 (6.2) 16.5 (6.1)
Phasing power (iso/ano) 0.15/1.83 Ð/0.96 0.58/0.55
RCullis 1.0/0.64 Ð/0.84 0.91/0.93
FOM (before/after
solvent treatment)
0.45/0.87
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them unsuitable for structure elucidation.
As a consequence, this crystal form was
abandoned. Crystals grown under condition
(ii) appeared one month after drop mixing.
They grew from heavy precipitate as
extremely thin hexagonal plates of small
dimensions (Fig. 1c). Efforts to increase the
crystal size, including seeding protocols,
yielded no improvement.
Finally, a customized screen resulted in an
additional crystal type grown from 100 mM
Tris±HCl pH 7.5, 2.0 M sodium/potassium
tartrate (condition iii). Crystals exhibited a
polyhedral habit and grew to ®nal dimen-
sions within two to three weeks of drop
mixing (Fig. 1d). The diffraction properties
of these showed them to be suitable for
structure elucidation.
5. Data collection and NCS analysis
Native diffraction data have been recorded
from crystals grown under conditions (ii)
and (iii). For condition (ii), data were
collected from a crystal extracted from the
drop shown in Fig. 1(c). Diffraction was
recorded to 2.4 AÊ resolution at beamline
XS0A6 (SLS, Villingen) using a MAR CCD
165 detector and under cryoconditions in
27.5%(v/v) glycerol. Re¯ections were
recorded in a single sweep of 70, using 1.0
non-overlapping rotation steps. Crystals
belong to space group P3. Unit-cell dimen-
sions and data statistics are given in Table 1.
The diffraction from these thin plate crystals
suffered strongly from radiation damage,
impeding the collection of complete data of
high quality. Analysis of the crystal lattice
using the self-rotation function in AMoRe
(Navaza, 2001) revealed NCS relations at
Eulerian angles  = 60 and 180,  = 
 = 0.
This is consistent with the presence of three
-chains in the asymmetric unit aligned with
the crystallographic c axis, which is in
agreement with the fact that the dimension
of this axis closely resembles the theoretical
length calculated for this coiled-coil.
X-ray data optimal for structure elucida-
tion were recorded to 1.6 AÊ resolution from
crystals grown under condition (iii). Data
collection took place at beamline ID14-2
(ESRF, Grenoble) on an ADSC Quantum 4
CCD detector and under cryoconditions
using 20%(v/v) glycerol as a cryoprotectant.
Re¯ections were recorded over a total
rotation range of 105, using 0.70 non-
overlapping steps and two sweeps at high
and low exposure doses (data statistics are
given in Table 1). Crystals belong to space
group P212121 as con®dently estimated from
the pattern of systematic absences along the
crystallographic axes. The calculated VM
value (Matthews, 1968) (Table 1) suggested
the presence of more than one chain in the
asymmetric unit of this crystal form.
However, inspection of self-rotation func-
tions and native Patterson maps did not
reveal NCS relations.
6. Phasing
Phasing was initially attempted by molecular
replacement (MR) in AMoRe (Navaza,
2001). Although DMPK-CC shares no
sequence similarity with other coiled-coils
for which structures are available, the
structural similarity within this fold was
expected to be suf®ciently high to yield
successful results in MR. This has been the
case for other folds with a highly conserved
architecture, such as the parallel -helix,
where correct solutions were obtained from
search models with sequence identity values
as low as 17% (Mayans et al., 1997). In the
current study, coiled-coil structures as well
as their constituent single chains have been
assayed for PDB entries 1avy, 1bb1, 1gzl,
1ij0 (trimeric models), 1ic2 (dimeric model),
2338 Garcia et al.  Coiled-coil domain of dystrophia myotonica kinase Acta Cryst. (2004). D60, 2336±2339
Figure 2
(a) Crystal lattices in the P3 and P212121 space groups. The asymmetric unit of the P3 cell contains three -helical
chains aligned with the c crystallographic axis. Each chain originates from the fusion of two consecutive short
helices as positioned by MR. To indicate this, one of the chains has its two halves coloured in a blue-to-red
gradient, where blue indicates the N-termini and red the C-termini. (b) View of the P3 lattice perpendicular to
the crystallographic threefold axis. Each NCS chain generates a full coiled-coil by applying crystal symmetry
(re¯ected by different colouring). Crystallographic threefolds are indicated. (c) Experimental skeletons (after
solvent treatment in SHARP) obtained by MAD phasing in P212121 symmetry. SeMet sites located using MR
phases and employed in phase calculation are shown as full circles. Five sites are unique, while one additional site
has two related peaks, possibly owing to a double Met conformation.
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1fe6 and 1gcl (tetrameric models). Only CC
fragments without discontinuities were
considered. All models were used as poly-
alanine variants to account for the lack of
sequence similarity. Because of the elon-
gated shape of the models, a wide range of
Patterson integration radii were tested. In
general, short chains performed better than
long ones, probably owing to long-range
deviation along the coiled-coil axis between
the search and target structures.
In space group P3, the best search model
consisted of a single -helical chain from 1ij0
(a trimeric variant of GCN4 leucine zipper
31 amino acids long). This yielded two best
MR solutions (correlation coef®cient 60.1%
and R factor 52.2% after rigid-body ®tting in
AMoRe in the resolution range 12±3.5 AÊ ),
which corresponded to two different halves
of the same -helical chain of DMPK-CC
(Fig. 2a). Both halves were fused to create
an optimized search model 62 residues long.
A new MR search resulted in three solutions
corresponding to three NCS copies (corre-
lation coef®cient 68.2%, R factor 47.1%;
Fig. 2a). Each chain generated a full trimeric
coiled-coil by applying crystal symmetry.
The lattice thus calculated (Fig. 2b) was in
good agreement with NCS data for this
crystal form.
In space group P212121, trimeric 1ij0 was
the best search model. Two solutions were
obtained (correlation coef®cient 53.3%, R
factor 54.2% after rigid-body ®tting in
AMoRe in the resolution range 12±3.5 AÊ ),
each corresponding to half of DMPK-CC
with a slight overlap along the helical axis.
An equivalent MR solution was obtained
when using the trimeric DMPK-CC model
obtained by MR in the P3 space group as a
search model.
Despite good crystal packing, the resul-
tant MR phases were of insuf®cient quality
to allow model building and re®nement.
Thus, experimental phasing was pursued by
MAD on an SeMet derivative crystallized in
space group P212121. Diffraction was
recorded at peak, in¯ection and high-energy
remote points at ID14-2 (ESRF, Grenoble)
(Table 1). Six selenium sites out of a total of
nine (it should be noted that the three
N-terminal Met residues are derived from
the plasmid and are expected to be structu-
rally disordered) have been located by
anomalous difference Fourier (>5) using
phases calculated from MR solutions
(Fig. 2c). The sites within the core of the MR
model are in good agreement with anom-
alous difference Patterson maps and are at
the expected separation distance along the
coil axis. Visual inspection of high-resolution
electron-density maps calculated from the
experimental phases using these selenium
positions showed the MR solutions to be
essentially correct and con®rmed the
trimeric state of DMPK-CC in these crystals.
However, they also revealed an inversion of
the -helix termini in the MR model, which
was probably a consequence of the lack of
de®nition in the helix when removing side
chains and at the resolution of the MR
studies. This explains the low quality of these
initial phases. Structure elucidation will now
proceed making use of experimental phases.
The fact that both crystal forms in this study,
which were obtained at high and low salt
conditions as well as at pH 4.6 and pH 7.5,
contain a trimer in their asymmetric units
leads us to speculate that the association
state of this coiled-coil must be stable.
However, further biophysical studies must
be undertaken to establish the oligomeric
state of this coiled-coil in solution and to
resolve whether the currently observed
arrangement might be the result of the
crystallization media or of packing forces.
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ABSTRACT Self-assembly via coiled-coil domains
(CC) is crucial for the regulation of the dystrophia
myotonica kinase (DMPK) -related family of kinases.
These CC domains are thought to form dimeric ar-
rangements and thus to mediate dimerization in these
enzymes. Using size exclusion chromatography com-
bined with multiangle static light scattering, we ana-
lyzed the oligomeric state of DMPK as well as that of a
truncated variant lacking the CC fraction. Remarkably,
both forms were found to assemble into robust dimers.
In contrast, the CC domain in isolation yielded trimeric
assemblies, indicating that the oligomerization proper-
ties of CC domains from this kinase family are more
diversified than anticipated. The crystal structure of
this CC has been elucidated to 1.6 Å resolution and its
properties in solution established using sedimentation
equilibrium and thermal denaturation. These data show
that, contrary to expectations, the self-assembly of
DMPK is not dictated by the association properties of
its CC domain. Instead, it appears to be driven by
sequence segments flanking both N and C termini of
the catalytic kinase fraction, as suggested by models of
head-to-head dimers based on small angle X-ray scatter-
ing data. Our findings support a shared pattern of
assembly across DMPK, ROCKs, and MRCK members
of this family.—Garcia, P., Ucurum, Z., Bucher, R.,
Svergun, D. I., Huber, T., Lustig, A., Konarev, P. V.,
Marino, M., Mayans, O. Molecular insights into the
self-assembly mechanism of dystrophia myotonica ki-
nase. FASEB J. 20, 1142–1151 (2006)
Key Words: kinase  coiled-coil  protein assembly  protein
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Self-assembly is a main feature of the dystrophia
myotonica kinase (DMPK) -related family of kinases.
These complex multidomain kinases share a highly
conserved catalytic domain and a coiled-coil fraction
(CC) involved in the regulation of their activity. To this
group belong DMPK (1, 2), Rho-associated kinases I
and II (ROCKI/ II, also known as  and , respectively)
(3, 4), C. elegans LET-502 (5), Drosophila Genghis Khan
kinase (Gek) (6), murine citron kinase (7), and rat
Cdc42 binding kinase (MRCK) (8), among others.
Most of these kinases act as effectors of small Rho
GTPases (Rho, Rac, and Cdc42 subclasses) known to
regulate cytoskeletal dynamics. Accordingly, several
members of the family are functionally linked to cy-
toskeletal reorganization events, as illustrated by the
involvement of Gek in actin polymerization (6) and the
role of citron kinase, LET-502, and ROCKII in regulat-
ing the cleavage furrow contraction during cytokinesis
(9–11).
DMPK is regarded as the defining member of this
kinase family. It is most closely related to MRCK and
ROCKs, with which it shares sequence similarity across
the N-terminal catalytic fraction but not across CC
moieties (Fig. 1). By analogy to other family members,
DMPK is suspected to regulate cytoskeletal events (12,
13) and may act as a downstream effector in the
regulatory pathways of RhoA (12) and Rac1 (14). Other
reports, however, defend that DMPK intervenes in the
modulation of the electrical excitability of the plasma
membrane (15, 16). Taken together, functional data
suggest that DMPK might be related to muscle stiffness
and hyperexcitability, heart conduction defects, and
cognitive deficit in a progressive neuromuscular disor-
der known as myotonic dystrophy (DM1), which is the
most common form of muscular dystrophy in adults
(17). DM1 patients suffer from DMPK insufficiency due
to the retention of mRNA transcripts in the nucleus
(18, 19). However, it is not currently understood how
low levels of this kinase affect cellular function, and
thus its involvement in disease remains polemic.
Oligomerization via CC segments is thought to be
central to the regulation of DMPK-related kinases. CC
motifs consist of two to five amphipathic -helices that
wind around each other to form, typically, a left-
handed supercoil. They mediate self-assembly events in
proteins but can also be implicated in refolding pro-
cesses and molecular recognition (for a recent review,
see ref 20). CC sequences are characterized by a repeat
1 Correspondence: Division of Structural Biology, Biozen-
trum, University of Basel, Klingelbergstr. 70, Basel CH-4056,
Switzerland. E-mail: olga.mayans@unibas.ch
doi: 10.1096/fj.05-5262com
1142 0892-6638/06/0020-1142 © FASEB
pattern of seven amino acids denoted a to g. Positions
a and d classically harbor hydrophobic residues, which
constitute the structural core of the motif. Positions e
and g often host charged groups that form networks of
intra- and interhelical salt bridges crucial to fold stabil-
ity and interchain recognition. CC domains from
DMPK-related kinases are believed to form dimeric
assemblies and thereby to mediate dimerization in
these enzymes. To date, only two closely related CC
fragments from this family have been characterized.
These correspond to the C-terminal, Rho binding
motifs of ROCKII-CC and ROCKI-CC that share 52%
sequence identity (Fig. 1). For these, crystal structures
have been reported in free form (21) and complexed
to RhoA (22), respectively, confirming that both coils
form parallel dimers. In a similar way, only a few
analytical studies have reported on the oligomerization
state of full-length kinases. Currently, data are available
only for DMPK (23) and ROCKs (24, 25), which have
been shown to adopt dimeric states. Despite the simi-
larity of these kinases, different mechanisms have been
proposed for their dimerization. While data on DMPK
defended a self-assembly driven by its CC motif (23),
the reports on ROCKs prove that CC moieties are not
required for their oligomerization. The latter agrees
with a biochemical study of MRCK, which also reported
self-association in the absence of CC fractions (26). The
associative interactions in ROCKs are the best under-
stood so far due to the recent availability of the crystal
structure from the dimeric N-terminal fraction (i.e.,
lacking CC segments) from ROCKI (25). This shows
how head-to-head dimers interact via a small, N-termi-
nal domain comprising the -helical LR region (Fig. 1)
as well as a tail, C-terminal to the kinase domain, which
wraps around the catalytic core to reach the subunit
interface. Given that dimerization segments show a
certain homology across DMPK, ROCKs, and MRCK
(Fig. 1), it would be reasonable to expect that related
mechanism of assembly could be supported by these
kinases, even if conflicting data have been reported
(23).
Moreover, different biochemical roles have been
attributed to the CC moieties of these kinases. The CC
domains of ROCKs and citron kinase act as intrasteric
inhibitors of their respective kinase domains and house at
their C termini binding motifs for small Rho GTPases,
where binding of the latter releases the inhibition (7, 27).
CC segments of MRCK (CC2/CC3) also act as intrasteric
inhibitors but do not host a GTPase binding region (26),
and physiological release factors are yet to be identified.
On the contrary, the CC fraction of DMPK (DMPK-CC)
has been proposed to act as an enhancer of its kinase
activity (23), although it is unknown whether this involves
transphosphorylation events as those observed in tyrosine
kinases. In summary, both the functionality of CC do-
mains from this family and the extent to which they
govern molecular assembly remain unclear. Given that
the CC from DMPK appears to differ from those of
ROCKs and MRCK both in its regulatory properties and
in its role during assembly (23), we have investigated the
architectural details of DMPK to assess whether a com-
mon association principle exists in this family of kinases.
MATERIALS AND METHODS
Cloning
Expression constructs were derived from human DMPK
cDNA (L08835) spanning residue ranges as shown in Fig 1.
DMPKVR was cloned into the EcoRI and SalI sites of the
insect cell expression vector pFastBac1 (Invitrogen, San Di-
ego, CA, USA). A His6-tag and a TEV (tobacco etch virus)
protease cleavage site were inserted N-terminal to the target
construct. DMPKCC/VR was cloned into pET-15b (Nova-
gen, Madison, WI, USA) using primers 5-GGAATTCCATA-
TGTCAGCCGAGGTGCG-3 and 5-CGGGATCCTTACCCC-
GTGACAGCTGTGG-3 with NdeI and BamHI restriction sites,
respectively. This vector adds a His6-tag and a thrombin
cleavage site N-terminal to the target protein. Cloning of
DMPK-CC has been previously reported (28). DMPK-CCN
was cloned into the pETM-11 vector, a modified version of
pET-24d (Novagen) that includes a His6-tag plus a TEV
protease cleavage site N-terminal to the expression construct.
This used primers 5-CGTTCGAAGACTACATGTTGGTG-
GAGGACGGGCTC-3 and 5-GGGGTACCTTACCCCGTGA-
CAGCTGTGG-3 carrying BbsI (NcoI-compatible) and KpnI
restriction sites.
Protein production
Sf9 cells were transfected with the bacmic cDNA construct of
DMPKVR according to the manufacturer’s instructions
Figure 1. Domain organization in DMPK, MRCK,
and ROCK. Domain composition of human
DMPK (Q09013–9), mouse DMPK (P54265), hu-
man MRCK (Q5VT26), rat MRCK (AF021935),
human MRCK (Q81WQ7), mouse ROCKII
(V58513), and mouse ROCKI (V58512). LR:
leucine-rich region; CC: coiled-coil; VR: region
variable across DMPK spliceoforms. CR: cys-
teine-rich domain, PH: pleckstrin homology
domain; CH: citron homology domain; PBD:
p21 GTPase binding domain. Sequence identity
to human DMPK is given as percentage where
applicable. DMPK constructs used in the cur-
rent study are shown.
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(Life Technologies Bac-to-Bac system). The transfected cells
were incubated for 3 days at 27°C and the supernatant,
containing recombinant virus for protein expression, was
collected. Amplified virus (10 ml) was added to 1  106 Sf9
cells and incubated at 27°C for 3 days. Lysis was performed by
incubation on ice for 30 min in the presence of DNase and
protease inhibitors (Complete EDTA-free; Roche, Nutley, NJ,
USA) in 50 mM Tris pH 8.0, 300 mM NaCl, 5 mM -mercap-
toethanol, 2% glycerol. A clarified supernatant was obtained
by centrifugation at 20,000 rpm and 4°C for 1 h. The protein
product was purified by affinity chromatography on a His-
Trap HP column (GE Healthcare) equilibrated in lysis media.
The bound protein was eluted by supplementing the medium
with 200 mM imidazole. Subsequent purification used size
exclusion chromatography on a Superdex 200 Tricorn 10/30
GL column (GE Healthcare) in 50 mM Tris pH 8.0, 150 mM
NaCl, 5 mM -mercaptoethanol, 2% glycerol.
DMPKCC/VR was expressed in E. coli Rosetta (DE3)
(Novagen) grown in LB medium supplemented with 34
g/ml of chloramphenicol and 100 g/ml ampicillin. Induc-
tion used 1 mM IPTG and incubation was overnight at 25°C.
Cells were harvested by centrifugation at 8000 g at 4°C for 15
min. Lysis was by French pressing in the presence of DNase
and protease inhibitors in 50 mM Tris pH 8.0, 50 mM NaCl,
5 mM -mercaptoethanol. The clarified supernatant, ob-
tained by centrifugation at 20,000 rpm (4°C), was purified by
affinity chromatography and subsequent gel filtration (as
described for DMPKVR) in lysis media. Expression and
purification of DMPK-CC were as reported (28). Production
of DMPK-CCN used protocols as for DMPK-CC, except that
all media were supplemented with 5 mM -mercaptoethanol.
All measurements used fresh preparations and sample iden-
tification was by peptide-digest mass spectrometry.
Structure determination
Crystallization, data collection, data statistics, and experimen-
tal phasing of DMPK-CC have been described (28). Briefly,
crystals grew from 100 mM Tris-HCl pH 7.5, 2.0 M Na/K
tartrate and 5–10 mg/ml protein solutions. X-ray diffraction
data collected at beamline ID14–2 (ESRF, Grenoble) re-
vealed the crystals to belong to space group P212121 with unit
cell dimensions of a  39.1 Å, b  46.2 Å, c  143.5 Å, and
three polypeptide chains per asymmetric unit. Experimental
phasing used 3	 MAD on an Se-Met derivative. Phase refine-
ment was in SHARP (29) and automatic model improvement
in ARP/warp v6.1 (30). Manual model building used the
software O (31) and refinement was in REFMAC (32). For
cross-validation, crystallographic data were divided into a
working and a test set using FREERFLAG (33). Restraints for
non-crystallographic symmetry were applied during the initial
phase of refinement and released at later stages. Geometrical
parameters of intermediate and final models were assessed
using PROCHECK (34). The final model lacks several N- and
C-terminal residues that could not be resolved in electron
density maps, namely 461–465/530–537 in chain A, 461–
463/528–537 in chain B and 461–465/527–537 in chain C.
This amounts to 
20% of disorder in the structure and
explains the slightly elevated R-factor values, which are some-
what above those characteristic of this resolution. Coordi-
nates have been deposited at the Protein Data Bank with
accession number 1WT6.
Analytical ultracentrifugation
Sedimentation velocity and equilibrium data were recorded
using an Optima XL-A analytical ultracentrifuge (Beckman
Instruments, Fullerton, CA, USA) equipped with 4 and
12-mm Epon double-sector cells in an An-60 Ti rotor and
absorption optics. Runs were performed at 20°C in 1) 50 mM
Tris pH 7.5, 50 mM NaCl and 2) 100 mM sodium phosphate
pH 7.0 using detection wavelengths of 277 nm and 234 nm.
Sedimentation velocity experiments were carried out at
54,000 rpm and 0.65 mg/ml sample concentration. Sedimen-
tation equilibrium measurements were performed at 19,000,
21,000, 24,000, and 26,000 rpm, and protein concentrations
of 0.16–3.3 mg/ml for DMPK-CC and 0.09–1.4 mg/ml for
DMPK-CCN, where optical density values remained in a
linear range. Average molecular masses were evaluated using
SEGAL (G. Machaidze and A. Lustig, unpublished software),
which adjusts the baseline absorbance to obtain the best
linear fit of ln(absorbance) vs. radial distance square. A
protein partial specific volume of 0.73 ml/g was used, while
solution density was taken as 1.003 g/ml and viscosity as 1.02
centipoise.
Circular dichroism spectroscopy
Thermal denaturation of DMPK-CC was monitored at 222 nM
on a 62A DS circular dichroism spectropolarimeter (AVIV)
equipped with a temperature-controlled quartz cell of 2 mm
optical path over a temperature range of 5–90°C. The scan
speed was 0.5°C/min with a spectral bandwidth of 2.0 nm.
Binding assays
The binding of DMPK-CC to DMPKCC/VR was assayed in
50 mM Tris-HCl pH 7.5, 100 mM NaCl by 1) affinity pull-down
assays using His6-tagged DMPKCC/VR immobilized in a
His-Trap HP column (GE Healthcare) vs. a flow of untagged
DMPK-CC; 2) simultaneous coexpression of both constructs
followed by attempts of copurification via metal affinity plus
size exclusion chromatography (protocols as above).
Size exclusion chromatography combined with multiangle
light scattering (SEC-MALS)
The oligomeric state of DMPKVR and DMPKCC/VR in
solution was determined via SECMALS measurements per-
formed on an ÅKTA explorer 10 system (GE Healthcare)
connected to a triangle light scattering detector and a differ-
ential refractometer (miniDAWN Tristar and Optilab, respec-
tively; Wyatt Technology, Santa Barbara, CA, USA). A Super-
dex 200 HR 10/30 column (GE Healthcare) was used in 50
mM Tris-HCl pH 8.0, 50 mM NaCl at a flow rate of 0.5
ml/min. Sample volumes of 50 l (DMPKVR) and 100 l
(DMPKCC/VR) were injected at a concentration of 2 mg/
ml. A specific refractive index increment (dn/dc) value of
0.185 ml/g was used. The data were recorded and processed
using ASTRA software (Wyatt Technology). To determine the
detector delay volumes and normalization coefficients for the
MALS detector, a BSA sample (Sigma A-8531) was used as
reference. Neither despiking nor band broadening correc-
tion was applied.
Small angle X-ray scattering (SAXS)
Synchrotron radiation SAXS data were collected on the X33
camera (35) of EMBL (DESY, Hamburg). Solutions of
DMPKCC/VR were measured at protein concentrations of
1.4, 3.8, 5.7, 8.5, and 9.3 mg/ml in 50 mM TrisHCl pH 8.0, 50
mM NaCl, 2.5 mM -mercaptoethanol at 4°C. Measurements
were recorded using a MAR345 IP detector at a sample
detector distance of 2.7 m and wavelength 	  1.5 Å in the
range of momentum transfer 0.011  s  0.45 Å–1. Exposure
time for a single measurement was 5 min. To check for
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radiation damage, two consecutive 3 min exposures at the
highest protein concentration were compared and no
changes were observed. The data were normalized, the scat-
tering of the buffer subtracted, and the difference curves
extrapolated to zero solute concentration using the program
package PRIMUS (36). The maximum particle dimension
Dmax, forward scattering I (0) and the radius of gyration Rg
were evaluated using GNOM (37). The molecular mass (MM)
of the solute was calculated by comparing its forward scatter-
ing with that of a reference solution of BSA (MM66 kDa).
The volume of the hydrated particle was computed using the
Porod invariant equation (38). The low resolution shape of
the molecule was computed ab initio using the program
DAMMIN (39), which uses an assembly of densely packed
beads to represent the protein molecule. Simulated anneal-
ing was used to build a compact, interconnected configura-
tion of beads inside a sphere with the diameter Dmax that fits
the experimental data Iexp(s) to minimize the discrepancy:
2
1
N  1 j  Iexp
sj cIcalc
sj
sj 
2
where N is the number of experimental points, c is a scaling
factor and Icalc(s), and (sj) are the calculated intensity and the
experimental error at the momentum transfer sj, respectively.
The scattering from the crystallographic model of ROCKI
(protein fraction of PDB entry 2ETR; 25) was calculated
using CRYSOL (40). The model of dimeric DMPKCC/VR
was constructed based on the structure of ROCKI using the
program BUNCH (41). The dimerization domains consisting
of the 70 N-terminal and 20 C-terminal residues of ROCKI
remained fixed during the calculations, so that the subunit
interface stayed unaltered. The kinase domain was allowed to
move as a rigid body while the missing C-terminal tail in
DMPKCC/VR was represented as an interconnected chain
of dummy residues (for domain definition, see Fig 6a) (42).
A simulated annealing protocol was used to position the
kinase domain and find the configuration of the C-terminal
fragment that could fit the experimental scattering while
obeying the P2 symmetry of the dimer.
RESULTS
Crystal structure of DMPK-CC
The structure of DMPK-CC (residues 461–537; Fig. 1)
has been elucidated by X-ray crystallography up to 1.6 Å
resolution. X-ray data statistics and model refinement
parameters are given in Table 1. Crystals contain three
polypeptide chains in the asymmetric unit, which form
a consecutive coil of 86.5 Å length, spanning residues
466–527 and comprising eight complete heptad re-
peats. They build a parallel, left-handed trimeric motif
(Fig 2a).
The architecture of DMPK-CC is restrained at its
terminal sections while a central region exhibits mod-
erate structural fluctuations as indicated by crystallo-
graphic temperature factors and interchain conforma-
tional agreement (Fig 2a, b). The relative structural
slackness at the middle point of the domain correlates
with a widening of the coil at that position (Fig 2c),
which is likely to be caused by the presence of a
sequence motif, 493-IRTD-496, with low propensity for
CC formation (estimated using MultiCoil; 43). Also
noticeable is a residue located upstream, R483, which
contributes a charged group in core position a with a
reduced Crick-phase (–2.8o instead of the commonly
TABLE 1. X-ray data statistics and model parameters
X-ray data
Space group P212121
Resolution (Å) 20–1.6 (1.69–1.6)
Unique reflections 33876 (3951)
Completeness (%) 96.3 (79.2)
Rsym(I) 0.059 (0.330)
Multiplicity 4.4 (2.3)
I/(I) 15.0 (2.5)
Model refinement
Resolution (Å) 20–1.6
Reflections working/free 32044/1712
R-factor/R-free (%) 22.7/27.0
Chains per asymmetric unit 3
No. protein/solvent atoms 1619/294
Average B (Å2) 26.05
Rmsd bond lengths (Å)/ angles (°) 0.019/1.717
Residues in Ramachandran core /
disallowed (%) 99.5/0
Figure 2. Crystal structure of DMPK-CC. a)
Ribbon representation colored in a blue-to-red
gradient according to crystallographic B-factors
(8 to 55 Å2), where blue designates low values.
Solvent atoms in the interior of the CC motif
are displayed as red spheres; b) Superimposition
of chains A, B, and C colored as in panel a. C
atoms of residues influencing coil parameters
are shown as black spheres; c) coil parameter
values for pitch, radius and residue tendency to
coil formation. Residues leading to coil alter-
ations are boxed; d) sequence alignment of
DMPK-CC and MRCK-CC3. Identity is shown in
yellow and similarity in green.
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encountered value of –40o, as calculated using Twister;
44). This leads to overtwisting of the subsequent coil
portion (Fig 2c) and an associated suboptimal hydro-
phobic core packing in that region. Thus, central coil
widening and pitch parameters appear not to simply
reflect crystal lattice restraints but to be an intrinsic
structural feature of this CC domain.
Residue arrangements around the 3-fold axis of
DMPK-CC are mostly symmetrical, an exception are the
side chains of F500, an aromatic residue in position d.
The presence of aromatic groups in core positions is
extremely rare in dimeric CCs, but it is observed in
trimeric motifs (45). For example, the trimeric coil of
lung surfactant protein D (46) contains F225 and Y228
in a and d positions, respectively, which exhibit similar
asymmetrical arrangements of their side chains. This is
likely to reflect the difficulty of packing bulky groups in
the limited interior of a trimeric coil. Remarkably,
DMPK-CC also houses several solvent molecules in its
core. In particular, its C-terminal section comprises an
internal cavity filled by solvent that stabilizes a polar
residue, N511, in a core position. A similar arrange-
ment has been found in other trimeric CCs, such as
bacteriophage T4 fibritin (47) and a domain of a coat
protein from MoMuLVirus (48). Such buried polar
groups in CCs are thought to contribute to the speci-
ficity of the motif and to maintain chain registry (49).
Other relevant interactions in DMPK-CC (Fig. 3) in-
clude 6 interchain and 2 intrachain salt bridges. Inter-
chain bridges help defining the association state of
CCs, while intrachain bridges are important for helix
stability (50). The interchain bridges of DMPK-CC
belong both to the classical types eg’RE and eg’ER and
to unusual core contacts of type ad’RE (notation as in
ref 40; where ’ designate residues in a subsequent
heptad repeat). Intrachain salt bridges in DMPK-CC
are of type bf RE. It is striking that the sequence of
DMPK-CC is rich in charged residues (16E, 9R, vs. 2D,
0K per chain), although less than half of these are
involved in interactions (8E, 4R, 0D). Thus, availability
of reactive groups in the surface of this domain is high
(predominantly of a negatively charged character and
toward the NH2 terminus of the domain), so that it
could support electrostatic binding to other molecular
components.
Characterization of DMPK-CC in solution
In agreement with crystallographic data, the association
state of DMPK-CC in solution is trimeric. One single
oligomeric species could be detected using native-
PAGE, size exclusion chromatography (Fig 4a), and a
sedimentation velocity study, which produced a single
migrating boundary corresponding to a S20W of 2,1.
Thus, the sample population in solution appeared to be
highly homogeneous, with no dynamic states of assem-
Figure 3. Intra- and interchain interactions in DMPK-CC.
Green represents hydrophobic groups, red is negatively
charged, blue is positively charged, and black, all other
residues. The central red sphere represents an internal
solvent atom located at the 3-fold axis and coordinating the
three side chains of N511. Interactions are shown as connect-
ing lines, where salt bridges are in black.
Figure 4. Biophysical characterization of DMPK-CC in solution. a) Size exclusion chromatogram in 50 mM Tris-HCl pH 7.5, 100
mM NaCl using a Superdex 75 Hi Load 16/60 column. A native-PAGE is shown in the inset; b) molecular mass calculated from
sedimentation equilibrium measurements for DMPK-CC (triangles) and DMPK-CCN (squares). Buffer conditions as in panel
a. Theoretical mass values for trimeric formations are indicated by horizontal bars, where a continuous line corresponds to
DMPK-CC and a dashed line to DMPK CCN. c) Thermal denaturation curve monitored by circular dichroism. First derivative
is shown.
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bly being observed. Sedimentation equilibrium analysis
of DMPK-CC yielded an average molecular mass (MM)
of 
33 kDa over the entire protein concentration
range assayed (0.16–3.3 mg/ml), consistent with the
single presence of trimers in the solutions (theoretical
MM for a trimer of this construct 34.9 kDa; Fig 4b).
Since the sample remained fully assembled at the
lowest concentration assayed, the Kd of the interaction
must be lower than 4 M.
These studies carried out at moderate ionic strength
(50–100 mM NaCl) and limited protein concentration
are in good agreement with crystallographic data ob-
tained from high salt solutions (2.0 M Na/K tar-
trate) or polyethylene glycol media and concentrated
protein samples (5–10 mg/ml), both at pH 4.6 and 7.5
(28). This suggests that the trimeric formations of
DMPK-CC are stable in a broad range of media condi-
tions. To gain further insight into the stability of this
domain, it was investigated by thermal denaturation
monitored by circular dichroism. A monophasic melt-
ing curve was recorded characteristic of a cooperative
helix-coil transition of the three chains as a single
domain, with a T1/2m of 46°C (Fig 4c). This measure-
ment was carried out in 100 mM sodium phosphate
buffer pH 7.0, 100 mM NaCl at a protein concentration
of 0.6 mg/ml. To account for specific buffer effects,
measurements were repeated in 50 mM bis-Tris pro-
pane pH 7.5, 100 mM NaCl with equivalent results. This
indicates a strong association of the component chains
and confirms the robustness of the assembly. There-
fore, it can be concluded that DMPK-CC has a strong
tendency to self-associate into well-defined trimeric
formations.
Oligomeric state of DMPK variants containing and
lacking the CC domain
The assembly level of a DMPK construct comprising the
LR sequence, the kinase domain, and the CC fraction,
DMPKVR (Fig. 1), was investigated using multiangle
light scattering coupled to size exclusion chromatogra-
phy (SEC-MALS). This construct closely resembles an
expressed DMPK spliceoform and is a suitable repre-
sentative of this kinase in the cell. The study yielded
MMs of 1227 kDa and 1245 kDa for protein concen-
trations estimated using UV-A280 and refractive index,
respectively. These values are in excellent agreement
with the calculated MM of 1202 kDa for a dimer of this
sample (Fig. 5). This result is consistent with previous
sedimentation equilibrium data on a comparable con-
struct of this kinase (23).
To investigate the contribution of DMPK-CC to the
dimerization of this kinase, a truncated variant lacking
the CC fraction, DMPKCC/VR (Fig. 1), was exam-
ined. Data from size exclusion chromatography and
native PAGE indicated the presence of a single species
of DMPKCC/VR in solution, and SEC-MALS measure-
ments confirmed that this corresponded to dimeric
formations (Fig. 5). The experimental MM estimated
for this sample was 1014 kDa and 1074 kDa using
UV-A280 and refractive index to estimate the protein
concentration, respectively. This is in close agreement
with the theoretical MM of 1066 kDa for a dimer of this
construct. Furthermore, samples remained monodis-
perse and data were consistent through injected pro-
tein concentrations of 0.3–2 mg/ml, indicating that
results are concentration independent (data not
shown). The assembly state of DMPKVR coincides
with that of DMPKCC/VR but not DMPK-CC, showing
that the association level of this kinase is not dictated by
the oligomerization properties of its CC domain and
that segments associated with the kinase domain bear
this function instead.
Analysis of DMPKCC/VR dimers by small angle
X-ray scattering
The kinase domain of DMPK is flanked by an N-terminal
region of 
65 residue length (LR) and a C-terminal tail
containing 
120-residues that links it to the CC domain
(Fig. 1). Recent crystallographic data on ROCKI (25)
show that, in that kinase, sequences both N- and C-
terminal to the kinase domain pack together to form a
dimerization domain. It has been shown that the single
presence of the -helical LR region is not sufficient to
secure assembly in this case, so that the removal of the
kinase C-terminal tail results in
80% monomeric species
(24). Given that ROCKI and DMPK share homology in
the mentioned regions (22% and 36% seq. id. in the LR
domain and kinase tail, respectively; Fig 6a), we investi-
gated whether DMPK might follow the same architectural
principles of ROCKI by analyzing the overall conforma-
tion of DMPKCC/VR dimers using SAXS.
The experimental SAXS pattern of DMPKCC/VR is
displayed in Fig 6b. The estimated MM, 95  10 kDa,
confirms that the protein is dimeric under the SAXS
experimental conditions. This is further corroborated
by the volume of the hydrated particle, 210  10 
103Å (3), noting that, for globular proteins, the hy-
drated volume in Å3 should be approximately twice the
MM in daltons. The radius of gyration Rg and the
maximum particle size Dmax were 39.9  0.6 Å and
Figure 5. SEC-MALS characterization of DMPKVR and
DMPKCC/VR. Molar mass (dots) and normalized UV sig-
nals are shown. The theoretical molar masses of the dimers of
DMPKVR and DMPKVR/CC (120.0 kDa and 106.6 kDa,
respectively) are indicated with horizontal lines.
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130  10 Å, respectively, suggesting an elongated
structure. This agrees with the low-resolution shape of
DMPKCC/VR reconstructed ab initio, which fits neatly
the experimental data with a discrepancy   0.95 (Fig
6b). A comparison of this with the crystal structure of
ROCKI indicates that DMPKCC/VR has a similar
overall conformation, also appearing to form head-to-
head dimers (Fig 6c). The low-resolution model of
DMPKCC/VR, however, displayed extra electron den-
sity that was not satisfied by the ROCKI structure, as can
be expected from the fact that each protomer of
DMPKCC/VR has 65 additional residues at its C
terminus (Fig 6a). The missing residues account for
14% of the total scattering mass of this sample. They
Figure 6. SAXS analysis of DMPKCC/VR
dimers (a). Sequence similarity between
DMPKCC/VR and the crystallographic model
of ROCKI (PDB code 2ETR). Sequence identity
is highlighted in yellow. Secondary structure
elements are as in ref 25. Domain definition is
as follows: red corresponds to the LR domain,
blue to the kinase domain, and golden to the
C-terminal tail. ROCKI residues involved in
dimerization are marked with an asterisk. b)
Experimental scattering of DMPKCC/VR (1)
and calculated patterns from the ab initio low-
resolution bead model (2), the ROCKI crystal-
lographic model (3) and the reconstructed
DMPKCC/VR model with an added C-termi-
nal fraction (4); c) ab initio model of
DMPKCC/VR (gray semitransparent beads)
superimposed on the model constructed by
adding C-terminal particles (orange beads) to
the protomers of ROCKI (C-trace). Domain
coloring as in a. Three orthogonal views are
shown.
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play a significant role in the scattering of this molecule,
possibly due to their contribution to an anisometric
molecular shape (see below), so that the patterns
computed from ROCKI yielded a poor fit to the exper-
imental data (6.6; Fig 6b). To construct a model of
DMPKCC/VR, the missing C-terminal portion was
generated for each monomer using beads and main-
taining a 2-fold symmetry as described in Materials and
Methods. Although during the calculation the kinase
domain was allowed to drift and rotate as a rigid body,
its position was practically unchanged with respect to
ROCKI. Models of DMPKCC/VR so generated
showed that the C-terminal portions of each protomer
formed rather compact formations, suggesting the ex-
istence of a protein domain at this position. A typical
model of DMPKCC/VR in solution provides a good fit
to the experimental data (1.75; Fig 6b) and agrees
well with the molecular shape calculated ab initio as
revealed by a comparative superimposition (Fig 6c). A
deviation between models, however, shows that the
volumes occupied by the C-terminal fraction are repre-
sented somewhat differently by the two modeling meth-
ods. It should be noted that the ab initio model was
obtained without imposing any prior knowledge or
symmetry restrictions, whereas the reconstructed
model applies a 2-fold symmetry that may not be
entirely adhered to by a potentially flexible C-terminal
tail. Such flexibility could underlie localized deviations
between otherwise consistent models and scattering
patterns.
CC domains can be found in proteins in combination
with other motifs that influence their association. The
most prominent example is that of the trimeric CC of
fibritin, which is followed by a C-terminal extension of

30 residue length that folds into a -hairpin (51).
This intertwines with equivalent -hairpins from other
subunits, being essential to achieve CC trimerization in
that case. Given that SAXS models of DMPKCC/VR
suggested the presence of a structural formation imme-
diately prior to the CC fraction, we assayed whether this
might act as an association motif that could modulate
CC stoichiometry. For this, we constructed an N-termi-
nally extended version of DMPK-CC, DMPK-CCN (Fig.
1), and analyzed its oligomeric state by sedimentation
equilibrium (Fig 4b). Results indicated that DMPK-
CCN remained trimeric (estimated MM 56.1 kDa
compared to a theoretical MM of 63.5 kDa for a trimer
of this construct), suggesting that possible structural
elements of the kinase-CC linker sequence do not
influence the oligomerization of this coil.
DMPK-CC is not involved in domain interactions
The CC fractions of ROCKs and MRCK have been
shown to interact directly with their respective kinase
domains, thereby acting as intrasteric inhibitors of
kinase activity (26, 27). In ROCKs, the interaction
involves the Rho binding site at the C terminus of its
long CC domain, whereas in MRCK the binding has
been mapped to a fragment spanning CC2/CC3, whose
deletion resulted in about a 3-fold increase in activity.
Given that DMPK-CC and MRCK-CC3 share certain
sequence similarity (up to 31% identity according to
isoforms) (Fig 2d), we investigated the possible interac-
tion of DMPK-CC with other domains in this kinase
using pull-down assays as well as coexpression/copuri-
fication experiments on DMPK-CC and DMPKCC/
VR. Binding between these species could not be de-
tected by either procedure, which yielded independent
original species. Hence, DMPK-CC appears to neither
interact with the kinase domain nor form a hetero-coil
against the -helical LR sequence. This indicates that a
CC association/dissociation regulatory model such as
that proposed for MRCK and ROCKs is unlikely to be
applicable to DMPK and that the kinase and CC
fractions component of DMPK are likely to be arranged
as architecturally distinct fractions, resulting in a glob-
ular portion and a filamentous shaft.
DISCUSSION
The CC domains of DMPK-related kinases are essential
to the regulation of their catalytic activities. However,
the molecular events mediated by these domains are yet
to be accurately understood. CC sequences in this
family exhibit large variability in length and composi-
tion, sharing little or no similarity. Only minimal struc-
tural data exist that aid to clarify the respective prop-
erties and functional roles of CC domains within this
family. Here we report the crystal structure of DMPK-
CC, which is unrelated to the ROCKs-CCs previously
described (21, 22). Contrary to the dimeric character of
the latter fragments, DMPK-CC forms a trimeric motif
that is characterized by rigid termini and a central
widening of its coil. It is currently unknown whether
this feature might reflect functional properties of this
domain. As proven by sedimentation equilibrium data,
the assembly level of DMPK-CC in solution coincides
with that in the crystal. No other oligomeric state has
been detected in the current study under a broad range
of protein concentration and ionic strength conditions.
Furthermore, thermal denaturation studies have shown
this assembly to be stable. Thus, our data prove that the
oligomeric states of CC domains from this kinase family
are more diversified than previously expected and that
more coils must be investigated before general conclu-
sions on their self-association properties can be drawn.
Experimental results on DMPK-CC contrast markedly
with sequence-based predictions, which suggests this
coil forms dimeric assemblies. For example, the soft-
ware MultiCoil (43) estimates 82% probability of dimer
vs. 10% trimer formation. The structural determinants
of CC association remain poorly understood, and thus
such predictions should be considered with caution.
Only a few systematic analyses have addressed the basis
of CC association experimentally, focusing on either
the role of hydrophobic core residues (52, 53) or salt
bridges (e.g., 54, 55). Consequently, cases are described
where experimental data disagree with predictions (for
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example, see ref 46). To understand the molecular
basis of DMPK-CC trimerization, we analyzed its inter-
chain contacts. The only factor that might be proposed
at this time to favor formation of trimers over dimers is
the presence of an aromatic residue, F500, at core
position a, since this is rarely observed in dimeric coils
(45). The contribution of the several salt bridges in
DMPK-CC to its oligomerization cannot be evaluated
based on current knowledge.
Given that CCs are established oligomerization mo-
tifs, these were initially thought to be indispensable for
the molecular assembly of DMPK-related kinases. How-
ever, recent studies of ROCKs have shown that other
domains mediate self-association in these kinases,
namely, the N-terminal LR region and a tail C-terminal
to the kinase domain (24, 25). Similarly, in the current
study, a truncated DMPK variant lacking the CC moiety
formed dimeric assemblies according to SEC-MALS
data. A low-resolution structural analysis of these
dimers using SAXS indicated that DMPK and ROCKI
share similar dimerization principles involving head-to-
head protomer interactions, even though a certain
number of residues involved in the dimerization of
ROCKI are not conserved in DMPK (Fig 6a). Our data
on the truncated DMPK variant differ from those of a
previous study (23), where a similar DMPK construct
was argued to be monomeric according to sucrose
density gradient sedimentation and pull-down assays.
The dimeric form in our study (residues 1–460) con-
tains 29 more residues at its C terminus than the
construct previously reported. The truncation in that
case might have disrupted a possible structural element
C-terminal to the kinase domain, which has been
insinuated by current SAXS data. More studies are
required to identify the exact structural details of this
segment of DMPK and to establish whether its integrity
is essential for the assembly of this kinase. Contrary to
that former study, we conclude that the CC domain of
DMPK is not required for its self-association and that a
common architectural design is likely to be shared by
the closest members of this family: DMPK, MRCK, and
ROCKs.
The fact that an interaction between DMPK-CC and
other domains in DMPK could not be identified in the
current study suggests it is unlikely that the assembly
properties of this CC are altered by a possible embed-
ding within the kinase core. Neither is the influence of
flanking structural elements expected, given that an
N-terminally extended CC construct retained the same
oligomerization concentration. Thus, we speculate that
the stoichiometry of this coil within the context of full
DMPK must be dominated by the prior association of
the N-terminal catalytic fraction into dimers. Prediction
data confirm that the DMPK-CC sequence is geometri-
cally compatible with a dimeric association, and it is
known that CC oligomerization can be dynamically
altered by local factors (20).
Oligomerization is crucial for the activation of nu-
merous kinases. Often self-assembly is directed to en-
sure efficient autophosphorylation in trans by increas-
ing the local concentration of catalytic domains (56).
Given that DMPK-CC does not determine the self-
association of this kinase and that, contrary to MRCK
and ROCKs, it does not act as an intrasteric inhibitor
but as an activator, further investigations are needed to
clarify whether its function might relate instead to the
achievement of an active conformation or even sub-
strate docking. Moreover, given the heterogeneity in
CC sequences and their diversified interaction patterns
across DMPK-related kinases, studies are required to
reveal the exact role of these moieties and to establish
the principles of their regulatory mechanisms.
Thanks go to Prof. B. Perryman for facilitating the initial
DNA coding for DMPK. A special mention goes to R. Ravelli
at ID14–2 (ESRF) for exceptional assistance during data
collection. Thanks go to S. Strelkov for critical reading of this
manuscript. Most sincere gratitude goes to Prof. A. Plu¨ckthun
for generous support with SEC-MALS. We acknowledge the
support of Swiss National Foundation (grant 3100A0–
100852) and to P.G. of Association Franc¸aise contre les
Myopathies (grant 9812).
REFERENCES
1. Fu, Y. H., Pizzuti, A., Fenwick, R. G., Jr., King, J., Rajnarayan, S.,
Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P.,
et al. (1992) An unstable triplet repeat in a gene related to
myotonic muscular dystrophy. Science 255, 1256–1258
2. Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A. J., Church,
D., Aburatani, H., Hunter, K., Stanton, V. P., Thirion, J. P., Hudson, T.,
et al. (1992) Molecular basis of myotonic dystrophy: expansion of a
trinucleotide (CTG) repeat at the 3 end of a transcript encoding a
protein kinase family member. Cell 68, 799–808
3. Nakagawa, O., Fujisawa, K., Ishizaki, T., Saito, Y., Nakao, K., and
Narumiya, S. (1996) ROCK-I and ROCK-II, two isoforms of
Rho-associated coiled-coil forming protein serine/threonine
kinase in mice. FEBS Lett. 392, 189–193
4. Ishizaki, T., Maekawa, M., Fujisawa, K., Okawa, K., Iwamatsu, A.,
Fujita, A., Watanabe, N., Saito, Y., Kakizuka, A., Morii, N., and
Narumiya, S. (1996) The small GTP-binding protein Rho binds
to and activates a 160 kDa Ser/Thr protein kinase homologous
to myotonic dystrophy kinase. EMBO J. 15, 1885–1893
5. Wissmann, A., Ingles, J., McGhee, J. D., and Mains, P. E. (1997)
Caenorhabditis elegans LET-502 is related to Rho-binding kinases
and human myotonic dystrophy kinase and interacts genetically
with a homolog of the regulatory subunit of smooth muscle myosin
phosphatase to affect cell shape. Genes Dev. 11, 409–422
6. Luo, L., Lee, T., Tsai, L., Tang, G., Jan, L. Y., and Jan, Y. N.
(1997) Genghis Khan (Gek) as a putative effector for Drosoph-
ila Cdc42 and regulator of actin polymerization. Proc. Natl. Acad.
Sci. USA 94, 12963–12968
7. Di Cunto, F., Calautti, E., Hsiao, J., Ong, L., Topley, G., Turco,
E., and Dotto, G. P. (1998) Citron rho-interacting kinase, a
novel tissue-specific ser/thr kinase encompassing the Rho-Rac-
binding protein Citron. J. Biol. Chem. 273, 29706–29711
8. Leung, T., Chen, X. Q., Tan, I., Manser, E., and Lim, L. (1998)
Myotonic dystrophy kinase-related Cdc42-binding kinase acts as
a Cdc42 effector in promoting cytoskeletal reorganization. Mol.
Cell. Biol. 18, 130–140
9. Madaule, P., Eda, M., Watanabe, N., Fujisawa, K., Matsuoka, T., Bito,
H., Ishizaki, T., and Narumiya, S. (1998) Role of citron kinase as a
target of the small GTPase Rho in cytokinesis. Nature 394, 491–494
10. Piekny, A. J., and Mains, P. E. (2002) Rho-binding kinase
(LET-502) and myosin phosphatase (MEL-11) regulate cytoki-
nesis in the early Caenorhabditis elegans embryo. J. Cell Sci. 115,
2271–2282
11. Kosako, H., Yoshida, T., Matsumura, F., Ishizaki, T., Narumiya,
S., and Inagaki, M. (2000) Rho-kinase/ROCK is involved in
cytokinesis through the phosphorylation of myosin light chain
1150 Vol. 20 June 2006 GARCIA ET AL.The FASEB Journal
and not ezrin/radixin/moesin proteins at the cleavage furrow.
Oncogene 19, 6059–6064
12. Jin, S., Shimizu, M., Balasubramanyam, A., and Epstein, H. F.
(2000) Myotonic dystrophy protein kinase (DMPK) induces
actin cytoskeletal reorganization and apoptotic-like blebbing in
lens cells. Cell Motil. Cytoskeleton 45, 133–148
13. Schulz, P. E., McIntosh, A. D., Kasten, M. R., Wieringa, B., and
Epstein, H. F. (2003) A role for myotonic dystrophy protein
kinase in synaptic plasticity. J. Neurophysiol. 89, 1177–1186
14. Shimizu, M., Wang, W., Walch, E. T., Dunne, P. W., and Epstein,
H. F. (2000) Rac-1 and Raf-1 kinases, components of distinct
signaling pathways, activate myotonic dystrophy protein kinase.
FEBS Lett. 475, 273–277
15. Mounsey, J. P., Mistry, D. J., Ai, C. W., Reddy, S., and Moorman,
J. R. (2000) Skeletal muscle sodium channel gating in mice
deficient in myotonic dystrophy protein kinase. Hum. Mol. Genet.
9, 2313–2320
16. Lee, H. C., Patel, M. K., Mistry, D. J., Wang, Q., Reddy, S.,
Moorman, J. R., and Mounsey, J. P. (2003) Abnormal Na
channel gating in murine cardiac myocytes deficient in myo-
tonic dystrophy protein kinase. Physiol. Genomics 12, 147–157
17. Harper, P. S. (1989) Myotonic Dsytrophy, Saunders, London/
Philadelphia
18. Davis, B. M., McCurrach, M. E., Taneja, K. L., Singer, R. H., and
Housman, D. E. (1997) Expansion of a CUG trinucleotide
repeat in the 3 untranslated region of myotonic dystrophy
protein kinase transcripts results in nuclear retention of tran-
scripts. Proc. Natl. Acad. Sci. USA 94, 7388–7393
19. Jiang, H., Mankodi, A., Swanson, M. S., Moxley, R. T., and
Thornton, C. A. (2004) Myotonic dystrophy type 1 is associated
with nuclear foci of mutant RNA, sequestration of muscleblind
proteins and deregulated alternative splicing in neurons. Hum.
Mol. Genet. 13, 3079–3088
20. Lupas, A. N., and Gruber, M. (2005) The structure of alpha-
helical coiled coils. Adv. Protein Chem. 70, 37–78
21. Shimizu, T., Ihara, K., Maesaki, R., Amano, M., Kaibuchi, K., and
Hakoshima, T. (2003) Parallel coiled-coil association of the RhoA-
binding domain in Rho-kinase. J. Biol. Chem. 278, 46046–46051
22. Dvorsky, R., Blumenstein, L., Vetter, I. R., and Ahmadian, M. R.
(2004) Structural insights into the interaction of ROCKI with
the switch regions of RhoA. J. Biol. Chem. 279, 7098–7104
23. Zhang, R., and Epstein, H. F. (2003) Homodimerization
through coiled-coil regions enhances activity of the myotonic
dystrophy protein kinase. FEBS Lett. 546, 281–287
24. Doran, J. D., Liu, X., Taslimi, P., Saadat, A., and Fox, T. (2004)
New insights into the structure-function relationships of Rho-
associated kinase: a thermodynamic and hydrodynamic study of
the dimer-to-monomer transition and its kinetic implications.
Biochem. J. 384, 255–262
25. Jacobs, M. D., Hayakawa, K., Swenson, L., Bellon, S. F., Fleming,
M., Taslimi, P., and Doran, J. (2005) The structure of dimeric
rock 1 reveals the mechanism for ligand selectivity. J. Biol. Chem.
Oct 24; [Epub ahead of print]
26. Tan, I., Seow, K. T., Lim, L., and Leung, T. (2001) Intermolec-
ular and intramolecular interactions regulate catalytic activity of
myotonic dystrophy kinase-related Cdc42-binding kinase alpha.
Mol. Cell. Biol. 21, 2767–2778
27. Amano, M., Chihara, K., Nakamura, N., Kaneko, T., Matsuura,
Y., and Kaibuchi, K. (1999) The COOH terminus of Rho-kinase
negatively regulates rho-kinase activity. J. Biol. Chem. 274,
32418–32424
28. Garcia, P., Marino, M., and Mayans, O. (2004) Crystallization and
preliminary X-ray analysis of the coiled-coil domain of dystrophia
myotonica kinase. Acta Crystallogr. D 60, 2336–2339
29. La Fortelle, E., and Bricogne, G. (1997) Methods Enzymol. 276,
472–494
30. Perrakis, A., Morris, R., and Lamzin, V. S. (1999) Automated
protein model building combined with iterative structure re-
finement. Nat. Struct. Biol. 6, 458–463
31. Jones, T.A, Zou, J.Y., Cowan, S. W., and Kjeldgaard, M. (1991)
Improved methods for building protein models in electron
density maps and the location of errors in these models. Acta
Crystallogr. A 47, 110–119
32. Murshudov, G. N., Vagin A.A., and Dodson, E. J. (1997)
Refinement of macromolecular structures by the maximum-
likelihood method. Acta Crystallogr D 53, 240–255
33. Collaborative Computational Project, N. 4 (1994) Acta Crystal-
logr. D 50, 760–763
34. Laskowski, R. A., MacArthur, M. W., Moss, D. S., and Thornton,
J. M. (1993) PROCHECK: a program to check the stereochem-
ical quality of protein structures. J. Appl. Crystallogr. 26, 283–291
35. Koch, M. H. J., and Bordas, J. (1983) X-ray diffraction and
scattering on disordered systems using synchrotron radiation.
Nucl. Instrum. Methods 208, 461–469
36. Konarev, P.V., Volkov, V.V., Sokolova, A.V., Koch, M. H. J., and
Svergun, D. I. (2003) PRIMUSa Windows-PC based system for small-
angle scattering data analysis. J. Appl. Crystallogr. 36, 1277–1282
37. Svergun, D. I. (1992) Determination of the regularization
parameter in indirect transform methods using perceptual
criteria. J. Appl. Crystallogr. 25, 495–503
38. Porod, G. (1982) Small angle X-ray scattering. (Glatter, O., and
Kratky, O., eds) Academic Press, London
39. Svergun, D. I. (1999) Restoring low resolution structure of
biological macromolecules from solution scattering using simu-
lated annealing. Biophys. J. 76, 2879–2886
40. Svergun, D. I., Barberato, C., and Koch, M. H. J. (1995)
CRYSOLa program to evaluate X-ray solution scattering of
biological macromolecules from atomic coordinates. J. Appl.
Crystallogr. 28, 768–773
41. Petoukhov, M. V., and Svergun, D. I. (2005) Global rigid body
modelling of macromolecular complexes against small-angle
scattering data. Biophys. J. 89, 1237–1250
42. Petoukhov, M. V., Eady, N.A., Brown, K. A., and Svergun, D. I.
(2002) Addition of missing loops and domains to protein
models by x-ray solution scattering. Biophys. J. 83, 3113–3125
43. Wolf, E., Kim, P. S., and Berger, B. (1997) MultiCoil: a program
for predicting two- and three-stranded coiled coils. Protein Sci. 6,
1179–1189
44. Strelkov, S. V., and Burkhard, P. (2002) Analysis of alpha-helical
coiled coils with the program TWISTER reveals a structural
mechanism for stutter compensation. J. Struct. Biol. 137, 54–64
45. Walshaw, J., and Woolfson, D. N. (2001) Socket: a program for
identifying and analysing coiled-coil motifs within protein struc-
tures. J. Mol. Biol. 307, 1427–1450
46. Hakansson, K., Lim, N. K., Hoppe, H. J., and Reid, K. B. (1999)
Crystal structure of the trimeric alpha-helical coiled-coil and the
three lectin domains of human lung surfactant protein D.
Structure Fold Des. 7, 255–264
47. Tao, Y., Strelkov, S. V., Mesyanzhinov, V. V., and Rossmann,
M. G. (1997) Structure of bacteriophage T4 fibritin: a seg-
mented coiled coil and the role of the C-terminal domain.
Structure 5, 789–798
48. Fass, D., Harrison, S. C., and Kim, P. S. (1996) Retrovirus
envelope domain at 1.7 Å resolution. Nat. Struct. Biol. 3, 465–469
49. Lumb, K. J., and Kim, P. S. (1998) A buried polar interaction
imparts structural uniqueness in a designed heterodimeric
coiled coil. Biochemistry 34, 8642–8648
50. Burkhard, P., Ivaninskii, S., and Lustig, A. (2002) Improving
coiled-coil stability by optimizing ionic interactions. J. Mol. Biol.
318, 901–910
51. Tao Y, Strelkov, S.V., Mesyanzhinov, V.V., and Rossmann, M. G.
(1997) Structure of bacteriophage T4 fibritin: a segmented coiled coil
and the role of the C-terminal domain. Structure 5, 789–798
52. Harbury, P. B., Zhang, T., Kim, P. S., and Alber, T. (1993) A
switch between two-, three-, and four-stranded coiled coils in
GCN4 leucine zipper mutants. Science 262, 1401–1407
53. Gonzalez, L., Jr., Woolfson, D. N., and Alber, T. (1996) Buried
polar residues and structural specificity in the GCN4 leucine
zipper. Nat. Struct. Biol. 3, 1011–1018
54. Kammerer, R. A., Jaravine, V. A., Frank, S., Schulthess, T.,
Landwehr, R., Lustig, A., Garcia-Echeverria, C., Alexandrescu,
A. T., Engel, J., and Steinmetz, M. O. (2001) An intrahelical salt
bridge within the trigger site stabilizes the GCN4 leucine zipper.
J. Biol. Chem. 276, 13685–13688
55. Meier, M., Lustig, A., Aebi, U., and Burkhard, P. (2002)
Removing an interhelical salt bridge abolishes coiled-coil for-
mation in a de novo designed peptide. J. Struct. Biol. 137, 65–72
56. Hubbard, S. R., and Till, J. H. (2000) Protein tyrosine kinase
structure and function. Annu. Rev. Biochem. 69, 373–398
Received for publication December 3, 2005.
Accepted for publication February 3, 2006.
1151OLIGOMERIZATION MOTIFS OF DMPK
63
Annex A
Studies on the oligomeric state of DMPK-CCN+
(Extended version of the DMPK-CC)
64
Annex A. DMPK-CCN+
65
A.1 Introduction
DMPK-CC has been found to constitute a trimeric motif both in solution and in the
crystalline state. On the contrary, the truncated DMPKΔCC/VR is a dimer according
to SEC-MALS and SAXS. Since the full-length DMPK has been shown to be
dimeric, the association of the whole system must be driven by a dimerization motif
other than the CC domain.
Interestingly, CC domains can be found in proteins in combination with other motifs
that influence their association. The most notorious example is that of the trimeric CC
of fibritin, which is followed by a C-terminal extension of ∼30 residues length, termed
“foldon”, that folds into a β-hairpin and serves as a registration motif for the triple CC
domain of fibritin (Tao et al. 1997). This small foldon domain has a β-propeller
conformation and can fold and trimerize autonomously (Frank et al. 2001). It has been
reported that fibritins with a deleted or mutated foldon domain fail to fold correctly,
whereas mutants with an altered CC motif but an intact foldon domain trimerize
successfully (Letarov et al. 1999).
SAXS models of DMPKΔCC/VR suggested the presence of a yet unidentified domain
in this kinase located immediately prior to its CC domain. In order to study whether a
CC-associated domain might modulate the oligomerization of DMPK-CC, an N-
terminally extended version of the latter, hereby termed DMPK-CCN+ was created and
its oligomeric state analyzed by sedimentation equilibrium.
The constructs employed in the current and the following studies are shown in Figure
A.1.
Figure A.1: Schematic domain representation of human DMPK constructs used in this study.
LR: leucine-rich region; CC: coiled-coil; VR: variable region are shown.
LR S/T KINASE CC VR
1        67                                  340            460      537            629
 DMPK
537460DMPK-CC
DMPK-CCN+ 369 537
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A.2    Experimental Work
A.2.1  DMPK-CCN+ native
A.2.1.1 Cloning
DMPK-CCN+ construct comprises the CC domain and the residues within the linker
region N-terminal to the CC. The C-terminal boundary of the kinase domain was
determined by sequence alignment with homologous kinases, and a caspase cleavage
site was found immediately after the kinase domain in the linker region at position
368. Therefore, in the expectation that the DMPK-CCN+ construct would be stable in
solution, its N-terminus was designed to start at this caspase cleavage site. Thus,
DMPK-CCN+ comprises residues 369-537, including the region that, according to
modelling based on SAXS data, might allocate a putative structural element C-
terminal to the kinase domain. An expression construct encoding DMPK-CCN+ was
derived from human DMPK complementary DNA (cDNA) (see Figure A.2).
The nucleotide sequence of the forward primer (N-terminus) was 5’-
CGTTCGAAGACTACATGTTGGTGGAGGACGGGCTC- 3’ with BbsI restriction
site, which creates a compatible overhang for NcoI in the vector pETM-11 (EMBL,
Figure A.3). The reverse primer (C-terminus) was
5’-GGGGTACCTTACCCCGTGACAGCTGTGG- 3’, which includes a KpnI
restriction site and was already employed to syntesize the DMPK-CC construct.
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Figure A.2: Design of DMPK-CCN+ constructs. Two constructs of DMPK-CCN+ were produced. The
first one corresponds to the wild-type, which contains the His6-tag and a TEV protease cleavage site.
The second one is a variant form of the former, where the cysteine at position 407 has been point
mutated into a serine.
Figure A.3: pETM-11 vector map. The pETM-11 expression vector (Günter Stier; EMBL plasmid
collection, Heidelberg, Germany) is a modified version of the pET24d with an upstream sequence
coding for a hexahistidine-tag (His6-tag) plus a TEV protease cleavage site followed by the non-
essential gene of a protein called MAD. For construct design, the MAD insert was excised and replaced
with the gene encoding the desired protein.
5’ -GGCTACTCCTAC TCC TCCATGGCCCTCAGGGAC- 3’
3’ -CCGATGAGGATG AGG AGGTACCGGGAGTCCCTG- 5’
    G  Y  S  Y   S   Y  M  A  L  R  D
 * 
HHHHHH-PMSDYDIPTTENLYFQ GAM-
TEV
 cleavage site
369 537
His6-TEV-DMPK-CCN+ wild type
pETM-11 vector
HHHHHH-PMSDYDIPTTENLYFQ GAM-
369 537
His6-TEV-DMPK-CCN+ mutant
pETM-11 vector
TEV
 cleavage site
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Polymerase chain reaction (PCR) was carried out with cDNA (150 ng) as a template,
direct and reverse primers, and DNA polymerase (Expand Long Template PCR
System, Roche) on a Tpersonal Biometra thermocycler. The PCR process consisted of
the following steps: (1) Initiation. The mixture was heated at 95 °C for 5 minutes to
ensure the melting of the DNA strands as well as the primers. (2) Melting. The
double-stranded DNA is heated at 95 °C for 30 seconds in order to separate the
strands. (3) Annealing. After separating the DNA strands, the temperature is lowered
to 55 °C and incubated for 30 seconds, so the primers can attach themselves to the
single DNA strands. (4) Elongation. Finally, the DNA-Polymerase has to copy the
DNA strands. It starts at the annealed primer and works its way along the DNA
strand. Elongation occurs by incubating at 72 °C for 1 minute. (5) Steps 2-4 are
repeated 30 times. The PCR product was verified on an agarose gel as illustrated in
Figure A.4.
Figure A.4: Verification of the PCR product on agarose gel. Lane 1, 1kb DNA ladder (Promega).
Lanes 2-3, agarose-gel purified PCR products with an expected MM of 504 base pairs (bp).
Subsequently, a PCR fragment of approximately 500 bp was gel-purified by using
QIAquick Gel Extraction Kit (Qiagen) from an approximately pure sample and cloned
cohesive-ended into the expression vector pETM-11. This modified version of pET-
24d (Novagen) includes a His6-tag plus a TEV (tobacco etch virus) protease-cleavage
site at the N-terminus to the expression construct.
Ligation employed the “Fast Ligation” method (Promega). Conventional ligation
requires a long incubation period (typically overnight) at temperatures ranging from
ladder PCR
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12-22 °C. The Fast Ligation provides an alternative method designed for the ligation
of cohesive-ended DNA inserts into plasmid vectors in 5 minutes at room temperature
(RT) with higher efficiency than traditional ligation procedures. This system, based
on T4 DNA ligase, is designed to eliminate any further purification prior to
transformation of ligated DNA.
The ligation mix (both complementarily digested PCR product and expression vector)
was incubated with Fast Ligation mixture for 10 minutes at RT followed by heat-
shock transformation into XLI-Blue cells at 42 °C for 90 seconds. The plasmid was
constructed in E. coli strain DH5α.
DNA manipulations and bacterial transformations were carried out using standard
protocols (Sambrook et al. 1989). The correct sequence of the clone was checked by
DNA sequencing (Microsynth AG, Balgach, Switzerland).
A.2.1.2  Over-expression
The plasmid coding for DMPK-CCN+ was transformed in E. coli Rosetta (DE3) strain
(Novagen). The cells were grown in Luria-Bertani broth (LB medium), supplemented
with 34 µg/ml chloramphenicol and 25 µg/ml kanamycin at 37 °C. At an optical
density (OD) of 0.6 at 600 nm, expression was induced by addition of 1mM isopropil-
β-D-thiogalactopyranoside (IPTG) and cells were incubated overnight at 25 °C until
an OD of 1.2 was reached.  The cells were harvested by centrifugation at 18,000 rpm,
for 30 minutes at 4 °C, washed with LB medium and stored at –80 °C.
A.2.1.3  Purification
For product purification, the cells were resuspended in lysis buffer composed of 50
mM Tris pH 7.5, 100 mM NaCl and 5 mM β-mercaptoethanol (β-ME) supplemented
with 40 mM imidazole, 1-5 µg/ml of DNAse, Phenylmethylsulphonylfluoride
(PMSF), a spatula-tip of lysozyme and a standard protease inhibitor cocktail without
the chelating agent ethylenediaminetetraacetic acid EDTA (Roche). Further cell lysis
was performed by sonication in ice (Branson Digital Sonifier) using a number of short
pulses (3-5 seconds) with pauses (7-10 seconds) to re-establish a low temperature.
The lysate was harvested by centrifugation at 18,000 rpm for 30 minutes at 4 °C and
the clarified supernatant was then purified by affinity chromatography on a His-Trap
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HP chelating column (GE Healthcare) pre-equilibrated in lysis buffer. To discard the
contaminant proteins the column was washed with lysis buffer followed by a gradient
of salt washes, where lysis buffer had been progressively supplemented with 150, 200
and 250 mM NaCl. Each step consisted of eight column volumes, always in the
presence of 40 mM imidazole. The bound protein was eluted by increasing the
imidazole concentration to 200 mM as shown in Figure A.5A.  The elution product
was then dialysed (membrane 12-14,000 KDa cut off, Spectra/Por) in 50 mM Tris-
HCl pH 7.5, 100 mM NaCl and 5 mM β-ME overnight at 4 °C. Subsequent
purification used size exclusion chromatography on a Superdex 200 Tricorn 10/300
GL column (GE Healthcare), equilibrated in 50 mM Tris pH 7.5, 100 mM NaCl and 5
mM β-ME. In the elution profile, two peaks were observed, which corresponded to
native DMPK-CCN+ and to lysozyme contaminant (according to mass spectroscopy),
respectively (Figure A.5B). DMPK-CCN+ eluted at 10.66 ml with an apparent MM
comprised between 440-232 kDa, much higher that expected for a dimer (46.8 kDa)
or a trimer (70.2 kDa), probably due to the anisotropic shape of the protein. This
protocol yielded ~10 mg of pure protein per liter of culture. The sample was stored at
4 °C for further studies. Fractions corresponding to native DMPK-CCN+ were pooled
and subjected to His6-tag cleavage. Tag removal used in-house produced TEV
protease (0.7 mg/ml) (see TEV-protease production protocol in Annex C) in 50 mM
Tris pH 8, 150 mM NaCl and 2 mM dithiothreitol (DTT) overnight at 4 °C. The
digested protein was purified on a second subtractive metal-affinity step employing a
His-Trap HP chelating 1 ml column (GE Healthcare). Tag-cleaved protein was
concentrated to 5 mg/ml with a 10 kDa cut off concentrator (Millipore) and stored at 4
°C. The protein obtained was pure according to SDS-PAGE (Figure A.6) and mass
spectroscopy. All purification procedures were executed at RT.
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Figure A.5: Purification of DMPK-CCN+ wild-type. (A) SDS-PAGE analysis of DMPK-CCN+ native
form (arrow) after a first purification using Ni-NTA chromatography. Lane 1, marker. Lanes 2-8,
elution fractions. (B) Elution profile of DMPK-CCN+ in a second purification step using size exclusion
chromatography on a Superdex 200 Tricorn 10/300 GL column (GE Healthcare). Two peaks were
observed, with the major one being DMPK-CCN+ and the second peak lysozyme. The inset shows a
SDS-PAGE gel of both peak fractions. Accordingly, fractions from DMPK-CCN+ were pooled and used
for further experiments. Positions of size standards thyroglobulin (669 kDa), ferritin (440 kDa),
catalase (232 kDa), aldolase (158 kDa), albumin (67 kDa) and chymotrypsinogenA (25 kDa) are
indicated.
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Figure A.6: SDS-PAGE of a subtractive purification of untagged DMPK-CCN+ protein. After
digestion with TEV protease, the purified untagged DMPK-CCN+ protein, with an expected MM of
19.4 kDa, was recovered in the flow-through (arrow) in a subtractive Ni2+-NTA affinity purification
step.
A.2.1.4  Protein determination
The protein concentration was determined by Bradford assay (Bradford 1976) with
standard Bovine serum albumin (BSA) as standard (Pierce). The Bradford Protein
Assay is based on the observation that the absorbance maximum for an acidic solution
of Coomassie Brilliant Blue G-250 shifts from 465 to 595 nm when binding to protein
occurs. The assay is useful since the extinction coefficient of a dye-albumin complex
solution is constant a 10-fold concentration range. The assay can be performed in the
presence of reducing agents such as DTT and β-ME.
The main disadvantage is that identical amounts of different standard proteins can
cause considerable differences in the resulting absorption coefficients. In addition to
this, the assay is non-linear over wide ranges, the dye binds strongly to quartz
cuvettes and some proteins precipitate in the dye reagent. The assay should be used
over narrow concentration ranges and plastic (or glass) cuvettes should be used.
In the current study, a calibration curve was constructed using standard BSA solution
(2.0 mg/ml) in the range of 0.2 -1 mg/ml. Protein samples with concentrations ranging
from 0.2-1 mg/ml were made up to 10 µl with distilled H2O in 1.5 ml eppendorf
microcentrifuge tubes.  1 ml of Bradford reagent was then added. The solution was
allowed to incubate at RT for 5 minutes before absorbances were read at 595 nm
wavelength using absorption spectroscopy (Hewlett Packard Model 8453 UV-VIS
system, Switzerland). Protein concentration estimations were calculated by
interpolation from the calibration curve.
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A.2.1.5  Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis
(SDS-PAGE)
Sodium-Dodecyl-Sulfate Polyacrylamide Gel Electrophoresis, or SDS-PAGE, is a
technique used in biochemistry and molecular biology to separate proteins according
to their size (length of polypeptide chain or MM). The solution of proteins to be
analyzed is first mixed with SDS, an anionic detergent, which denatures secondary
and non–disulfide–linked tertiary structures, and applies a negative charge to each
protein in proportion to its mass.
Electrophoresis was carried out using 15% SDS-PAGE gels, according to the method
of Laemmli (Laemmli 1970). Protein bands were visualized with Coomassie Brilliant
Blue staining and the MM determination was performed referring to low molecular
weight (LMW) SDS (GE Healthcare) as standards.
A.2.1.6  Oxidation analysis
Proteins that contain thiol groups are susceptible to oxidation by free radicals,
electrophilic molecules, and nitric oxide donors. Oxidation leads to the formation of
disulfide bridges either within, or between polypeptidic chains.  Particularly, cysteine
is a highly vulnerable oxidative target because of the reactivity of the thiol group.
Cysteines readily dimerize oxidatively to cystine. The tendency of proteins with free
thiol groups to form artifactual disulfide-linked aggregates during and after
purification is well known and can often be detected by comparing apparent size
using reducing and non-reducing SDS-PAGE. Thus, in order to decipher whether
DMPK-CCN+ suffered from cysteine-oxidation upon storage, the protein was purified
both in the presence and in the absence of reducing agent (β-ME).
Interestingly, one unique band was observed under reducing conditions, while two
bands appeared when ß-ME was not employed (Figure A.7). Inter-chain oxidation in
this case must be mediated by C407, the only cysteine residue present in the sequence
of this construct.
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Figure A.7: Oxidation test of DMPK-CCN+. To investigate the oxidation of DMPK-CCN+, the protein
was expressed and further purified by Ni2+-NTA affinity chromatography, both in the presence and in
the absence of the reducing agent β-ME. The presence of a second band at high MM under non-
reducing conditions is indicated with a red arrow. Expected MMs for both monomeric and dimeric
forms of DMPK-CCN+are also indicated.
A.2.1.7  Crystallization
Several crystallization trials were attempted for both His-tagged and cleaved DMPK-
CCN+ native proteins using the hanging-drop vapour-diffusion method (Suzuki et al.
1993) using 24-well VDX crystallization plates (Hampton Research) at RT. Each
drop contained 2 µl of protein solution (5 mg/ml and 1 mg/ml of His-tagged or
cleaved DMPK-CCN+, respectively) and an equal amount of crystallization reservoir
solution, equilibrated against 1 ml reservoir solution. Initial screening was performed
using Sparse matrix screens (kits I and II from Molecular Dimensions) based on the
procedure of Jancarik & Kim (Jancarik 1991). In parallel, crystallization conditions
that yielded crystals for DMPK-CC were assayed. No crystals were obtained for
DMPK-CCN+ native under any of the protein concentrations and crystallization
conditions tested.
+  β -ME
97 
66 
45 
30 
20 
14
–  β -ME
46.8 kDa   (DIMER)
23.4 kDa (MONOMER)
Annex A.  DMPK-CCN+
75
A.2.2  DMPK-CCN+ mutant
A.2.2.1  Cloning
In order to prevent protein aggregation mediated by cysteine oxidation, in vitro site-
directed mutagenesis was carried out (QuikChange Site Directed Mutagenesis Kit,
Stratagene). The cysteine at position 407 was point mutated into a serine, creating a
mutant hereon called pETM-11:DMPK-CCN+C407S (Figure A.2). Serine was chosen
because its volume and composition are very similar to those of cysteine, but instead
of a reactive sulfhydryl it contains a hydroxyl group. The pETM-11:DMPK-CCN+
wild-type plasmid was used as a template DNA and  the two mutagenic primers
utilized to amplified the mutated DMPK-CCN+ are as follows:
5’ -GGCTACTCCTACTCCTCCATGGCCCTCAGGGAC- 3’
3’ -CCGATGAGGATGAGGAGGTACCGGGAGTCCCTG- 5’
Positive clones pETM-11:DMPK-CCN+C407S were verified by DNA sequencing
(Microsynth AG, Balgach, Switzerland). Primers were purchased from Microsynth
and used after dissolving in distilled water.
 A.2.2.2  Over-expression and purification
Expression of DMPK-CCN+C407S was as for the wild-type (see section A.2.1.2).
Purification was performed in a single-step purification using a Ni2+-NTA affinity
chromatography column. The protein obtained with this procedure was pure
according to SDS-PAGE and was used in subsequent crystallization trials. His6-tag
removal was as for the wild-type (see section A.2.1.3). Pure tag-cleaved protein was
then concentrated to 20 mg/ml at 4 °C and was also used in subsequent crystallization
trials. Protein procedures were executed at RT and protein concentration was
measured employing the BCA method (Pierce) (see section A.2.2.3). As for the wild-
type form, this protocol yielded ~10 mg of cleaved pure protein per liter of culture.
Despite size exclusion chromatography was not required for purification of DMPK-
CCN+C407S, comparison of the elution profile of DMPK-CCN+C407S with that of the
wild-type over a size exclusion column showed that the mutant eluted from the
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column with a retention time similar to the wild-type protein. This suggested that the
quaternary structure of the wild-type protein is unaltered in the mutant.
A.2.2.3  Protein determination
Protein concentration was determined by bicinchoninic acid assay (also known as
BCA assay). The BCA assay is a biochemical procedure for detecting the presence of
protein in a solution that changes colour from green to purple in proportion to protein
concentration in a given sample, which can then be measured using colorimetric
techniques.
There is no perfect assay method for determining protein concentration.  Each of the
many methods has numerous advantages and disadvantages. Accordingly, the BCA
assay is a popular choice for the assay of protein concentration due to its high
sensitivity, compatibility with detergents and with a wide range of common buffer
components and its overall simplicity. Although the BCA assay requires more time
than the Bradford technique, BCA has some advantages over the former protein
determination method besides those mentioned above; it has less variability, the color
complex is stable and it is applicable over a broad range of protein concentration.
DMPK-CCN+C407S protein concentration was estimated using the BCA assay with
BSA as protein standard, following the manufacturer's protocols (Pierce). This
procedure employs two reagents: A) a stock BCA solution containing 1 g
bicinchoninic acid (BCA), 2 g sodium carbonate, 0.16 g sodium tartrate, 0.4 g NaOH,
and 0.95 g sodium bicarbonate per 100 ml of aqueous solution and B) 0.4 gm cupric
sulfate (5 x hydrated) in 10 ml distilled water. The BCA assay relies on two reactions.
First, the Cu2+ ions, BCA and the peptide bonds or protein residues such as cysteine,
cystine, tryptophan and tyrosine, form a complex, which reduces Cu2+ to Cu+1. The
amount of Cu2+ reduction is proportional to the amount of protein present in the
solution. Then, the Cu+1 ion and BCA form a complex that has a purple-blue color
and strong absorption at 562 nm. The protein concentration can be quantified by
measuring the absorption spectra and comparing with protein solutions with known
concentrations.
The BCA assay was carried out as follows: protein sample with concentrations
ranging from 0.05 – 0.25 mg/ml were made up to 50 µl 5 mM Hepes pH 7.2 buffer
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supplemented with 1% SDS, in 1.5 ml eppendorf microcentrifuge tubes.  1 ml of
working reagent, composed of 1part of reagent B and 50 parts of reagent A, was then
added. The solution was incubated at 60 °C for 30 minutes, and absorbances were
measured at 562 nm wavelength using absorption spectroscopy (Hewlett Packard
Model 8453 UV-VIS system, Switzerland). Protein concentrations were estimated by
interpolation from the calibration curve.
A.2.2.4  Characterization of DMPK-CCN+ mutant in solution
A.2.2.4.1 Blue-Native Polyacrylamide Gel-Electrophoresis (BN-PAGE)
Blue Native Polyacrylamide Gel Electrophoresis  (BN-PAGE) is a charge shift
method, in which proteins run on PAGE in the absence of SDS and are separated
according to their mass-charge ratio.
To assess the different oligomerization states possible for DMPK-CCN+C407S, a
native gel analysis was performed, followed by Coomassie staining for protein. The
separation was performed on a gradient gel (10-16%), in the presence of blue cathode
buffer (15 mM Bis-Tris-HCl pH 7.0, 50 mM Tricine and 0.005 % Coomassie Brilliant
Blue G-250) and anode buffer (50 Bis-Tris-HCl pH 7.0). Special standard markers
(ferritin 440 KDa, catalase 332 KDa, aldolase 158 kDa, albumin 66 kDa and
ovalbumine with 43 kDa) were used for identification. The experiment was conducted
overnight at 15 mA or 100 V. BN-PAGE revealed a single band with an apparent
molecular mass (MM) of ~140-150 kDa, as illustrated in Figure A.9. Remarkably,
this value was much higher than expected for a dimer or a trimer. This was in
accordance with results obtained from size exclusion chromatography. Therefore, it
can be concluded that DMPK-CCN+C407S exists as a single species, similar to
DMPK-CCN+, however, MM cannot be assessed probably due to the anisometric
dimensions of the molecule.
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A.2.2.4.2 Analytical Ultracentrifugation
Theodor Svedberg invented the analytical ultracentrifuge in 1923, and won the Nobel
Prize in Chemistry in 1926 for his research on colloids and proteins using the
ultracentrifuge. Analytical ultracentrifugation (AU) is a versatile and rigorous
technique that provides quantitative information about the sizes and shapes of
macromolecules in solution. Two types of analytical centrifugation experiments exist,
which are very complementary: sedimentation velocity and sedimentation
equilibrium.
Sedimentation velocity measures how fast the macromolecules move in response to
centrifugal force. The sedimentation boundary movement gives information about
mass and shape of macromolecules.
Sedimentation velocity experiments are performed at high-speed rotation (30,000 -
50,000 rpm) and this type of experiment can determine the following: sample
homogeneity (or heterogeneity) in protein mass and conformation, sedimentation
coefficients of solute, presence of aggregates and their size distribution, overall
shape/assymetry of macromolecules, MM and stoichiometry.
669
440
332
158
67
43
Figure A.9: Blue Native-PAGE analysis (10-16%)
of purified DMPK-CCN+ sample. The presence of a
single species is indicated (arrow). MM markers from
top: thyroglobulin (669 kDa), ferritin (440 kDa),
catalase (232 kDa), bovine serum albumine (67 kDa)
and ovalbumine (43 kDa).
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Sedimentation equilibrium is based on the balancing of centrifugal force and
diffusion of the particle in order to form a solute gradient, which remains constant for
an indefinite period of time. This experiment is usually performed at a lower rotor
speed and takes several days to complete. This technique allows determination of the
following: MM, binding constants, oligomeric state, and the non-ideality of the
solution.
To assess the oligomerization state and homogeneity of untagged DMPK-CCN+C407S
in solution, analytical ultracentrifugation experiments were carried out. Sedimentation
velocity and equilibrium data were recorded using an Optima XL-A analytical
ultracentrifuge (Beckman Instruments) equipped with 4 and 12-mm Epon double-
sector cells in an An-60 Ti rotor and absorption optics. Runs were performed at 20 oC
in 50 mM Tris pH 7.5, 50 mM NaCl using a detection wavelength of 230 nm.
Sedimentation velocity experiments were carried out at 50,000 rpm and 0.67 mg/ml
sample concentration for checking monodispersity (Figure A.10). Sedimentation
equilibrium measurements were performed at different speeds  (13,000, 15,000 and
24,000 rpm) and protein concentrations of 0.09-1.4 mg/ml, where OD values
remained in a linear range, to analyze the self-association state of DMPK-CCN+C407S
(Figure A.11). Average MMs were evaluated using SEGAL (G. Machaidze & A.
Lustig, unpublished software), which adjusts the baseline absorbance to obtain the
best linear fit of ln (absorbance) versus radial distance square. A partial specific
volume of 0.73 ml/g and a solution density of 1.005 g/ml were used; for the
conversion of S’ to S20w, the solution viscosity was taken as 1.31 centipoise.
In agreement with the results obtained by BN-PAGE, one single oligomeric species
could be detected using the sedimentation velocity technique, which produced a
single migrating boundary corresponding to a sedimentation coefficient S20W of 1.9.
Thus, the sample population in solution appeared to be highly homogeneous, with no
dynamic states of assembly being observed. Sedimentation equilibrium analysis of
untagged DMPK-CCN+C407S yielded an average MM of ~56 kDa over the entire
protein concentration range assayed (0.09-1.4 mg/ml), compared to a theoretical MM
of 58.2 kDa for a trimer of this construct (Figure A.12).
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Figure A.10: Sedimentation velocity profile of DMPK-CCN+. Sedimentation velocity revealed a
monodisperse species (S20,w=1.9 S). Measurements were performed at 20 °C in 50 mM Tris pH 7.5, 50
mM NaCl with a loading concentration of 0.67 mg/ml using a detection wavelength of 232nm. Runs
were carried out at a rotor speed of 50,000 rpm for 190 minutes. The direction of the sedimentation is
from left to right.
Figure A.11: Sedimentation equilibrium ultracentrifugation of DMPK-CCN+. Experiments were
performed at a rotor speed of 15,000 rpm in buffer 50 mM Tris pH 7.5, 50 mM NaCl at 20 °C with
loading concentrations of 0.13 mg/ml, monitoring absorbance at 231 nm. The natural logarithm of the
absorbance at 280 nm is plotted against the square of the radial position as shown in the inlet.
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Figure A.12: Sedimentation equilibrium experiments for DMPK-CCN+. MM calculated from
sedimentation equilibrium experiments on untagged DMPK-CCN+ (triangles). Experiments were
performed in buffer 50 mM Tris pH 7.5, 50 mM NaCl at 20 °C and rotor speeds of 13,000 rpm with
loading concentrations ranging from 0.1 to 0.27 mg/ml. Runs were carried out using a detection
wavelength of 230 nm Theoretical mass values for dimeric and trimeric formations of DMPK-CCN+ are
indicated by an horizontal bar, where a continuous line corresponds to the trimer and a dashed line to
the dimer.
A.2.3   Crystallization
Several crystallization trials were undertaken for tag-cleaved DMPK-CCN+C407S
protein utilizing the hanging-drop vapour-diffusion method (Suzuki et al. 1993) using
24-well VDX plates (Hampton Research) at RT. Each drop contained equal volumes
(2 µl) of protein solution and crystallization reservoir solution, equilibrated against 1
ml reservoir solution. Protein concentration varied from 3 to 20 mg/ml. A wide
variety of crystallization conditions were tested using several commercially available
sparse matrix screens. Sparse matrix screens employed include kits I and II from
Hampton Research and Molecular Dimensions, Wizard and Cryo screens from
Emerald Biostructures as well as systematic polyethylene glycol (PEG)/Ion screens,
which screens a complete profile of anions and cations in the presence of PEG 3350
with pH 4.5 - 9.2 (Hampton Research). Besides this, The Quik Screen (Hampton
Research) was used to test 0.8 - 1.8 M Sodium/Potassium Phosphate versus pH 5 - 8.2
in a grid format. In addition, Initial crystallization was also attempted using
crystallization conditions as those of DMPK-CC. No crystal growth was observed for
DMPK-CCN+C407S under any of the protein concentrations and crystallization
conditions tested.
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A.3 Discussion
In order to study whether the presence of a CC-associated domain in DMPK might
modulate the oligomerization of its CC domain, as suggested by reported SAXS
experiments on DMPKΔCC/VR, an N-terminally extended version of DMPK-CC,
named DMPK-CCN+ was created and its oligomeric state analyzed by sedimentation
equilibrium. Crystallization was attempted in a wide range of crystallization
conditions for DMPK-CCN+ but no crystals were obtained under any of the conditions
tested. A possible explanation may be that the protein suffered from aggregation due
to oxidation of the sample, degradation or even additional residues N-terminal to the
CC might have also created a tail disorder, thus, preventing protein from
crystallization.
The presence of oxidation in the sample was assessed by expressing DMPK-CCN+
both in the presence and in the absence of a reducing agent. As a result, one unique
band was observed when the protein was expressed under reducing conditions, while
two bands appeared when β-ME was not employed, indicating oxidation in the
sample. In order to prevent oxidation, the C407, the only present in the DMPK-CCN+
sequence was point mutated into a serine, creating the DMPK-CCN+ mutant termed
DMPK-CCN+C407S.
Analysis of DMPK-CCN+C407S using native PAGE and sedimentation velocity
techniques yielded one single oligomeric species, indicating the sample population in
solution to be highly homogeneous. Furthermore, sedimentation equilibrium analysis
of DMPK-CCN+ mutant yielded and average MM of 56 kDa over the entire protein
concentration range assayed (0.09-1.4 mg/ml), compared to the theoretical MM of
58.2 KDa for a trimer of this construct. Contrary to expectations, results showed that
DMPK-CCN+ mutant, in accordance with DMPK-CC, remained trimeric in solution
and no additional oligomerization motif was identified. However, it might be possible
that such motif existed but needed the presence of additional residues or even the
whole kinase to be structurally or functionally integral. Crystallization of mutant
DMPK-CCN+C407S yielded no crystal form.
The nature of this region of DMPK will be revealed by structural data on full-length
DMPK. Nevertheless, crystallization of the full-lengh DMPK construct has been
attemped by Zöhre Ucurum in our laboratory, so far without success.
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Moreover, it is known that CC oligomerization can be altered by enviromental
conditions, such as pH and temperature. For example the TlpA protein of Salmonella
encodes a repressor protein that makes use of the CC motif to sense temperature
changes. At temperatures below 37 °C, TlpA forms a dimer that can bind DNA and
act as a repressor. Whereas temperatures above 37 °C cause the CC dimerization
domain to unfold. The random coiled monomers are unable to remain bound to DNA,
lifting the repression of the promoter (Hurme et al. 1996; Hurme et al. 1997). An
example for pH regulation of a CC dimer is the apoptosis-associated protein Par-4.
The C-terminal region of Par-4, required for apoptotic activity, self-association and
association with all presently known interaction partners, contains a CC domain
(Diaz-Meco et al. 1996; Sells et al. 1997). The protein forms a CC dimer only at an
acidic pH and low temperature. Through site-directed mutagenesis predicting the
effects of unfavorable charged residues at higher pH, Par-4 was altered from a pH-
dependent, labile dimer into a pH-independent, stabile dimer (Dutta et al. 2003).
Oligomerization is crucial for the activation of numerous kinases. Often, self-
assembly is aimed to ensure efficient autophosphorylation in trans by increasing the
local concentration of catalytic domains (Hubbard and Till 2000). Given that DMPK-
CC does not mediate the self-association of this kinase and that, contrary to MRCK
and ROCKs, it does not act as an intrasteric inhibitor but as an activator, further
investigations are needed to clarify whether its function might relate instead to the
achievement of an active conformation or even substrate docking. Supporting this
idea, recent studies on a DMPK variant carrying a mutated CC domain, showed that it
was still capable of autophosphorylation and transphosphorylation of peptides, but the
rate of its kinase activity was significantly lowered (van Herpen et al. 2006). A
possible explanation for this could be that distortion of the CC structure affects
conformational flexibility in the kinase domain itself and that this feature is needed
for efficient intramolecular autophosphorylation (van Herpen et al. 2006). Moreover,
binding of the DMPK to MYPT2, a paralogue of the DMPK natural substrate
MYPT1, was strongly reduced, proposing that the DMPK-CC motif may be important
in strengthening the binding between DMPK and MYPT2, and bringing protein
sequences, crucial for cross-link formation, in close proximity (van Herpen et al.
2006).
In conclusion, the identification of the additional domain has not taken place, but if
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such domain existed, it might not be sufficient to modulate the oligomerization
properties of DMPK-CC.
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B.1 Introduction
The functionality of CC domains from the DMPK-related family of kinases remains
unclear. Apart from their multimerization properties, different biochemical roles have
been attributed to these moieties. CC motifs of ROCKs and Citron kinase have been
found to act as intrasteric inhibitors of their respective kinase domains and harbour at
their C-termini binding motifs for small Rho GTPases, where binding of the latter
relieves the inhibition (Di Cunto et al. 1998; Amano et al. 1999). Whereas CC
segments of MRCK (CC2/CC3) also act as intrasteric inhibitors but do not host a
GTPase binding region (Tan et al. 2001) and physiological release factors are yet to
be identified (see Figure 1.5 in section 1.4.3).
Full-length ROCK, in the absence of effector molecules, exists in an autoinhibited
state. The C-terminal region of ROCK, encompassing CC and PH domains, has been
shown to partially inhibit the kinase catalytic activity by binding directly to the kinase
domain (Amano et al. 1999). When GTP-bound RhoA interacts with to the Rho-
binding region of the CC domain, the contacts between the catalytic kinase domain
and the C-terminal region are disrupted, relieving the inhibition (Ishizaki et al. 1996).
Cleavage of the C-terminal inhibitory domain from the catalytic domain by caspase-3
during apoptosis also activates the enzyme (Coleman et al. 2001; Sebbagh et al.
2001). An analogous form of truncated Citron kinase has also been observed in vivo
(Di Cunto et al.  98). It has been reported that arachidonic acid cancels the inhibitory
effect of RB/PH region, and activates ROCK in vitro (Feng et al. 1999).
Unlike ROCK, the regulation of MRCK activity does not appear to involve the PH
domain; instead, a small region within the extensive MRCK CC region, located at the
end of the distal CC2/CC3 domains, termed KIM (KI motif), acts as a negative
autoregulatory domain by complexing to and inhibiting the catalytic domain (Tan et
al. 2001; Ng et al. 2004). Activation of the kinase was observed upon binding of
phorbol ester to the neighbouring CR domain, presumably by releasing the constraint
of the inhibitory effect on the catalytic activity. Co-expression of MRCKγ KIM is
sufficient to inhibit the activity of either MRCKα or MRCKγ (Ng et al. 2004).
On the contrary, the CC domain of DMPK (DMPK-CC) has been proposed to act as
an enhancer of its kinase activity (Zhang and Epstein 2003), although it is still
unknown whether this involves transphosphorylation events as those occuring in
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tyrosine kinases. Recent studies using a DMPK form where its CC was mutated into a
segment with low coil-forming probability, showed that autophosphorylation and the
transphosphorylation activity towards a peptide substrate, KKRNRRLTVA (Wansink
et al. 2003),  was 2-3-fold reduced when compared with the corresponding activities
of wild-type DMPK, suggesting that the DMPK-CC region must have a facilitating
role in the determination of DMPK activity (van Herpen et al. 2006).
The trimeric assembly of DMPK-CC differs from that of the full-length kinase, which
is dimeric. Dynamic alterations in the oligomeric state of DMPK-CC might be
explained by embedding of the CC motif within the kinase core. Therefore, given that
DMPK-CC shares certain sequence similarity with the CC domains CC2/CC3 of
MRCK (up to 30 % identity according to isoforms), a similar regulatory model to that
proposed for MRCK might be applicable for DMPK (Figure B.1). Therefore, to assess
whether the DMPK-CC is an autoregulatory region, the ability of the CC domain to
interact with other domains within the kinase was investigated. Binding studies of
DMPK-CC and a truncated DMPK variant lacking the CC domain, DMPKΔCC/VR,
were performed.
Figure B.1: Domain organization in DMPK, MRCK and ROCKs. Domain composition of human
DMPK (Q09013-9), mouse DMPK (P54265), human MRCKα (Q5VT26), rat MRCKα (AF021935),
human MRCKβ (Q81WQ7), mouse ROCKII (V58513), mouse ROCKI (V58512). LR indicates a
leucine-rich region, CC the coiled-coil, VR a region variable across spliceoforms, PDB is the GTPase
binding domain. Sequence identity to human DMPK is shown as percentage and on a per domain basis.
Identity between the PBD domains of ROCKI and II is also shown.
  1        67                                  340        460      537                629
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B.2 Experimental Work
B.2.1  Cloning and protein production
Cloning and production of DMPK-CC and DMPKΔC C/VR was as previously
reported (Chapters 2 and 3, respectively). The DMPKΔCC/VR construct was
provided by Rainer Burcher (Biozentrum, University of Basel).
B.2.2  Determination of protein concentration
The concentration of DMPK-CC was determined by the Bradford protein assay as
reported for the DMPK-CCN+ wild-type form (see section A.2.1.4).
DMPKΔCC/VR protein concentration was determined with absortion spectroscopy
(Hewlett Packard 8453, HP845X UV-Visible system, Switzerland) at 280 nm. The
theoretical extinction coefficient ε  at 280 nm for DMPKΔCC/VR was found to be
56,260 M-1 cm-1 based on the method by Gill and von Hippel (Gill and von Hippel
1989).
B.2.3  In vitro Binding Studies
Binding studies of DMPK-CC to DMPKΔCC/VR were as follows:
A) Ni2+-NTA Pull-down assays using His6-tagged DMPKΔCC/VR immobilized
on a His-Trap HP column versus a flow of untagged DMPK-CC
Both DMPK-CC and DMPKΔCC/VR were expressed separately. Expression and
purification procedures have been described (Chapters 2 and 3, respectively).
DMPKΔCC/VR was loaded and immobilized on a His-Trap HP column pre-
equilibrated in 50 mM Tris-HCl pH 7.5, 100 mM NaCl. The His6-tag of DMPK-CC
was removed using TEV protease (see Annex C) and the cleaved protein was applied
to the column. The mixture was incubated for 4 hours at 30 °C in the column and the
bound protein eluted from the resin with 200 mM imidazole. A temperature of 30 °C
was chosen for this study since most of the reported work on expression and
purification of DMPK has been carried out at this temperature (Bush et al. 2000).
Untagged DMPK-CC eluted entirely in the flow-through, whereas His-
DMPKΔCC/VR eluted in the presence of 200 mM imidazol. No complex DMPK-
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CC:DMPKΔCC/VR was observed within the elution fraction. Lysozyme was
observed in the elution fractions, identified according to mass spectroscopy. (Figure
B.2).
Figure B.2: Pull-down assay for His-tagged DMPKΔCC/VR against a flow of untagged DMPK-
CC. DMPK-CC does not bind to DMPKΔCC/VR and elutes completely in the flow-through (FL)
fractions, while DMPKΔCC/VR and the lysozyme contaminant co-elute (E) at 200 mM imidazole.
Washes (W) with 40 mM imidazole are shown (SDS-PAGE analysis).
To confirm results obtained by pull-down assays, and make sure that the lack of
interaction was not due to compromised accessibility of the binding site by the in-
column immobilization, we examined the interaction by incubating sample mixtures in
solution and subsequently analysing them by size exclusion chromatography.
B) Co-purification attempts of DMPK-CC and DMPKΔC C/VR using size
exclusion chromatography after incubation of the mixture
Both purified proteins were incubated together at a 1:1 molar ratio under two sets of
conditions: i) at 30 °C for 40 minutes and  ii) at RT overnight.
Three different runs were then performed on a size exclusion chromatography column
(Superdex 200 16/60, GE Healthcare) for the samples incubated under conditions i;
DMPK-CC and DMPKΔCC/VR proteins, as well as the mixture containing the putative
complex DMPK-CC:DMPKΔCC/VR were loaded and purified separately on a gel
filtration (Superdex 200 16/60, GE Healthcare) column pre-equilibrated in buffer
containing 50 mM Tris-HCl pH 7.5, 100 mM NaCl. The combined elution profiles are
Ni2+-NTA Pull-down assay
FL          W                  E
Lysozyme
 Untagged 
  DMPK-CC
His-DMPKΔCC/VR9766
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30
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shown in Figure B.3. DMPK-CC eluted in a single peak at 73.4 ml. DMPKΔCC/VR
eluted in a major peak at 62.3 ml, although the elution profile exhibits “shoulders”,
indicating the presence of a number of discrete complexes of various sizes possibly due
to the presence of contaminants. Finally, purification of the mixture over the gel
filtration column revealed several peaks identical to those obtained when the samples
were applied separately. This indicated that DMPK-CC and DMPKΔCC/VR did not
form any complex under these binding conditions. Similar elution profile was obtained
when the samples were incubated under conditions ii.
Figure B.3: Purification of DMPK-CC, DMPKΔCC/VR and DMPK-CC:DMPKΔCC/VR mixture
by size exclusion chromatography (Superdex 200 16/60 Healthcare). (A)  The elution profiles of
DMPK-CC (), DMPKΔCC/VR (o) and the mixture DMPK-CC:DMPKΔCC/VR (—) show that no
binding occurred between DMPK-CC and DMPKΔCC/VR when both proteins were in incubated
together at a 1:1 molar ratio for 40 minutes at 30 °C under the conditions of this study. Positions of size
standards ovalbumin (43 kDa), catalase (232 kDa) and ferritin (440 kDa) are indicated. (B) The SDS-
PAGE analysis shows the elution peaks of DMPK-CC:ΔMPKΔCC/VR, with lanes 1, 2 and 3
corresponding to DMPKΔCC/VR and lane 4 to DMPK-CC. Lane 4 also shows the presence of
DMPKΔCC/VR.
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The lack of binding in samples expressed separately could be due to partial
misfolding of the binding motifs, which might require of the partner to achieve a
native bound state. To account for possible structural dissorders or aberrations at this
respect, we analyzed interaction of the samples when present together during their
folding step in the bacterial cell by co-expression studies and subsequent co-
purification by Ni2+-NTA affinity and size exclusion chromatography.
C)     Co-expression of both constructs followed by co-purification by metal-affinity
and size exclusion chromatography
Plasmids carrying constructs for both DMPK-CC and DMPKΔCC/VR were co-
transformed in E. coli Rosetta (DE3) strain (Novagen). Culture, lysis and purification
conditions were as for separate constructs (Chapters 2 and 3, respectively). The cells
were grown in LB medium supplemented with 34 µg/ml chloramphenicol, 25 µg/ml
kanamycin and 100 µg/ml ampicillin at 37 °C. Co-expression was induced at an OD
of 0.6 by addition of 1mM IPTG and cells were incubated overnight at 30 °C. Co-
purification of DMPK-CC and DMPKΔCC/VR was first attempted using a metal-
affinity step in 50 mM Tris pH 7.5, 100 mM NaCl and 5 mM β-ME. Elution fractions
were subjected to further size exclusion chromatography on a Superdex 200 Tricorn
10/300 GL column (GE Healthcare). The profile of the size exclusion chromatogram
of the co-expressed sample was very similar to that obtained when the samples where
expressed and purified independently. No complex was observed (Figure B.4).
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Figure B.4: Purification of co-expressed DMPK-CC and DMPKΔCC/VR by size exclusion
chromatography. (A) Elution profile of the mixture of DMPK-CC and DMPKΔCC/VR on a Superdex
200 Tricorn 10/300 GL column (GE Healthcare) shows that the samples elute in two different peaks
corresponding to DMPKΔCC/VR and DMPK-CC. Positions of size standards thyroglobulin (669 kDa),
ferritin (440 kDa), catalase (232 kDa), Aldolase (158 kDa) and Albumin (67 kDa) are indicated. (B)
SDS-PAGE analysis lanes 1 and 2 correspond to DMPKΔCC/VR and lane 3 to DMPK-CC.
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B.3 Discussion
To assess whether DMPK-CC is an autoregulatory region, as it occurs in ROCK and
MRCK kinases, and if its oligomeric properties might change by interacting within
the catalytic domain, we have looked into the possible interaction of DMPK-CC and
the latter. Binding studies of DMPK-CC and a truncated DMPK variant lacking the
CC domain, DMPKΔCC/VR, were performed by pull-down assays, co-purification
trials, as well as co-expression/co-purification experiments. Binding between these
species could not be detected by any of the procedures, which yielded independent
original species. Hence, DMPK-CC appears neither to interact with the kinase domain
nor to form a hetero-coil against the α-helical LR sequence, also present in the
DMPKΔCC/VR construct assayed. This indicates that a CC association/dissociation
regulatory model such as that proposed for MRCK and ROCKs might not to be
applicable to DMPK. In the current study, complex formation was always assessed by
methods based on column fractionation and no in-solution method was attempted
(such as isothermal titration calorimetry or surface plasmon resonance). Thus, it
should not be excluded that the shier forces of the resin could have prevented
complex formation. However, our results are in agreement with recent studies on
DMPK (Zhang and Epstein 2003; van Herpen et al. 2006) where co-
immunoprecipitation experiments on various N- and C-terminal DMPK truncated
mutants showed that the CC domain does not interact with the DMPK variant
containing only the kinase domain.
Based on these results, it is unlikely that the assembly properties of this CC are
altered by a possible embedding within the kinase core. These results also indicate
that architecturally, DMPK must consist of a globular fraction and structurally
independent shaft. Further details on DMPK architecture are expected from structural
studies on full-length forms of DMPK, which are being carried out in our laboratory
by Zöhre Ucurum.
Given the heterogeneity in CC sequences and their diversified interaction patterns
across DMPK-related kinases, studies are required to reveal the exact role of these
moieties and to establish the principles of their regulatory mechanism.
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C.1  Introduction
TEV protease is the common name for the 27 kDa catalytic domain of the Nuclear
Inclusion a (NIa) protein encoded by the tobacco etch virus (TEV). Because its
sequence specificity is far more stringent than that of factor Xa, thrombin, or
enterokinase, TEV protease is a very useful reagent for cleaving fusion proteins. It is
also relatively easy to over-produce and purify large quantities of the enzyme. TEV
protease recognizes a linear epitope of the general form E-X-X-Y-X-Q-G/S, with
cleavage occurring between Q and G or Q and S. However, the most commonly used
sequence is E-N-L-Y-F-Q-G.
The TEV protease employed in this study was produced in-house and consists of the
27 kDa catalytic domain with an N-terminal His6-tag. The seven amino acid
consensus sequence is E-N-L-Y-F-Q-G. Cleavage occurs between the conserved Q
and G residues.
C.2  TEV protease production
Protein expression was carried in E. coli BL21 (DE3) pLysS strain using pET-24d
(Novagen) plasmid, which carries a C-terminal His6-tag and a kanamycin resistance
marker. The cells were grown in 500 ml of LB medium, supplemented with 34 µg/ml
chloramphenicol and 25 µg/ml kanamycin at 37 °C. Expression was induced by
addition of 1 mM IPTG at an OD of 0.6 at 600 nm, and cells were incubated
overnight at 20 °C.  The cells were harvested by centrifugation at 18,000 rpm, 30
minutes at 4 °C, washed with LB medium and stored at –80  °C until required. Cell
lysis, centrifugation and chromatography stepts were carried out at 4 °C.
For purification, the cell paste was defrosted and resuspended in lysis buffer (50 mM
Tris pH 8.0, 200 mM NaCl and 1 mM β-ME supplemented with 10 mM imidazole, 1-
5 µg/ml of DNAse, PMSF, and standard protease inhibitor cocktail without EDTA
(Roche).
Further cell disruption was achieved by sonication with cooling (Branson Digital
Sonifier) using a number of short pulses (3-5 seconds) with pauses (7-10 seconds) for
3 minutes time. Debris was removed by centrifugation at 20,000 rpm for 45 minutes
and imidazole was added to the supernatant to a final concentration of 10 mM. Then,
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the supernatant fraction was applied to a Ni2+-NTA affinity column (GE Healthcare)
pre-equilibrated in binding buffer (50 mM Tris pH 8.0, 300 mM NaCl and 1 mM β-
ME supplemented with 10 mM imidazole and 20% glycerol). To remove
contaminants, the column was washed with binding buffer followed by a gradient of
imidazole washes, where binding buffer had been progressively supplemented with 30
and 80 mM imidazole. Each step was composed of ten column volumes. Purified
protein was further eluted with binding buffer containing 300 mM imidazole.
The elution product was dialysed (membrane 12-14,000 KDa cut off, Spectra/Por) in
50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM DTT and 20% glycerol overnight at 4
°C.
C.3  TEV protease reaction conditions
The reaction buffer used for TEV protease was 50 mM Tris-HCl pH 8.0, 150 mM
NaCl and 1mM DTT. TEV protease is maximally active at 34 °C, however, cleavage
can be performed at temperatures as low as 4 °C. The duration of the cleavage
reaction was overnight at 4 °C or 1 hour at RT (TEV protease is only 3-fold less
active at 4 °C than at RT). After digestion of the fusion protein substrate with TEV
protease, the cleaved protein was recoved in the flow-through after a subtractive
affinity purification step, while the uncleaved sample and the His-tagged TEV
protease were absorbed to the affinity resin.
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4.1 Introduction
By analogy to other family members, DMPK is expected to modulate cytoskeletal
events (Jin et al. 2000; Schulz et al. 2003) and to possibly act as down-stream effector
in the regulatory pathways of small Rho GTPases. Shimizu and co-workers (Shimizu
et al. 2000) suggested that the cytoskeleton-linked Rho GTPase Rac1 interacts with
DMPK and co-expression of Rac and DMPK triggers its activity in a GTP-dependent
manner. Protein binding studies were performed to examine a possible interaction
between DMPK and the three small GST-tagged Rho GTPases RhoA, Rac1 and
Cdc42 by GST pull-down assays (Shimizu et al. 2000). Equal amounts of bacterially
expressed fusion proteins RhoA, Rac1 and Cdc42 were incubated with bacterially
expressed FLAG-tagged DMPK and then glutathione-sepharose beads. Bound
proteins were eluted from beads by boiling in SDS sample buffer and separated by
SDS-PAGE. The presence of DMPK was further detected on Western blots of the
solubilized Rac1 complexes, but not of the other GTPases by anti-FLAG. These
results were further confirmed by an independent experiment using Rac1 expressed in
mammalian cells, indicating that Rac1 physically interacts with DMPK. Furthermore,
co-transfection of DMPK with constitutively activated Rac1 mutated variants,
activated DMPK transphosphorylation of histone H1 by almost 3-fold, consistent with
a potential regulatory interaction.
Since DMPK close relatives ROCK and Citron kinase, have been found to contain a
GTPase binding domain within their CC motif, it is logical to speculate that the
interaction between DMPK and Rac1 might take place via its CC segment.
In order to investigate a possible interaction between DMPK-CC and the small
GTPase Rac1, in vitro binding studies of DMPK-CC and Rac1 have been performed.
For this, a Rac1 mutant protein (Rac1+), containing a glutamine to leucine
substitution at amino acid 61 (Q61L mutation) was employed. This particular
mutation was originally described in Ras, where it inhibits GAP-stimulated GTPase
activity and therefore, unlike wild-type Rac1, remains in the GTP-bound state during
the course of the binding study. Nevertheless, neither CRIB nor REM motifs have
been described for DMPK.
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4.2 Experimental Work
4.2.1 Rac1 and Rac1+ production
Bacterial expression constructs pGEX-4T3 encoding both human wild-type Rac1 and
Rac1+, constitutively active Q61L mutant, were kindly provided by Daniel W. Baird
at Cornell University, Ithaca, New York.
Plasmid pGEX-4T3 encodes a thrombin cleavage site between the GST affinity tag
and the N-terminal target protein. The nucleotide sequences of the two clones were
confirmed by DNA sequencing (Microsynth AG, Balgach, Switzerland).
Plasmids coding for Rac1 and Rac1+ were used to transform E. coli Rosetta (DE3)
strain (Novagen). Over-expression of the GST-Rac1 and Rac1+ fusion proteins was
achieved by growing the cell cultures in LB medium supplemented with 34 µg/ml
chloramphenicol and 100 µg/ml ampicillin at 37 °C. Expression was induced by
addition of 1 mM IPTG at an OD600 of 0.6 and cells were incubated overnight at 20
°C. Cells were pelleted by centrifugation at 18,000 rpm for 30 minutes and stored
frozen at -80 °C. The cell pellets were then resuspended in lysis buffer containing 50
mM Tris 7.5, 100 mM NaCl, supplemented with 1-5 µg/ml of DNAse, PMSF, a
spatula-tip of lysozyme and standard protease inhibitor cocktail without EDTA
(Roche). Further cell lysis was performed by sonication in ice (Digital Sonifier,
Branson) using a number of short pulses (3-5 seconds) with pauses (7-10 seconds).
The cell lysate was clarified by centrifigation at 18,000 rpm for 30 minutes at 4 °C.
The supernatant was loaded onto a 1 ml GSTrap FF column (GE Healthcare), which
had been pre-equilibrated in lysis buffer.  The unbound protein was washed out and
the bound protein eluted by supplementing the buffer with reduced gluthathione 8.0.
All the buffers were filter-sterilized before use and contained freshly prepared 5 mM
β-ME. The eluted fractions were pooled and dialysed against 20 mM Tris pH 7.5, 50
mM NaCl, 1 mM EDTA, 1 mM DTT. The overall yield was estimated to be 5-10 mg
of pure Rac1 and 5-10 mg of Rac1+ per liter of E. coli culture. Purified Rac1 and
Rac1+ were subsequently used for in vitro binding studies to the CC domain of the
DMPK protein kinase. Protein concentrations were determined with absorption
spectroscopy at 280 nm. The theoretical Extinction coefficient ε of Rac1 and Rac1+
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was calculated to be 62,900 M-1 cm-1 according to Gill and von Hippel (Gill and von
Hippel 1989).
Figure 4.1: SDS-PAGE analysis of wild-type GST-Rac1 purification by
GST-affinity chromatography. The recombinant GST-Rac1 protein is ∼ 49
kDa, consisting of the 21.5 kDa Rac1 protein plus a 27 kDa N-terminal GST tag.
4.2.4  In vitro Binding Studies
Binding studies between DMPK-CC and both Rac1 and Rac1+ were attempted as it
follows:
A) Affinity pull-down assays using GST-tagged Rac1 immobilized on a GSTrap
FF column versus a flow of His-tagged DMPK-CC in the presence of a GTP
analogue (GTPγ S), followed by a Ni2+-NTA affinity chromatography step
 In vitro binding studies protocols were carried out with a modification of Barz et al.
(Barz et al. 2000). A GSTrap FF column was equilibrated in binding buffer (20 mM
Tris pH 7.5 / 50 mM NaCl / 1 mM EDTA / 1 mM DTT). Then, GST-tagged Rac1 was
loaded onto the column at a flow rate of 0.15 ml/min, followed by washes with 7
column volumes (CV) nucleotide depletion buffer (NDB) containing 20 mM Tris pH
7.5 / 50 mM NaCl / 1 mM EDTA / 1 mM DTT / 5% glycerol / 0.05% Triton X-100 to
deplete wild-type Rac1 of bound GDP and GTP, and incubated for 20 minutes at RT.
To load the non-hydrolyzable GTPγS, washing was continued with 8 CV GTP
analogue loading buffer (20 mM Tris pH 7.5 / 50 mM NaCl / 1 mM DTT / 5%
glycerol / 0.05% Triton X-100 /10 mM MgCl2+ / 20 µM GTP analogue) and incubated
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for 30 minutes at RT. The His-tagged DMPK-CC was then added to GST-Rac1 and
the mix was incubated for 1 hour at 4 °C. Unbound DMPK-CC was removed with
washing buffer (20 mM Tris pH 7.5 / 50 mM NaCl 1 mM DTT) and elution was
accomplished by addition of 15 CV elution buffer (20 mM Tris pH 7.5 / 50 mM NaCl
1 mM DTT 10 mM glutathione). Where indicated, DMPK-CC was used instead of
Rac1 as a negative control. Rac1 was observed to elute mainly in fractions 1 and 2
(1.5 ml each). Therefore, these fractions were pooled and further purified by affinity
chromatography using a nickel resin according to the manufacturer's instructions in
order to co-isolate DMPK-CC and Rac1 proteins. Where indicated, Rac1 was used
instead of DMPK-CC as a negative control (Figure 4.2).
During these studies, no interaction between DMPK-CC and Rac1 was detected in the
presence of GTPγS. DMPK-CC was revealed mainly in the flow-through during the
GST pull-down assay as depicted in the SDS-PAGE analysis A. However, Rac1
appears in the elution fraction of the His-pull down (B), probably due to binding to
lysozyme.
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Figure 4.2: Overview of the binding assay flow scheme of GST-tagged Rac1 and His-tagged
DMPK-CC using GST-pull downs followed by His-pull downs. GST-tagged Rac1 was loaded onto
GSTrap FF column pre-equilibrated in binding buffer, followed by washes with NDB to deplete Rac1
of GDP and GTP, and incubated for 20 minutes at RT. To load the non-hydrolyzable GTP analogue,
(GTPγS), the column was subsequently washed with GTP analogue loading buffer and incubated for 30
minutes at RT. The His-tagged DMPK-CC was then added to GST-Rac1 and the mix was incubated for
1 hour at 4 °C. Unbound DMPK-CC was removed with washing buffer and elution was by addition of
10 mM glutathione. Elution fractions were pooled together and further loaded onto a His-Trap HP
column. Purification was according to the manufacturer's instructions. The inlets show the non-
hydrolyzable GTP analogue, guanosine-5'-0-3-thiotriphosphate (GTPγS) and the SDS-PAGE analyses
of GST-pull downs (A) and His-pull downs (B).
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B) Affinity pull-down assays using His-tagged DMPK-CC captured on a Ni2+-
NTA column versus a flow of GST-tagged Rac1 and Rac1+
Expression and purification of DMPK-CC, Rac1 and Rac1+ were as previously
reported (Chapter 2 and sections 4.2.2-3). First, to obtain the active conformation of
Rac1, the purified GTPase was incubated with 1:1 molar ratio of MgCl2+ and a 2-fold
molar excess of GTPγS for 30 minutes at RT. During the incubation process, the
sample precipitated or aggregated. Therefore, the incubation temperature was lowered
to 4 °C, with no better results. Finally, Rac1 was incubated with 5 mM MgCl2+ and a
2-fold molar excess of GTPγS for 15 minutes at 30 °C in the presence of 10 mM
EDTA to facilitate nucleotide exchange, as described in Knaus et al. (Knaus et al.
1992). Subsequently increasing the MgCl2+ concentration (to 50-70 mM) stopped the
nucleotide exchange. The sample did not precipitate nor aggregate under these
conditions.
Co-purification of DMPK-CC and both Rac1 and Rac1+ was attempted by affinity
pull-down assays using His-tagged DMPK-CC immobilized on a His-Trap HP
column (GE Healthcare) versus a flow of either activated GST-tagged Rac1 or
constitutively active Rac1. His-pull down assays results revealed no binding of
DMPK-CC and Rac1 proteins (Figure 4.3).
Figure 4.3: SDS-PAGE analysis of His-pull-down assays using His-tagged DMPK-CC captured
on a His-Trap HP column versus a flow of GST-tagged activated Rac1. (A) Lane 1-3, flow-through
of the purified Rac1 loaded onto the Ni2+-NTA affinity column with immobilized His-tagged DMPK-
CC. Lanes 4-7, washes. Lanes 8-13, elution with elution buffer containing 200 mM imidazole. DMPK-
CC and Rac1 were indicated with a red and a green arrow, respectively.
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Besides this, co-expression of DMPK-CC and Rac1+ was also attempted. However,
no co-expression was observed, resulting in the loss of Rac1+. The inability of both
plasmids to coexist might be explained by incompatibility of the plasmids.
4.3 Discussion
In order to study whether the binding of Rac1 to DMPK could be mapped to its CC
domain, in vitro binding assays of His-tagged DMPK-CC with either activated GST-
tagged Rac1 or constitutively active Rac1 mutant have been tested. Binding studies
included His- and GST-pull-downs.
Binding studies revealed no detectable specific interaction of DMPK-CC with either
wild-type Rac1 or the constitutively active Rac1 mutant in any of the assays
performed. Previous studies (Shimizu et al. 2000) employed Western blotting
techniques, which are much more sensitive than SDS-PAGE. Moreover, they used the
full-length DMPK kinase for the binding assays, which suggests that Rac1 interaction
to DMPK and subsequent activation, presumably involve other regions apart from the
CC motif, as it occurs for MRCK. Nonetheless, binding studies between full-length
DMPK and the three small GTPases Rho, Rac1 and Cdc42, using His- and GST-pull-
downs as well as co-expression followed by co-purification using native-PAGE were
performed in our group by Zöhre Ucurum.  However, no interaction was observed
between DMPK and any of the GTPases.
Current results apparently disagree with reported studies, which defend that Rac1 can
physically interact with DMPK, thereby triggering its trans-phosphorylation activity
in a GTP-sensitive manner (Shimizu et al. 2000).
It should be borne in mind that the presence of the complex was always assessed on
column runs and any non-column based method has been employed. Thus, it should
not be excluded that the shier forces of the resin could have avoided complex
formation.
In conclusion, we have shown that DMPK is unlikely to interact with Rac1 through its
CC region under the conditions tested. A possible explanation for this might be that
the GTPase-kinase interaction needs of any region in DMPK out of the CC domain to
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be effective. Besides, the level of assembly of DMPK-CC in isolation might no the
same than in the context of the full-kinase.
Therefore, to analyse the binding between DMPK-CC and Rac1, binding studies
should employ untagged proteins. Likewise, other purification methods than those
column-based such as western blot should also be tried. Furthermore, in order to gain
a better understanding of the interactions of DMPK and Rac1 and to investigate
whether the small GTPase is responsible for the subsequent activation of the kinase,
further experiments should be performed within the context of the full DMPK kinase
taking into account tags and plasmids employed.
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5.1 Introduction
According to the RNA gain-of-function hypothesis, nuclear accumulation of the
DMPK expanded-repeats cause DM disease via recruitment of the splicing regulator,
CUG-BP, which subsequently causes misregulated splicing of a subset of pre-mRNAs
that are natural CUG-BP targets. Given the involvement of this novel splicing-
regulator CUG-BP in DM1 pathogenesis and its expected role as DMPK substrate,
CUG-BP was incorporated in the current study, both in its full-length form and as a
subfragment encoding CUG-BP-RRM1-2 (sequence coding for RRM1 and RRM2
domains of CUG-BP). The primary goal of this work was to establish their
recombinant over-expression for further biophysical studies both in the absence and
presence of DMPK.
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5.2 Experimental Work
5.2.1 Cloning
Expression constructs were derived from human CUG-BP cDNA (residues 1-482) in
the pET15b vector (Figure 7.1) provided by Maurice Swanson, University of Florida.
Fragments 1-482 (full-length) and 1-186 (sequence encoding RRM1 and RRM2
domains of CUG-BP) were digested from pET15b and subcloned into the pETM-11
expression vector.
The sequence coding for the full-length CUG-BP was amplified by PCR with Expand
Long Template PCR System (Roche) using the forward primer 5'-
CGTTCGGTCTCACATGAACGGCACCCTGGACCAC-3' with BsaI restriction site,
which creates a compatible overhang for NcoI in the vector and the reverse primer 5'-
CGCGGATCCTTAGTAGGGCTTGCTGTCATTC-3' which includes a BamHI
restriction site. The sequence coding for RRM1-2 domains of CUG-BP was amplified
with Pfu polymerase (Stratagene) using the same sense primer than the full-length
C U G - B P  a n d  t h e  a n t i s e n s e  p r i m e r  5 ' -
CGCGGATCCTTAAGCAAATTTTACCACCATG-3' which includes a BamHI
restriction site. PCR was carried out as reported for DMPK-CCN+ (see section
A.2.2.1), slightly modified for the full-length CUG-BP cDNA fragment, where the
cycle profile was: 5 minutes at 95 °C (Initiation), then 45 seconds at 95 °C (Melting),
45 seconds at 60 °C (Annealing) and 2 minutes at 72 °C (Elongation) for a total of 30
cycles, followed by 30 minutes at 72 °C. The PCR products were then digested with
NcoI and BamHI enzymes (sites are underlined in the primers) and ligated into the
pETM-11 vector with T4 DNA ligase as previously described for DMPK-CCN+ (see
section A.2.2.1).
DNA manipulations and bacterial transformations were carried out using standard
protocols (Sambrook et al. 1989). Transformants were assayed for correct
incorporation of the insert by PCR screening and their sequence verified by DNA
sequencing (Microsynth AG, Balgach, Switzerland).
The resulting clones were termed CUG-BP (full-length) and CUG-BP-RRM1-2  (1-
186), respectively.
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Figure 5.1: Design of CUG-BP constructs. Two constructs of CUG-BP were produced. The first one
corresponds to the full-length CUG-BP and the second one is a shorter variant, which encodes for the
RNA-binding motifs 1 and 2 (RRM1-2) of CUG-BP. Both constructs contain the His6-tag, shown in red,
and a TEV protease cleavage site with its recognition sequence marked in green.
5.2.2 Over-expression
CUG-BP and CUG-BP-RRM1-2 were expressed in E. coli Rosetta (DE3) (Novagen)
grown in LB medium supplemented with 34 µg/ml chloramphenicol and 25 µg/ml
kanamycin at 37 °C. Expression was induced by addition of 1mM IPTG at an OD600
of 0.6 and cells were incubated overnight at 25 °C.  Cells were harvested, washed
with LB medium and stored at –80 °C.
5.2.3 Purification of full-length CUG-BP
Cells were resuspended in lysis buffer composed of 50 mM Tris pH 7.0, 150 mM
NaCl and 5 mM β-ME supplemented with 10 mM imidazole, 1-5 µg/ml of DNAse,
PMSF, a spatula-tip of lysozyme and standard protease inhibitor cocktail without
EDTA (Roche). Cell lysis was performed by sonication in ice (Branson Digital
Sonifier). The lysate was harvested by centrifugation at 18,000 rpm for 30 minutes at
4 °C and the clarified supernatant was subjected to a single-step purification using
Ni2+-NTA affinity chromatography pre-equilibrated in lysis buffer. The bound protein
was eluted with 200 mM imidazole.
 RRM1      RRM2       Divergent domain      RRM3
TEV
Cleavage site
       HHHHHHPMSDYDIPTTENLYFQ GAM –
 RRM1      RRM2
TEV
Cleavage site
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1 482
1 186
His6-TEV-CUG-BP 
pETM-11 vector
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SDS-PAGE of purified CUG-BP showed protein degradation (Figure 5.2). Two
strong bands, along with several minor bands were identified as CUG-BP by peptide
mass fingerprinting (PMF) technique. The sizes of the two major bands were ~55 and
27 kDa. The higher band corresponded to the expected MM of full-length CUG-BP
(theoretical MM of 54.7 kDa). This result suggests that full-length CUG-BP could
have been cleaved during expression generating this unexpected truncated CUG-BP
form.
Figure 5.2: SDS-PAGE analysis of CUG-BP full-length purification on a Ni2+-NTA affinity
column. Lane 1, flow-through (FL). Lanes 2-6, elution fractions using 200 mM imidazol. Lane 7,
elution with 400 mM imidazol. All fractions contain 1.5 ml. Lane 8, marker. CUG-BP full-length and
the 27 kDa band are indicated with red and green arrows, respectively. Bands identified as CUG-BP by
mass spectroscopy are shown with black arrows.
5.2.4 Peptide Mass fingerprinting
In order to analyze the nature of the multiple bands appeared during the full-length
CUG-BP purification procedure, and to check whether the sample suffered from
degradation, a peptide mass fingerprinting experiment was performed.
PMF is an analytical technique developed by John Yates and colleagues (Griffin et al.
1995) used to identify proteins by matching their constituent fragment masses
(peptide masses) to the theoretical peptide masses generated from a protein or DNA
database.
In first, Protein bands of the SDS-gel corresponding to the MMs of the target protein
were cut and subjected to trypsic digestion. Subsequently, the absolute masses of the
digested fragments were accurately measured using matrix-assisted laser
desorption/ionization time of flight (MALDI-TOF) mass spectrometric analysis.
MALDI-TOF mass spectra were acquired on a Bruker Reflex III instrument (Bruker
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Daltonik). Peptides were analysed either in linear or in reflector mode by using a-
cyano-4-hydroxycinnamic acid (1 mg/ml in 80% acetonitrile / 0.1% TFA) matrix. The
matrix molecules are required for the desorption of the peptide molecules. Samples
were prepared by mixing 1 ml peptide solution with 1 ml matrix solution. Then, 300
nl of the mix were pipetted onto a MALDI target. Matrix and peptide molecules co-
crystallized on the MALDI. The instrument was calibrated with angiotensin II,
substrate P, bombesin, and ACTH-18-39. For each proteolysis intermediate, the MMs
of the ejected species were measured and searched in the sequence library of the
theoretically trypsined CUG-binding proteins using the programme MASCOT. These
fragments were used to map the boundary of the proteolysis intermediate protein. The
PMF was carried out by the group of Dr. Paul Jenö, Biozentrum, Basel.
As a result, according to PMF experiment, all bands tested were identified as CUG-
BP. Therefore, CUG-BP protein suffered from degradation. In addition, since the
major band observed of ~27 kDa has also been identified as CUG-BP, it is likely that
it corresponds to a truncated form of the full-length CUG-BP protein as a
consecuence of cleavage of the latter occurred during the expression.
5.2.5 Purification of CUG-BP-RRM1-2
For CUG-BP-RRM1-2 purification, lysis was achieved as for the full-length CUG-BP
construct in a lysis buffer composed of 50 mM Tris pH 8.5, 150 mM NaCl and 5 mM
β-ME. Clarified supernatant was applied to a Ni2+-NTA column (GE Healthcare) pre-
equilibrated in lysis buffer. The bound protein was eluted with 200 mM imidazole.
SDS-PAGE analysis of the Ni2+-NTA fractions showed one major band
corresponding to CUG-BP-RRM1-2 (theoretical MM of 24.1 kDa) along with some
contaminant proteins. Elution fractions were then pooled and dialysed (membrane 12-
14,000 KDa cut-off, Spectra/Por) in 50 mM Tris-HCl pH 8.5, 150 mM NaCl and 5
mM β-ME overnight at 4 °C. The His6-tag was removed by incubation with TEV
protease and separation of the cleaved protein was performed on a second metal-
affinity step as previously reported (see section A.2.2.3). The last purification step
used size exclusion chromatography on a column (Superdex 200 Tricorn 10/300 GL,
GE Healthcare), equilibrated in 50 mM Tris pH 8.5, 150 mM NaCl and 5 mM β-ME
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(Figure 5.3). The fractions corresponding to pure CUG-BP-RRM1-2 were then pooled
and concentrated to approximately 20 mg/ml (10,000 Da MW cut-off, Millipore) for
the subsequent crystallization trials. This protocol yielded approximately 3 mg per
liter of culture of pure protein. All purification procedures were executed at RT and
protein concentration was measured utilizing both Bradford assay (Bradford 1976)
and BCA method (Pierce).
Figure 5.3: Purification of CUG-BP-RMM1-2 by size exclusion chromatography. Elution profile
of CUG-BP-RMM1-2 on a Superdex 200 Tricorn 10/300 GL column (arrow). Elution peak is labeled
with its peak elution volume. The inlet shows an SDS-gel of the elution peak fractions, with highly
purified CUG-BP-RMM1-2 (arrow).
5.2.6 Crystallization
Crystallization trials for non-tagged CUG-BP-RRM1-2 were carried out at RT using
the hanging-drop vapour-diffusion technique on 24-well VDX plates (Hampton
Research) (Suzuki et al. 1993). Each drop contained equal volumes (2 µl) of protein
solution and crystallization reservoir solution, equilibrated against 1 ml reservoir
solution.
Protein concentration varied from 4 to 15 mg/ml. A large range of crystallization
conditions were tested using numerous commercially available sparse matrix screens
including kits I and II from Hampton Research and Molecular Dimensions, Wizard
and Cryo screens from Emerald Biostructures as well as polyethylene glycol (PEG)
screens with pHs varying from 4.5 to 9.2 (Hampton Research).  Besides this, The
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Quik Screen (Hampton Research) was used to Screen 0.8 - 1.8 M Sodium/Potassium
Phosphate versus pH 5 - 8.2 in a grid format.
No crystal growth was observed for CUG-BP-RRM1-2 under any of the protein
concentrations and crystallization conditions tested.
5.3 Discussion
In order to characterize CUG-BP, we have cloned two constructs encoding CUG-BP
(full-length CUG-BP) and CUG-BP-RRM1-2 (sequence coding for RRM1 and RRM2
domains of CUG-BP). Purification of the short construct yielded single pure protein,
apparently stable, whereas, isolation of the long construct has not been possible due to
progressive protein degradation. His-tagged proteins were expressed in E.coli and
purification employed Ni2+-NTA affinity and size exclusion chromatography. SDS-
PAGE analysis of purified CUG-BP-RRM1-2 showed the presence of a single band at
the expected MM (24.1 kDa). Pure protein was concentrated and used for
crystallization trials. However, no crystal growth was observed. In the case of the full-
length CUG-BP, SDS-PAGE analysis during protein purification showed protein
degradation.
So far, little information is available on CUG-BP production procedures. Two main
research groups have lead studies on this novel alternative splicing-regulator. The first
group employed extracts from mammalian HeLa cells, fibroblast and myotubes as
protein sources and further purification was by denaturation/elution techniques. The
second group utilized bacterially expressed His-tagged CUG-BP and purification was
performed by metal affinity chromatography. Interestingly, bound protein eluted in
the presence of high concentrations of EDTA. Since we have attempted expression of
stable full-length CUG-BP so far without success, protein degradation might be
explained by improper folding caused by the affinity tags or the absence of needed
post-tranlational modifications. Nevertheless, any of the previous group referred to
the stability of the protein, yields nor crystallizations trials attempted. Therefore, in
order to purify stable protein, different expression systems, as well as untagged
protein should be used. Crystallization was attempted for CUG-BP-RRM1-2 in a wide
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range of crystallization conditions, but no crystals growth was observed.
The characterization of CUG-BP is of great interest since it is involved in the
pathogenesis of DM and it could serve as a new therapeutic target for eventual
treatment of DM patients.
119
Chapter 6
Crystallization of the N-terminal Z1Z2
of human titin
Marino, M., Zou, P., Svergun, D.I., Garcia, P., Edlich, C., Simon, B., Wilmanns, M.,
Muhle-Goll, C. & Mayans, O. (submitted). The Ig-doublet Z1Z2 – a model system for
the hybrid analysis of conformational dynamics in poly-Ig tandems from titin.
The crystallization in this chapter is my responsibility.
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Summary
Titin is a gigantic elastic filament that determines sarcomere ultrastructure and
stretch response in vertebrate muscle. It folds into numerous Ig and FnIII domains
connected in tandem. Data on interdomain arrangements and dynamics are
essential to understand the architecture and function of this filament. We have
performed a mechanistic analysis of the conformational dynamics of a two Ig
fragment from the N-terminus of titin, Z1Z2, using in combination X-ray
crystallography, SAXS, NMR relaxation data and residual dipolar couplings. Z1Z2
adopts a defined semi-extended conformation in solution, where close-hinge
arrangements represent low probability states. Although specific interdomain
contacts are not encountered, the linker acquires semi-rigid properties via a weak
hydrophobic component, which appears to allow “viscous” modular oscillations but
prevents free motions. Thus, Z1Z2 constitutes an adaptable modular system with
restricted dynamics. Linker adaptability allows Z1Z2 to induced-fit its binding
partner telethonin, where a pre-existent conformation prevents an entropically
unfavorable complexation and, possibly, contribute to selective partner recruitment
onto the repetitive surface of the filament. The molecular interconversion of Z1Z2
conformations is analyzed.
Filamentous proteins are characterized by intrinsic flexibility and a poorly defined long-
range order that defies the elucidation of its atomic principles. Crystallographic
approaches suffer from troubled crystal growth and crystalline conformations can be of
doubtful biological relevance, while NMR methods based on NOE-derived distance
restraints are compromised by the scarcity of close contacts across modular components,
which prevents an accurate description of the overall conformation. These difficulties
have obstructed the analysis of a crucial modular protein, titin, which via formation of
giant filaments controls the ultrastructure and passive mechanics of vertebrate muscle.
Titin is central to muscle elasticity, stretch-stress biomechanical pathways and
myofibrillogenesis (for a review see Granzier and Labeit, 2004). It folds into ~300 Ig and
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FnIII modules assembled in tandems that span over 1 µm length from the Z-disc, at the
beginning of the sarcomere, to the central M-line. To date, atomic models have only been
reported for a few components of titin (listed in Marino et al., 2005) primarily as isolated
domains that do not clarify further the architecture of this filament. An initial insight into
domain arrangements in the tandems has been obtained through non-atomic methods
such as small angle X-ray scattering (SAXS), NMR relaxation studies and electron
microscopy. These have addressed I91-I92 (formerly I27-I28) and I91-I94 from the distal
I-band of titin (Improta et al., 1998); the Ig-doublet Z1Z2 at the N-terminus (Zou et al.,
2003) and I65-I70 from the skeletal I-band (Marino et al., 2005). Complementary,
interactions between consecutive Ig in I-band fragments I10-I11 and I91-I96 (Politou et
al., 1996; Scott et al., 2002) have been examined using thermodynamics of unfolding,
cross-linking and inter-Ig complexation. Taken together, these data suggest that Ig
modules of titin follow a “beads-on-a-string” model of organization with limited
interdomain motion but weakly interacting neighbouring modules. However, in the
absence of atomic models of tandem domain fragments of titin, the molecular principles
underlying the conformation and dynamics of this filament remain unclear.
Here, we analyze the conformational dynamics of the N-terminal doublet Z1Z2. This is
integral to the sarcomeric Z-disc, where it interacts with the small protein telethonin
(Mues et al., 1998). Overexpression of Z1Z2 and telethonin disrupts the association of
titin filaments and the ultrastructure of the Z-disc (Gregorio et al., 1998), highlighting the
central skeletal role of these components. The crystal structure of Z1Z2 complexed to
telethonin has been recently reported (Zou et al., 2006), this being the only domain pair
of titin for which a model is available. The complex consists of a pseudosymmetric
arrangement where two antiparallel Z1Z2 sandwich one telethonin molecule. The latter
forms an elongated _-sheet structure that interacts with its two Z1Z2 partners via main-
chain hydrogen bonds, thereby mediating titin assembly and anchoring at the Z-disc. We
investigate here the atomic characterization of isolated Z1Z2 applying in combination X-
ray crystallography, SAXS, NMR 15N relaxation studies and residual dipolar couplings
(RDC). Our findings provide an understanding of the structural dynamics of this doublet
and its possible significance for the complexation of telethonin. Thus, Z1Z2 constitutes
the first Ig-tandem of titin for which an architectural, dynamic and binding
characterization becomes completed. This might serve as a model system to understand
further the molecular mechanisms of the large poly-Ig arrays of titin.
Conformational dynamics of Z1Z2
124
RESULTS
Crystal structures of two conformational states
The crystal structure of Z1Z2 has been elucidated at 2.0 Å resolution. Data and model
statistics are given in Table 1. Z1 and Z2 belong to the I(intermediate)- set of Ig folds
(Harpaz and Chothia, 1994). They share 41% seq. id. and high structural similarity (rmsd
~1.02 Å calculated for C_ atoms using TOP; Lu, 2000). The crystal type used in this
study contains three Z1Z2 copies per asymmetric unit, corresponding to two different
conformations (Fig 1a). One copy exhibits an extended domain arrangement where the
two Ig are in almost coaxial orientation. The two others display a compact, V-shaped
conformation in which the two Ig nearly pack laterally. Values for hinge opening and
domain torsions in these models are given in Table 2. The two compact models are
basically identical (rmsd 0.67 Å for C_ atoms from the entire molecule). These data
reveal that domains in Z1Z2 can undergo long-range, complex motions.
In the crystal, every Z1Z2 copy binds a metal ion (Fig 1a). The latter is thought to be
cadmium, which was present in large quantity in the crystallization medium. This was
supported by anomalous diffraction data recorded at _=1.54 Å, which yielded peaks of
16.5_, 15.4_ and 14.0_ height for metal sites calculated using apo-Z1Z2 phases. In its
open conformation, Z1Z2 coordinates the metal via residues from Z1 (E26 and H28) and
Z2 (E165) of another molecule. In the closed forms, metal binding involves both Z1
(E26, H28) and Z2 (E155) from a same molecule. Here, metal coordination constitutes
the most prominent interaction across domains where, otherwise, only scarce, non-
conserved contacts are observed, namely hydrogen bonds Z1:Q13–Z2:D159 (2.53 Å) and
Z1:Q10–Z2:E155 (2.45 Å) respectively for each closed model. The open conformation is
void of any specific Ig-Ig contacts, but it includes a weak hydrophobic component at the
linker region derived from the clustering of the aliphatic portion of E19 and L18 in Z1,
the aliphatic chain of E100 at the linker and I130 in Z2 (Fig 1b).
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The arrangement of Ig modules in Z1Z2 depends on the conformation of a three-residue
linker with sequence “AET” (residues 99-101). Both in open and closed models, linker
groups are well defined in electron density maps (Fig 1c) and their crystallographic
thermal factors do not deviate significantly from the protein average. A comparative
analysis of main chain torsion angles across models shows that residue A99 constitutes
the effective hinge in these structures. A99 changes its conformation from extended to
helical by a rotation around its dihedral angle psi (Fig 1d). Thus, the long-range domain
motions in these structures are torsional in nature and derive primarily from a rotation
around one single main chain bond, that additionally acts here as mechanism of hinge
closure.
Domain orientation as derived from RDC data
Crystal structures may suffer from distortions due to packing forces or exhibit selected
conformations that, even if sparsely populated in solution, might favour specific lattice
contacts. Thus, we analyzed the relative orientation of domains in Z1Z2 using NMR data
derived from RDC in a partial alignment medium (Tjandra et al., 1997; Bax et al., 2001).
RDC define an external coordinate system for the molecule of interest termed the
“alignment tensor”, which is characterized by the axial component Da and the rhombicity
R. For a modular protein, the orientation of each domain can be determined separately
within this coordinate frame and the relative interdomain orientation deduced (Losonczi
et al., 1999).
Partial alignment of Z1Z2 was induced using compressed, positively charged
polyacrylamide gels (Ulmer et al., 2003; Cierpicki and Bushweller, 2004). Chemical shift
analysis (Edlich and Muhle-Goll, 2003) showed that the secondary structure elements of
the molecule in solution are identical to those in the crystal. Only a single set of chemical
shifts was observed for all residues, including linker residues, suggesting that in solution
Z1Z2 either adopts a preferential conformation or alternative forms are dynamically
averaged. The linewidth of linker and core residues was equivalent. The backbone torsion
angles of the linker groups derived from the chemical shifts indicated an extended
conformation for all three residues, but did not fit any of the two crystallographic
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arrangements. Similarly, RDC values calculated from each of the crystal models, or a
linear combination of these, did not fit the experimental data. The goodness-of-fit factor
Q remained above 0.6 in all cases, whereas values of 0.25-0.40 are typical for fits of
crystal structures at 1.8-2.5 Å resolution (Cornilescu et al., 1998). Individual domains
also yielded poor fits, especially Z2 (Q factors for RDC of secondary structure elements
from Z1 and Z2 were 0.38 and 0.60, respectively) (Fig 2a & b). Furthermore, values for
the Da component of the alignment tensor obtained by singular value decomposition
(SVD) were underestimated by 27% for Z2 compared to the value obtained from the
powder pattern. This indicated a high degree of structural “noise” in the protein models
compared to the solution structure (Zweckstetter and Bax, 2002). While the error in the
crystallographic coordinates was calculated as 0.27 Å based on a Luzatti plot (Luzatti,
1952), the structural variability of the individual Ig as estimated from the rmsd in atom
positions across models was ~0.56 ± 0.10 Å for Z1 (residues 4-98) and ~0.39 ± 0.14 Å
for Z2 (residues 102-194) (TOP software; Lu, 2000). This showed that the local geometry
within domains varies slightly, possibly justifying the poor agreement between calculated
and experimental RDC.
Because of the mismatch in RDC values, the Da and R components of the alignment
tensor could not be determined accurately. Thus, we tested the dependence of the
calculated domain orientation on these parameters by refining the individual domains
against experimental RDC data under an extensive range of values. Da and R quantities
were varied stepwise and sweeping the range of values between those determined by
SVD and those from the powder pattern. Only RDC data for residues in secondary
structure elements were used in the calculation since these were less affected by
structural variability. Only well isolated RDC peaks with good intensity were considered
(Fig 2a & b). Data were not detectably correlated (Fig 2d). During these calculations,
which employed simulated annealing, the crystal structures were kept virtually
unchanged by means of geometrical restraints. The influence of force constants for
geometrical and experimental RDC terms was assessed, revealing that NH bonds
underwent a reorientation of 5
o
-10
o 
depending on the force applied. These changes are
within the NH-bond variability calculated from the superposition of individual crystal
structures which amounted to as much as 30
o
 in loops and 14
o
 in secondary structure
elements. This work proved the calculated orientation of both HN vectors and alignment
tensor to be robust, so that domain arrangements obtained by the diverse protocols were
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in agreement by 10
o
. Final orientations were computed by refinement of full structures,
where translational drifts between the two Ig were restrained by confining the linker
using two further RDC and additional torsion angle restraints derived from the chemical
shifts. As for individual Ig, calculated orientations remained within a _10
o
 range (Fig 2c).
From all trials performed, a representative family of conformers (n=200) was obtained
(Fig 3c), where the alignment tensor calculated from full structures corresponded exactly
to the average obtained from individual domains.
The conformers so calculated divided into four clusters (Fig 3c). This segregation arises
from the four-fold degeneracy of the RDC values, which are even functions of _ and _
polar angles of the respective HN-bonds and the alignment tensor (see methods, eq. 1). In
order to unambiguously determine domain orientations by RDC, measurements in
different media are needed that, by comparative analysis, can resolve this degeneracy and
allow the selection of a given cluster. In the current case, additional RDC data could not
be recorded because Z1Z2 interacted with all other media assayed (5% [w/v]
hexaethylene glycol monododecyl-ether [C12E6]/n-hexanol, phages, DHPC/DMPC).
None of the four clusters of conformers calculated from polyacrylamide gels coincided
with available crystal structures, so that also these could not point to a representative
cluster. Finally, we carried out cluster selection by comparison to SAXS data that report
on the average conformation of a molecule in solution.
Average conformation in solution determined by SAXS
The overall parameters of Z1Z2 derived from SAXS are similar to those reported (Zou
et al., 2003) (Fig 3a). The experimental radius of gyration, Rg= 3.1±0.05 nm, and
maximum size, Dmax= 11.0±1.0 nm, indicate an anisometric structure. This is further
confirmed by the profile of the distance distribution function (Fig 3a), typical of
elongated particles (Feigin and Svergun, 1987). A low-resolution model of Z1Z2
reconstructed ab initio fitted optimally the experimental data (χ=0.74; Fig 3a) and
displayed two separated domains in a semi-extended conformation (Zou et al., 2003)
(Fig 3b).
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In order to validate crystallographic and RDC models their fitting to SAXS data was
analyzed (Fig 3a). The scattering calculated from the compact crystal structure failed to
fit the experimental scattering (χ=3.63). The extended crystal form yielded a significantly
better fit (χ=1.22), but the computed pattern still deviated noticeably from the data.
Calculations on the 200 RDC conformers showed that the 50 models with lowest
discrepancy values (χ=0.80 – 0.93) constituted a defined cluster (Fig 3c). The best-fitting
RDC conformer within this cluster (χ=0.80) was neatly superimposable with the ab initio
SAXS model computed independently (Fig 3b). The full RDC cluster yielded a fit with
χ=0.90, while the best possible mixture of crystallographic models (85% extended plus
15% compact) provided _=1.00, better than those of each model separately but still worse
than any of the RDC conformers in the chosen cluster. This suggested that crystal models
are worse representatives of the average conformation of Z1Z2 in solution than RDC
conformers, whose domain arrangement (Table 2) is more bent than the extended crystal
structure (Fig 4a). No improved fit was achieved by assaying populations of mixed
crystal and RDC models and best mixtures never contained more than 34% of the
compact crystal model, indicating that, if present in solution, compact conformations
amount to only a minor fraction of the population. Thus, it can be concluded that the
selected RDC cluster is a good representative of Z1Z2 in solution.
Absence of fast interdomain motions
Modular flexibility around a hinge region can result in fast interconverting conformations
and give rise to uncertainty in domain arrangements calculated by RDC. To assess
whether fast domain motions take place in Z1Z2 and to address motion on a per residue
basis, we measured 15N relaxation data (R1, R2) and heteronuclear NOE values at 800
MHz. The latter were evenly distributed around an average of 0.76, at exception of the
two N-terminal residues (Fig 3d). The C’D loop region of Z1, which includes a two-
residue insertion respect to Z2, displays reduced values of ~0.5, indicating that this is less
rigid than the core of the domain. Of the residues in and around the linker region, only
T101 shows a reduced NOE value of 0.56. Neither the R2 nor R1 values of the linker
residues deviated noticeably from an average value. Correspondingly, the Lipari-Szabo
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order parameter S2 (that describes the angular motion for each residue) of linker residue
T101 was only slightly diminished from the average value of 0.8-0.9 to a value of 0.75.
These data indicate that ultra-fast interconversion of Z1Z2 conformations in solution is
unlikely.
The size and shape of the molecular diffusion tensor can also be determined from
relaxation data. The diffusion tensor calculated for Z1Z2 was clearly anisotropic whereas
a flexible domain arrangement would have yielded more isotropic values. Unfortunately,
the quality of our data did not allow us to determine motional parameters on a per residue
basis or to calculate domain arrangements from the individually determined diffusion
tensors. Instead, we used relaxation values to estimate the mobility of Z1Z2 through
comparison to other proteins.
This approach has been used previously in the study of Fn9-Fn10 from fibronectin
(Spitzfaden et al., 1997). There, the 15N relaxation behaviour of a native construct was
compared to that of engineered variants with increasing number of glycine linker residues
that progressively abolished the native contacts between domains. In that work, both T1
and T2 values varied significantly with linker length, reflecting an increase in modular
flexibility and, hence, the comparative rigidity of the native protein. For Z1Z2, average
R1 and R2 values of 1/1000ms and 1/60 ms, respectively, are consistent with those from
a slightly elongated linker construct (2 added residues) of the FnIII doublet. The values
are also fully consistent with those measured for an I-band pair from titin, I91-I92
(formerly I27-I28) (Improta et al., 1998). In Z1Z2, the overall correlation time  τ
c
 of 14.2
ns (TENSOR2; Dosset et al., 2000) is below that expected for a rigid domain
arrangement (~20 ns) but distinctly different from the value of a mobile two-domain
construct (~9 ns) (Spitzfaden et al., 1997). Based on this comparison, Z1Z2 appears to
tumble as a fairly rigid body in solution in the nanosecond timescale. Its linker exhibits
certain rigidity, even that this is not as pronounced as that of Fn9-Fn10.
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DISCUSSION
Here we present a comprehensive, mechanistic analysis of the conformational dynamics
of an Ig-doublet from titin. This is based on the comparison of crystallographic models,
RDC conformers, 
15
N NMR relaxation values and low resolution SAXS data. Crystal
structures reveal the atomic details of the molecule, particularly of linker groups, but in
this study the presence of mixed conformers within one same asymmetric unit hints at the
influence of external forces on domain arrangement. RDC data allow determining
unbiased interdomain orientations in solution - albeit at a four-fold degeneracy - but
require the availability of a structural model for ready interpretability. To resolve the
RDC degeneracy, independent measurements are needed that confirm the calculated
domain orientation. In this study, this was achieved using SAXS data, which on their own
only allow a global description of the average molecular shape. To assess whether such
averaged conformations in solution result from possible dynamic-averaging due to
molecular flexibility or correspond to conformationally monodisperse samples, NMR
relaxation methods can be applied that measure motions in a polypeptide chain on a per
residue basis in the subnanosecond time scale. The study reported in this manuscript
combines all these methodologies to conclude on the conformational properties of Z1Z2.
Our findings suggest that Z1Z2 adopts a preferential conformation in solution, even if
the length of its three-residue linker (_10 Å) and the lack of Ig-Ig contacts could well
allow for complex modular motions. Structural models calculated independently using
RDC and SAXS agree excellently in revealing Z1Z2 in a semi-extended conformation
(Table 2; Fig 3b). Structural noise (Zweckstetter and Bax, 2002) and/or dynamical
averaging (Bertini et al., 2004) can account for a reduced consistency between crystal
structures and RDC values as seen here. The conformation calculated for Z1Z2,
however, is unlikely to merely correspond to an average of fast interconverting forms in
solution, since 15N relaxation data did not reveal fast motions within the linker region
(Fig 3d) and values are consistent with at least a semi-rigid arrangement.
The fact that little structural restrictions oppose interdomain re-arrangements in Z1Z2
suggests that this might undergo moderate or even long-range motions either derived
from relatively slow dynamics (below the NMR time scale) or adaptation to a local
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environment, for example an induced-fit to a binding partner or a crystalline lattice. The
several Z1Z2 conformations identified to date (Fig 4a) confirm that these events do, in
fact, take place. The extended crystal structure of Z1Z2 identified in this study is closely
related to the preferential state in solution but it has a wider hinge opening (Table 2),
likely to reflect an accommodation to lattice interactions. The compact crystal model,
however, appears to represent a lowly populated state in solution. The fact that this is
enriched in the crystal indicates that it is favoured by the crystallization medium and/or
selectively incorporated into the lattice. Considering that the conformational energy of
Z1Z2 must account for hinge geometry as well as Ig-Ig interactions, it is feasible that
cadmium binding, the only prominent interdomain contact in this case, could have
driven and locked the molecule into this state. This metal, abundant in the
crystallization medium, is unlikely to be physiologically relevant. This is supported by
the fact that metal ions were not found in the crystal structure of Z1Z2 complexed to
telethonin (Zou et al., 2006).
Z1Z2 bound to telethonin is fully extended (Zou et al., 2006) (Table 2, Fig 4a), probably
resulting from an induced-fit of Z1Z2 permitted by its adaptable linker. The interaction is
highly selective, even that it merely relies on main chain groups that mediate the
formation of an intermolecular β-sheet and, as shown by mutagenesis (Zou et al., 2006),
it is sequence independent. In titin, numerous Ig are encountered along the filament,
where pairs with similar linker length and close structural similarity to Z1 and Z2 are
abundant, particularly in the skeletal I-band section (Fig 4c) (Marino et al., 2005). Partner
recognition under these conditions could be expected to involve primarily steric criteria.
Hence, we speculate that the pre-existent conformation of Z1Z2, where interacting
surfaces are in a productive spatial arrangement, must contribute to an effective and
selective binding, whereas free inter-Ig motions would render such complexation
sterically and entropically unfavourable. This hypothesis is supported by recent dynamic
simulations (Lee et al., 2006) in which crystallographic coordinates of Z1Z2 in its
complexed state were freed from the telethonin partner and equilibrated on its own in
solution. Results showed how the linker region changed its geometry from fully extended
to slightly bent, so that the angle between domains decreased Conformational dynamics
of Z1Z2
to 137° at the end of the simulation, which is in agreement with the experimental
conformation of Z1Z2 in solution calculated in the current study (Table 2).
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The comparative analysis of Z1Z2 conformations reveals the molecular mechanisms of
linker adaptability and, thus, of interdomain motions. In the conformations so far
identified, variations in hinge opening are associated with domain torsions, as revealed
by the direction of the inter-rotation axes (Fig 4a). Structures of free Z1Z2 show that an
acute domain closure can be achieved by rotation around a single main chain bond. On
the other hand, interconversion of the several extended arrangements involves only
slight rotations of the linker groups. Interestingly, both in the acute hinge closure and
the extended domain variations observed in this study, residue A99 constitutes the
central mechanical point of torsion (Fig 4b), probably because of the absence of a
hindering side chain. Even that moderate domain re-arrangements across extended
conformations involve only minor alterations of the linker, NMR relaxation data show
that modular dynamics is restricted in Z1Z2. This is unusual, given the absence of Ig-Ig
contacts and the relatively long linker. Data available on other poly -Ig and -Fn
proteins indicate that, commonly, modules within tandems stabilize their respective
orientations either by close domain-domain interactions, such as in fibronectin (Leahy
et al., 1996), or by stiffening the conformation of its linker sequences, as cadherin
which uses calcium binding (Boggon et al., 2002). The linker of Z1Z2 appears to be
semi-rigid, deformable, but not freely flexible. This might be due to its minor
hydrophobic component (Fig 1b), which could be speculated to act as a “greasy”
domain interface allowing viscous domain oscillations but preventing free motions.
Extreme domain rearrangements such as that of the compacted Z1Z2 alter the
disposition of hydrophobic groups significantly and, in the absence of compensatory
inter-domain forces, might be unfavourable.
Long poly-Ig tandems predominate in the I-band of titin (Fig 4c). Their elastic properties
are central to the passive mechanics of the sarcomere (references within Granzier and
Labeit, 2004). Understanding the mechanical function of these tandems intrinsically
requires knowledge of their conformation and dynamics. Z1 and Z2 share high structural
resemblance to modules in the prominent skeletal I-band fraction (Fig 4c), which are
characterized by conserved sequence motifs at their N-terminal loop cluster (for a
description of Ig and linker conservation at the I-band see Marino et al., 2005).
Furthermore, the linker length of Z1Z2 coincides with that of the regularly interspersed
super-repeats pairs (Fig 4c). NMR relaxation data on Z1Z2 are consistent with those
reported for I91-I92 (formerly I27-I28) from the distal I-band (Improta et al., 1998),
suggesting that I-band modules and Z1Z2 exhibit comparable dynamics even that I91 and
I92 do not retain conservation of its N-terminal loop cluster. As in Z1Z2, I91-I92
appeared to show a small degree of bending respect to a fully linear conformation, with
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an estimated hinge opening value of ∼155° according to SAXS data (Improta et al.,
1998). Furthermore, calculations on a six-Ig fragment from the skeletal I-band, I65-I70,
based on electron microscopy and SAXS data and following a freely-joint chain polymer
model suggested a certain stiffness of the chain and an average opening angle between
any two-Ig in this fragment of ∼143° (Marino et al., 2005), in agreement with
observations in the current study. This indicates that the conformational dynamics of
Z1Z2 might be closely related to that of I-band Ig-tandems. Consequently, modules
within the I-band tandems of titin might resemble Z1Z2 in constituting adaptable,
modular formations with extended domain arrangements, characterized by a restricted
and slow dynamics - probably reflecting a certain viscosity due to small hydrophobic
interdomain surfaces. As in Z1Z2, it could be expected that at least the longer linkers (3-4
residues) of I-band pairs might be able to adopt a preferential conformation at
equilibrium in solution but could undergo long-range motions, likely to involve domain
torsions, when subjected to directed stretch-contraction forces in the sarcomere.
Additional data on poly-Ig arrays of titin will have to become available to confirm
whether this might constitute a generic conformational principle of the structure and
mechanics of this filament.
METHODS
Crystal structure determination
The cloning, expression and purification of Z1Z2 from human titin (residues 1-196;
EMBL X90568) have been recently reported (Zou et al., 2003). Crystallization used the
hanging-drop method. First, thin needles grew from 100 mM MES pH 6.5, 50 mM
CdSO4 and 1 M sodium acetate at a protein concentration of 30 mg/ml. The needles
were used for microseeding of solutions containing 100 mM MES pH 5.5, 200 mM
CdSO4, 400 mM sodium acetate and 1520 mg/ml protein. Crystals grew as clusters of
thin plates (thickness ∼15 µm). Single crystals were excised from the clusters.
For X-ray data collection, crystals were frozen at 100K in mother liquor solutions
Conformational dynamics of Z1Z2
134
supplemented with 30% [v/v] glycerol as cryoprotectant. Although initial diffraction was
measurable up to 1.5 Å resolution, radiation damage limited effective recordings to 2.0 Å
and required frequent recentering to irradiate fresh portions of the crystal. Data
processing used MOSFLM/SCALA (Leslie, 1992; Evans, 1993). Phasing was by
molecular replacement using a poly-alanine model derived from the single Ig domain of
telokin (1FHG) (approx. 40% seq. id. to Z1 or Z2 and accounting for 1/6 of the
asymmetric unit) as search model in AmoRe (Navaza, 2001). Five Ig domains could be
located, resulting in a correlation coefficient of 30.5% and R-factor of 49.9%. The sixth
domain was revealed in electron density maps after initial model refinement had taken
place. Manual model building used O (Jones et al., 1991), while refinement employed
overall anisotropic B-factor scaling, bulk solvent correction and restrained atomic B-
factor minimization in CNS (Brunger et al., 1998). Non-crystallographic symmetry
restraints were applied across individual domains during the early stages of refinement
and progressively released. Experimental data were divided into a working and a test set
using FREERFLAG (Collaborative Computational Project N. 4, 1994). The solvent was
built with ARP/warp (Perrakis et al., 2001) and validated visually in electron density
maps. The final model includes all protein residues for each Z1Z2 copy in the
asymmetric unit.
Model coordinates and structure factor amplitudes have been deposited at the
Protein Data Bank with accession code 2A38.
NMR spectroscopy
Spectra were acquired in 20 mM sodium phosphate buffer pH 6.8, 100 mM NaCl at a
protein concentration of 0.4 mM and 22oC. Spin-state-selective 15N-TROSY experiments
without 1H decoupling were recorded on a 15N-labeled sample to extract HN–N dipolar
coupling at 22oC on either a Bruker DMX600 or DMX500 spectrometer, both equipped
with a cryoprobe. A laterally compressed 7% polyacrylamide gel consisting of 50%
positively charged copolymer (cross-linking ratio 20:1): (3-acrylamidopropyl)-
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trimethylammonium (Ulmer et al., 2003; Cierpicki and Bushweller, 2004) with a
compression ratio of 17/23 was used as alignment medium.
Relaxation and Dynamics
Standard sets of 15N R1, R2, and (1H-15N)NOE relaxation experiments were measured at
800 MHz. The program TENSOR2 (Dosset et al., 2000) was used for data analysis.
NMR structure evaluation and calculation
RDC values can be calculated from the polar angles of the respective HN-bonds
in the alignment tensor frame, following:
RDC=Da*((3cos_2_1)*1.5*Rsin_2cos2_)(eq. 1), where Da and R specify
the axial component and the rhombicity of the tensor.
Values for Da and R were obtained either by SVD (Losonczi et al., 1999) or optimized
from a systematic grid search. A modification of the program Aria1.2/CNS was used for
structure calculation (Linge et al., 2001). This employs a non-crystallographic symmetry
term to harmonically restrain the coordinates of the individual domains to the respective
crystal structures. An artificial tetra-atomic molecule representing the axes of the
alignment tensor was allowed to float during the torsion angle dynamics period of the
refinement protocol (Clore et al., 1998). This allows reorientation of the domains to
match the experimental RDC during simulated annealing while a minor local
reorientation of the HN vectors is permitted. Hydrogens were added to the crystal
structures with CNS (Brunger et al., 1998). The final calculation of the domain
orientation used common Da and R values of -7 and 0.5 obtained from the powder
pattern, but results were essentially unchanged if other and/or two separate values were
employed. Torsion backbone angles calculated from chemical shifts (Cornilescu et al.,
1999) were added to restrain the conformation of the linker. 500 conformers were
computed in each calculation trial, of which the best 200 were refined in an explicit water
shell.
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SAXS
SAXS data were collected at X33, EMBL (DESY, Hamburg) using a linear gas detector
and at a wavelength _=1.5 Å. Solutions of Z1Z2 were measured at concentrations of 2.0,
5.0 and 10.0 mg/ml. Data acquisition and processing was as reported (Zou et al., 2003).
The low resolution model of Z1Z2 was constructed ab initio using the program GASBOR
(Svergun et al., 2001). The scattering from crystal structures and RDC models was
calculated using CRYSOL (Svergun et al., 1995). The volume fractions of mixed
populations of conformers were computed with OLIGOMER (Konarev et al., 2003).
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FIGURES
Figure 1: Crystal structure of Z1Z2
a. Superimposition of open- and close-hinge crystallographic conformations. To enhance
visualization of the domain torsion, _-sheets of Z1 are coloured differently. Metal ions
and coordinating protein residues are displayed. The rotation axis is shown, where the
magnitude of the rotation is ~155o (determined using DYNDOM; Hayward and Lee,
2002); b. Hydrophobic component of the linker region of open Z1Z2, where non-polar
groups are coloured green; c. (2Fobs-Fcalc)_calc electron density maps contoured at 1_ for
the open (above) and close (below) hinge conformations; d. Ramachandran plot for linker
residues in open- (black) and closed-(red) conformations;
Figure 2: RDC analysis
Comparison of experimental and calculated RDC values for a. Z1 and b. Z2 domains.
Experimental data are shown using a continuous line and small circles. The dotted line
represents calculated average values for the individual Ig of all three crystallographic
copies (Da=-7; R=0.5). Error bars indicate the corresponding lowest and highest values.
c. Comparison of domain orientations in models best satisfying RDC data resulting from
diverse refinement protocols. Backbone atoms are shown. d. Globe of NH vector
distribution (dotted lines). The alignment frame is depicted as solid lines, where z-, x-
and y- axes are denoted by a black, red and green sphere, respectively.
Figure 3: Conformational analysis of Z1Z2 in solution
a. Scattering patterns from Z1Z2 sample and its models: (1) experimental data;
scattering computed from (2) ab initio sphere model, (3) extended crystal model, (4)
compact crystal model, and (5) best SAXS-fitting RDC model. Insert: distance
distribution of Z1Z2; b. ab initio model of Z1Z2 (golden spheres) superimposed on
the best SAXS-fitting RDC model (wireframe). The views shown correspond to a -
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90o rotation around the vertical axis; c. Family of RDC conformers (n=200)
superimposed on Z1 composed of four defined conformational clusters. Conformers
are colour coded according to their fitting discrepancy to SAXS data as follows: red
indicates the best fitting cluster with χ values of 0.80-0.93, green corresponds to
χ=0.96-1.19; blue to χ=1.3-1.39; cyan to χ=1.20-1.50 and black to χ>2.22; c.
Heteronuclear NOE values per residue. Secondary structure elements are shown in
cyan. Linker groups are in red.
Figure 4: Inter-domain motions in Z1Z2 and relation to Ig-tandems of the I-band.
a. Stereo representation of models of Z1Z2 superimposed on Z2 (green). Z1 is coloured
coded so that dark brown represents the telethonin-bound form (9) (1YA5, where the
main area of interaction to telethonin is coloured purple), red shows the crystallographic
open form, orange the best SAXS-fitting RDC model and pink the closed crystal model.
Domain arrangements are described in Table 2. Inter-rotational axes are displayed, where
the axis in black relates telethonin-bound and crystal open Z1Z2; the axis in grey relates
the open crystal structure to the best SAXS-fitting RDC conformer; and the axis in blue
relates open and closed crystal models; b. Detailed view of the linker region of crystal
structures, where rotational axes are coloured as in a.; c. Poly-Ig composition of the I-
band of titin, where Ig domains and linker segments are represented by filled boxes. For
simplicity, N2A, N2B and PEVK elements are excluded. Constitutively and differentially
expressed I-band fractions are indicated, the latter being prominent in skeletal muscle. Ig
domains coloured orange are of the same type that Z1 and Z2, sharing a conserved N-
terminal loop cluster (as described in Marino et al., 2005). Linkers depicted in light blue
consist of very short sequences (0-1 residue), while longer linkers of comparable length
to that of Z1Z2 are shown in dark blue (3-4 residues). Super-repeats are indicated by a
capped-bar. Modules for which an atomic structure has been elucidated are marked by a
thick bar. Fragments boxed correspond to I91-I92, whose domain arrangement has been
analyzed by SAXS and its relaxation times by NMR, and I65-I70, whose conformational
parameters has been studied by SAXS and electron microscopy.
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Table 1: X-ray data statistics and model refinement parameters
Space group  P1
Unit Cell  (a, b, c) 55.40 Å, 56.29 Å, 74.41 Å
                 (α, β, γ) 71.96°, 88.49°, 75.41°
Beamline  X06SA (SLS)
Wavelength  0.920 Å
Resolution (Å) 20 – 2.0 (2.05 – 2.0)
Unique reflections 51011 (2876)
Completeness (%) 91.4 (69.4)
Rsym(I) (%) 9.2 (34.9)
<I>/σ(I) 8.9 (2.8)
Redundancy 1.8 (1.4)
R-factor / Rfree(%)& 20.91 /25.46
No. of Protein residues 582
No. of Solvent / Metal atoms 457 / 3
Ramachandran plot
          Favored / disallowed regions 93.2%  /  0%
Rmsd bonds (Å) / angles (o) 0.007 / 1.45
& The R-free set comprised 1296 reflections corresponding to 2.3% of the total data.
Table 2: Domain arrangements in Z1Z2 models
Open form Compact form RDC cluster best SAXS-fitting RDC Z1Z2:telethonin
Hinge opening angle (o) 146.3 36.7 / 37.6 131.2 ± 10.3               136        167
Domain torsion (o) +75 -99 +89.5 ± 10.2   +85        +48
Summary
149
 Summary
The primary objective of this study was to investigate the complex mechanism of regulation of
DMPK. CCs are thought to form dimeric arrangements in the DMPK-related family of kinases and
thus to mediate dimerization in these enzymes. We analyzed the oligomeric state of the CC domain
of DMPK using analytical ultracentrifugation and established that, in isolation, this motif forms
trimers as unique species.  Its crystallographic structure was elucidated to analyze inter-chain
interactions and establish the molecular principles of this unexpected level of association. Using
size exclusion chromatography combined with multi-angle static light scattering, we analyzed the
oligomeric state of DMPK as well as that of a truncated variant lacking the CC region.
Interestingly, both forms were found to associate into robust dimers. In contrast, DMPK-CC in
isolation is a trimeric motif, indicating that the self-assembly of DMPK is not dictated by the
association properties of its CC domain. Instead, it appears to be driven by sequence segments
flanking both N and C termini of the catalytic kinase fraction, as suggested by models of head-to-
head dimers based on small angle X-ray scattering data. In order to decipher the presence of a
possible structural element C-terminal to the kinase domain, native PAGE and sedimentation
velocity analyses of an N-terminally extended DMPK-CC were performed, however such motif was
not identified. In addition, the absence of interaction between DMPK-CC and other domains in
DMPK, suggested that a CC association/dissociation regulatory model such as that proposed for
MRCK and ROCKs might not be applicable for DMPK. Thus, we speculate that the oligomeric
state of this CC within the context of full DMPK must be dominated by the prior association of the
N-terminal catalytic fraction into dimers. In addition, DMPK is unlikely to interact with Rac1
through the CC region under the condition tested. A possible explanation might be that the GTPase-
kinase interaction needs of any region in DMPK out of the CC domain to be effective or even, the
level of assembly of DMPK-CC in isolation might not be the same than in the context of the full-
kinase. Given the heterogeneity in CC sequences and their diversified interaction patterns across
MDPK-related family of kinases, studies are required to reveal the exact role of these moieties and
to establish the principles of their regulatory mechanisms.
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